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ABSTRACT

Shih, Han. Ph.D., Purdue University, August 2016. Development of Orthogonally
Crosslinked Thiol-ene Hydrogels for Encapsulation of Pancreatic β-cells. Major
Professor: Chien-Chi Lin.
Type I diabetes mellitus (T1DM) is an autoimmune disease caused by autoreactive T-cell-mediated destruction of insulin-producing β-cells. Effective encapsulation
strategies can protect the transplanted islets from direct attack by host immune cells while
maintaining insulin secretion. To achieve this goal, I have developed a hydrogel
conformal

coating

using

a

visible

light-mediated

interfacial

thiol-ene

photopolymerization. Unlike conventional chain-growth visible light polymerizations, no
additional cytotoxic co-initiator or co-monomer was required in thiol-ene gelation
scheme for rapid gelation. More importantly, islets coated with thiol-ene gel maintained
their viability and function in vitro. In addition to microencapsulate β-cells, the second
objective of my dissertation focuses on developing a macroencapsulation technique using
thiol-ene hydrogel with bioactivity and anti-inflammatory property. While islet
transplantation holds potential in permanently reversing T1DM, this procedure initiates a
cascade of inflammatory processes. To address this issue, we have developed thiol-ene
hydrogel crosslinked by thiolated β-cyclodextrin (βCD). The conjugation of amphiphilic
βCD affords enhanced loading and prolonged release of curcumin, an anti-inflammatory
drug candidate but with poor water solubility. In addition, bioactive peptide such lamininderived peptide flanked with two cysteine residues could be readily incorporated through
orthogonal crosslinking, thus mimicking extracellular microenvironment in the pancreatic
islets. Finally, in order to provide coated β-cells with an ideal biomechanical
microenvironment, it is essential to identify a suitable gel stiffness to support the viability

xxi

and functions of β-cells. To this end, a thiol-allylether hydrogel with on-demand tunable
matrix stiffness was developed. Specifically, host molecule βCD was immobilized in the
hydrogel network to provide binding sites for soluble guest molecule poly(ethylene
glycol)-adamantane. Gel stiffness was tuned through introducing reversible host-guest
interactions. After in situ stiffening of the cell-laden hydrogel, the encapsulated β-cells
showed increased in insulin mRNA expression, suggesting the profound impact of matrix
stiffness on pancreatic β-cell fate.
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CHAPTER 1
INTRODUCTION

In 2012, 29.1 million of Americans were diagnosed with diabetes. Among them,
1.3 million have suffered from Type 1 diabetes mellitus (T1DM), which is an
autoimmune disorder caused by auto-reactive T-cells that destroy insulin-producing
pancreatic β-cells in the islets of Langerhans [1]. The destruction of β-cells leads to
inadequate insulin secretion, which leads to hyperglycemia. Current standard of therapy
to restore glucose homeostasis is through multiple daily insulin injections or implantation
of insulin delivery devices [2]. However, tight glycemic control through insulin
administration requires frequent monitoring of blood glucose levels. In addition, patients
experience various degrees of discomfort from exogenous insulin delivery. While whole
pancreas or islet transplantation can provide T1DM patients with insulin-independence,
these approaches are reserved for diabetic patients with hypoglycemia unawareness due
to a significant shortage of donor organs [3-5]. The outcome of islet transplantation,
however, is heavily influenced by blood mediated inflammatory response (IBMIR),
which can destroy more than half of the transplanted islets shortly after surgery [6-8].
Furthermore, patients receiving donor islets are required to undergo lifelong
immunosuppressant therapy. In order to improve the lifespan of transplanted islets,
scientists and engineers have been developing encapsulation technologies to separate
allogenic or even xenogenic islets from host tissues [9-18]. To this end,
microencapsulation and macroencapsulation strategies have been introduced as devices to
improve the outcome of islet transplantation [19-24]. Table 1.1 summarizes the
advantages and disadvantages of each encapsulation approach. A successful
permselective immune isolation barrier should be able to prevent infiltration of host
immune cells while permitting facile exchange of nutrients and metabolites,
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including oxygen, glucose, and insulin [2]. More importantly, this encapsulation strategy
should support the survival and preserve the functions of cells.

Table 1.1. Advantages and disadvantages of microencapsulation and macroencapsulation
techniques
Microencapsulation
Macroencapsulation
 Reduced diffusion barrier
 Easy to retrieve transplant
 Low transplant volume
 Easy to incorporate
biomolecules
Advantages
 Easy to characterize material
properties


Disadvantages


Difficult to retrieve
transplants
Difficult to incorporate
biomolecules
Difficult to characterize
physical properties of
materials




Hindered permeability
Higher transplant volume

The global goal for this dissertation is to develop microencapsulation and
macroencapsulation techniques for synthesizing biomimetic materials to overcome some
of the challenges facing islet transplantation. Thiol-ene hydrogels formed by radical
mediated photopolymerizations have emerged as a versatile biomaterial platform for
controlled release and tissue engineering applications. Chapter 2 of this dissertaion
includes the mechanisms and the applications of thiol-ene photopolymerization. During
my graduate studies, I have developed a cytocompatible visible light mediated stepgrowth thiol-ene polymerization scheme. The focus of this dissertation was to capitalize
on this innovative gelation chemistry for the development of microencapsulation and
macroencapsulation techniques to encapsulate β-cells. The following specific objectives
are proposed:

Objective

1:

Establish

a

visible

light

mediated

interfacial

thiol-ene

photopolymerization for microencapaulation of islets. In Chapter 3, a cytocompatible
visible light-mediated interfacial thiol-norbornene photopolymerization scheme was
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developed for creating hydrogel conformal coating on pancreatic islets. I investigated the
tunability of this microencapsulation technique, as well as the viability and function of
coated islets.

Objective 2: Synthesize biomimetic and anti-inflammatory thiol-ene hydrogel for
macroencapsulation of β-cells. To suppress the potential inflammatory response, I have
developed thiol-ene hydrogel crosslinked by either thiolated β-cyclodextrin (βCD)
derivative (Chapter 4). βCD derivatives were synthesized and characterized for the
crosslinking

of

βCD-PEG

hybrid

hydrogels

via

radical-mediated

thiol-ene

photopolymerizations. Further investigation was conducted on the delivery of a model
hydrophobic drug, and the testing of the cytocompatibility of these step-growth
hydrogels. To introduce biofunctionality to the otherwise inert thiol-ene hydrogels, in
Chapter 5, a laminin-derived peptide flanked with two cysteine residues were readily
incorporated through orthogonal crosslinking to recapitulate islets extracellular
microenvirnment to support β-cells survival.
Objective 3: Investigate the effect of biomechanical stimulus on the survival of βcells. Utilizing thiol-ene hydrogel that contains chemically immobilized βCDs, the
mechanical properties of the hydrogels could be tuned via host-guest interactions
between

βCD

and

adamantane

functionalized

PEG.

The

development

and

cytocompatibility of this hydrogel platform were included in Chapter 6. Most
importantly, I evaluated the effect of biomechanical changes on the viability and
functions of β-cells.
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CHAPTER 2
DYNAMIC CONTROL OF DEGRADABLE
THIOL-ENE HYDROGELS

2.1 Abstract

Thiol-ene hydrogels formed by radical mediated photopolymerizations have
emerged as a versatile biomaterial platform for controlled release and tissue engineering
applications. In this step-growth photopolymerization scheme, multi-arm poly(ethylene
glycol)-norbornene (PEGNB) reacts with dithiol or bis-cysteine containing cross-linkers
to form chemically cross-linked hydrogels. Thiol-ene hydrogels can be prepared via UV
light or visible light irradiation, depending on the type of photoinitiator used. Thiol-ene
reaction is not oxygen inhibited, which yields a rapid gelation kinetics. The step-growth
polymerization affords an idealized network structure with independently tunable
biochemical and biophysical matrix properties. Thiol-ene hydrogels can be rendered
completely non-degradable, degradable only by hydrolysis, proteolysis, photolysis, or by
the combination of different mechanisms. If PEG-ester-norbornene (PEGeNB) is used,
the gels can be degraded hydrolytically due to the presence of ester bonds within the
macromer. On the other hand, the use of PEG-amide-norbornene (PEGaNB) renders the
gels hydrolytically stable. If cell-mediated or user-controlled gel degradation is desired,
bis-cysteine peptide linker containing enzyme-sensitive or photolabile sequence can be
used to cross-linked the gels. The capability of thiol-ene hydrogels to undergo diverse
gelation and degradation permits researchers to design versatile hydrogel matrices
suitable for protein delivery and three dimensional (3D) cell culture. Due to the

Chaper 2 here is as appeared in Chapter 12 by H. Shih and C. Lin, Biodegradable Polymers. Volume 2:
New Biomaterial Advancement and Challenges, Editor: Chu CC. Nova Science Publishers. 2015, (ISBN:
978-1-63483-652-4)
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orthogonal nature of the thiol-ene reaction, post-gelation modification in the presence of
cells can be easily achieved, given that sufficient norbornene groups are available
following the initial gelation. This attractive feature allows researchers to introduce
biochemical motifs, in a spatial-temporally controlled manner, to guide cell
morphogenesis in 3D.

2.2 Introduction

2.2.1 Photopolymerization to Prepare Hydrogels

Photo-initiated radical polymerizations have received significant attention for in
situ cell encapsulation and controlled delivery of biological molecules, in large part due
to rapid and ambient gelation conditions and the stability of the covalently crosslinked
networks [25-30]. Synthetic macromers are increasingly developed for radical-mediated
hydrogel synthesis. Depending on the reactivity of the macromer functional groups,
hydrogels can be prepared from chain-growth, step-growth, or mixed-mode
photopolymerization [31]. In chain-growth photopolymerization (Figure 2.1A), vinyl
monomers/macromers are cross-linked into hydrogels due to propogation of carbonyl
radicals across the unsaturated vinyl groups. In step-growth photopolymerization, crosslinking occurs between two mutually reactive groups located on multi-functional
macromers (Figure 2.1B). A mixed-mode polymerization is the combination of both
chain-growth and step-growth polymerizations, given that the macromer used (e.g.,
poly(ethylene glycol) diacrylate) possesses reactivity in both mechanisms [32].
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A.

B.

Figure 2.1. Schematics of hydrogels formed by: (A) Chain-growth photopolymerization
using linear homo-bifunctional macromer to produce a heterogeneous network. (B) Stepgrowth photopolymerization of multifunctional and mutually reactive monomers. An
idealized network structure is produced using a stoichiometric molar ratio of the two
functional groups.

2.2.2 Photoinitiation Systems for the Polymerization of Hydrogels

Radical-mediated photopolymerization is a well-established technique to prepare
hydrogels for biomedical applications. Typically, a light source that emits lights in the
cytocompatible wavelengths (e.g., λ > 365 nm) is used to excite photoinitiator molecules.
Following light exposure, a type I or cleavage-type photoinitiator (Figure 2.2) readily
absorbs photons from the light source and decomposes into two primary radicals to
initiate gelation [33]. On the other hand, a type II photoinitiator abstracts hydrogen from
a co-initiator, thus generating secondary radicals that initiate crosslinking [33-35].
Adequate solubility of a photoinitiator in an aqueous solution and sufficiently high molar
absorptivity at cytocompatible wavelengths are major factors concerning the suitability of
a photoinitiator to initiate photopolymerization for preparing cytocompatiblie hydrogel.
Only a few photoinitiators fulfill these criteria, such as type I initiators Irgacure-2959 (I-
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2959, Figure 2.2A) [36, 37] and lithium arylphosphanate (LAP, Figure 2.2B) [38], as
well as type II initiator eosin-Y [34, 35, 39]. Commercially available I-2959 has low
water solubility (< 0.5 wt%) and low molar absorptivity at cytocompatible wavelengths
(e.g., at 365nm , ε < 10 M-1cm-1). In addition, I-2959 cannot be used in visible lightmediated photocrosslinking due to its near zero molar absorptivity at wavelengths higher
than 400 nm. While LAP is highly water-soluble (> 5 wt%) and has high absorbance at
365 nm (ε ~ 200 M-1cm-1), its excitability in visible light range is limited (ε ~ 30 M -1cm-1
at 405 nm) [38]. On the other hand, type II photoinitiator such as eosin-Y is highly water
soluble and can be readily excited by visible light (ε > 100,000 M-1cm-1 at 515 nm).
Eosin-Y has been used to initiate the gelation of chain-growth poly(ethylene glycol)
diacrylate (PEGDA) hydrogels. Unfortunately, a co-initiator (e.g., triethanolamine, TEA)
is required for generating sufficient radicals and a co-monomer (e.g., 1-vinyl-2pyrrolidinone, NVP) is often used to achieve high and rapid functional group conversion.
The adjustment of various gelation components can be complicated and this is perhaps
why UV-mediated photopolymerizations, even with potential biosafety concerns, is still a
preferred method for preparing hydrogels.
A.

B.

Figure 2.2. Photo-cleavage of type I photoinitiator I-2959 (A) and LAP (B).
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Chain-growth polymerized network
Hydrogels crosslinked by radical-mediated chain-growth photopolymerization
have been used for numerous drug delivery and tissue engineering applications. In
general, any hydrophilic macromer with terminal or internal vinyl groups can be crosslinked into hydrogel via chain-growth polymerization, as long as the vinyl groups are
capable of undergoing homopolymerization. Poly(ethylene glycol) diacrylate or
dimethacrylate (PEGDA or PEGDM, Figure 2.3) are among the most commonly used
macromers for preparing chain-growth hydrogels. Typically, a cleavage type
photoinitiator is used in conjunction with a UV light source to generate radicals for
initiating the cross-linking process. This reaction can be carried out in aqueous solution
and under mild reaction conditions, making it suitable for in situ protein or cell
encapsulation. The crosslinking density of the chain-growth hydrogels can be tuned by
adjusting light exposure time or by altering the concentrations of the starting macromers.
However, free radicals initially generated from photoinitiators have long half-life in
chain-growth polymerization due to the continuous propagation of the radical species
along the vinyl groups [40]. When performing in situ cell or protein encapsulation, these
radicals may increase cellular damage, protein denaturation, or undesired proteinpolymer reactions.

A.

B.

C.

Figure 2.3. Structures of PEGDA (A), PEGDM (B), and acryalted PLA-PEG-PLA (C).
Furthermore, these chain-growth hydrogels are typically non-degradable in a mild
aqueous environment. Degradable hydrogels are particularly useful as provisional
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matrices for tissue regeneration and as carriers for controlled protein delivery [41-44].
Among all degradation mechanisms, hydrolytic degradation of synthetic hydrogels has
received significant attention due to the simplicity of hydrolysis mechanism and welldefined polymer chemistry [45-47]. Although it is possible to render PEG hydrogels
degradable, it requires the synthesis of macromers with build-in degradability. For
example, hydrolytically degradable block co-polymer such as PLA-PEG-PLA (PLA:
polylactic acid) can be synthesized through ring-opening co-polymerization of PEG and
lactide. After end-capping the linear co-polymer with acrylates, the resulting macromers
(Figure 2.3C) can be polymerized into a chain-growth network with various degrees of
hydrolytic degradability, depending on the number of lactide units incorporated in the
PLA blocks. Hydrogels prepared from these block copolymers are hydrolyzed to form
lactic acid and PEG [45, 46]. The hydrolytic degradation rate of these hydrogels could be
tuned and predicted by using copolymers with different lengths of lactide repeating units
[45, 46].
In addition to the PLA-PEG-PLA copolymers, other hydrolytically labile
hydrogels were prepared by incorporating ester bonds to the termini of PEG macromers
prior to acrylation or methacrylation [48, 49]. Regardless of their degradability,
homopolymerized vinyl-based hydrogels contain heterogeneous and dense hydrophobic
polyacryalte kinetic chains (Figure 2.1A) that may cause adverse effects on the stability
of the encapsulated molecules. These high molecular weight polyacrylate kinetic chains
are not degradable [50], which could cause difficulty in clearance in vivo.

Step-growth thiol-ene network
In addition to chain-growth photopolymerized network, hydrogels can also be
prepared via a radical mediated step-growth photopolymerization. Anseth and colleagues
introduced a new class of PEG-based hydrogels formed by radical-mediated orthogonal
thiol-ene photo-click reaction [38]. In this system, low intensity and long wavelength (5 –
10 mW/cm2, 365 nm) UV light was used to generate thiyl radicals from thiol-containing
molecules (e.g., bis-cysteine-containing oligopeptides). These thiyl radicals react with
ene moieties on norbornene-functionalized multi-arm PEG to create orthogonal thiol-
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ether linkages and a step-growth network (Figure 2.4A). Central to this gelation scheme
is the multi-arm PEG macromers, which can be synthesized through either esterification
of hydroxyl-terminated multi-arm PEG with norbornene acid or amide bond formation
between amine-terminated multi-arm PEG with norbornene acid. The thiol-ene hydrogels
obtained from this thiol-ene photoclick chemistry can be degraded hydrolytically via
ester bond hydrolysis if PEG-ester-norbornene (PEGeNB) is used to form thiol-ene
hydrogels (Figure 2.4B). Conversely, the gels remain hydrolytically stable when PEGamide-norbornene (PEGaNB) is used (Figure 2.4C). This thiol-ene reaction scheme
preserves all advantages offered by photopolymerizations, including rapid, ambient, and
aqueous reaction conditions, as well as spatial-temporal control over gelation kinetics.
Furthermore, step-growth thiol-ene photo-click reactions are not oxygen inhibited [51],
which is beneficial for achieving rapid gelation compared with acrylate-based chaingrowth photopolymerizations at equivalent macromer functionality [52]. Comparing with
step-growth Michael-type gelation, thiol-ene photo-click reactions have reduced disulfide
bond formation due to radical-mediated cleavage [53], thus increasing the extent of
crosslinking and higher mechanical properties at a similar macromer content [38].
Furthermore, the orthogonal and step-growth nature of norbornene-sulfhydryl reaction
permits dynamic modification of hydrogel biochemical and biophysical properties in the
presence of cells [38]. Several cell types have been encapsulated successfully using thiolene hydrogels, including human mesenchymal stem cells [54], fibroblasts [38, 55],
fibrosarcoma [55], valvular insterstitial cells [56], and radical-sensitive pancreatic -cells
[52]. Enzymatically degradable peptides could be utilized to crosslink thiol-ene hydrogels
for creating an enzyme-responsive hydrogel network [57].
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A.

B.

C.

Figure 2.4. (A) Mechanism of radical-mediated thiol-ene photo-click reaction. (B)
Synthesis route of PEG-tetra-ester-norbornene (PEG4eNB). (C) Synthesis route of PEGtetra-amide-norbornene (PEG4aNB).
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Early works on thiol-ene gelation have focused on the use of UV light and
cleavage-type initiators. Recently, Lin and colleagues developed visible light mediated
thiol-ene gelation using a type II photosensitizer eosin-Y as the sole photoinitiator [58,
59]. Mechanistically, visible light (400-700 nm) excites eosin to abstract hydrogen atoms
from thiol-bearing molecules, which generate thiyl radicals that cross-link with
norbornene groups through the same radical-mediated thiol-ene photo-click reactions
(Figure 2.4A). In this gelation scheme, no co-initiator or co-monomer is needed to
achieve gelation, thus improves the cytocompatibility of the gelation system for in situ
cell encapsulation (Shih and Lin, 2013).

2.3 Thiol-ene Hydrogel Network Crosslinking

2.3.1 Improved gelation kinetics and efficiency

Hydrogels can be prepared by photopolymerization through either a chain-growth
or

a

step-growth

mechanism.

While

conventional

chain-growth

radical

photopolymerization is sensitive to inhibition by molecular oxygen, orthogonal thiolnorbornene or thiol-ene photo-click reaction is not oxygen inhibited. Therefore, it yields
rapid gelation kinetics and higher degree of functional group conversion [51, 60].
Experimentally, it was determined that at the same functional group concentration, the
gelation of step-growth thiol-norbornene reaction occurs 20-time faster than acrylatebased chain-growth photopolymerization (e.g., gel points of 3 to 7 seconds for thiolnorbornene reaction and 1 to 2 minutes for acrylate-based homopolymerization).
Hydrogels

prepared from thiol-norbornene

photopolymerization of PEG-based

macromers also have higher gel fraction and stiffness compared with acrylate-based
hydrogels with the same functional group concentrations [52]. For example, step-growth
hydrogels prepared from PEG4NB and a peptide cross-linker Cys-Gly-Gly-Tyr-Cys
exhibited consistently high gel fractions of 92-95%, whereas chain-growth hydrogels
based on homopolymerization of PEGDA only yielded gel fractions of 63-84%.
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Hydrogels with high gel fraction are desirable because the unreacted macromer
components (due to lower gelation efficiency) may leach out from the hydrogels and
complicated experimental results, especially for in vivo studies.

2.3.2 Improved network ideality

While

both

are

initiated

from

light-induced

radical-mediated

photopolymerization, step-growth thiol-norbornene hydrogels formed with multi-arm
PEG-norbornene (e.g., PEG4NB) have a completely different network structure
compared with chai-growth homopolymerization of PEGDA. Another hydrogel system
formed by a step-growth reaction is the Michael-type addition reaction. For example,
multi-arm PEG-acrylate or PEG-vinylsulfone reacts orthogonally with thiol-terminated
cross-linkers to yield a step-growth hydrogel network [61]. Although these step-growth
hydrogels are useful in in situ cell encapsulation and protein delivery, they are known to
have slower gelation kinetics at a physiological pH (minutes to hours) as compared with
radical-mediated step-growth thiol-ene gelation (seconds to minutes). Recently, Shih and
Lin compared the gelation kinetics of PEG-based hydrogels formed by these two types of
step-growth polymerized hydrogels, namely radical-mediated thiol-ene photo-click
reaction and Michael-type conjugation addition [62]. In this study, 4-arm PEGnorbornene (PEG4NB) and 4-arm PEG-acrylate (PEG4A) having the same molecular
weight (MWA = 20 kDa) and functionality (fA = 4) were used as the macromers, while
dithiothreitol (DTT) was used as a bi-functional (fB = 2) cross-linker in both systems. In
situ rheometry was used to monitor the gelation kinetics. As shown in Figure 2.5, the
radical-mediated thiol-norbornene gelation exhibited much faster (>250-fold faster) gel
points when compared with gelation caused by Michael-type addition reaction. Michaeltype hydrogels formed from PEG4A and DTT also had a significantly lower shear
modulus upon complete gelation.
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A.

B.

Figure 2.5. In situ rheometry of step-growth hydrogels: (A) Thiol−ene photoclick
polymerization (4 wt % PEG4NB-DTT). UV light was turned on at 30 s. (B) Michaeltype addition (4 wt % PEG4A-DTT). Temperature reached 37 °C at 15 s [62].
Apart from the difference in gelation kinetics, these two step-growth gelation
systems (i.e., thiol-norbornene and thiol-acrylate Michael-type) also exhibit different
degrees of network non-ideality. In principle, hydrogels prepared from an orthogonal
reaction should have the same network structure if there is no non-ideality in
polymerization. Specifically, at an identical macromer concentration and without any
structural defect, hydrogels crosslinked by these macromers should have the same degree
of crosslinking, which can be estimated by measuring hydrogel equilibrium swelling ratio
(q):
𝑞=

𝑊𝑆𝑤𝑜𝑙𝑙𝑒𝑛
𝑊𝐷𝑟𝑦

(2.1)

where WSwollen is hydrogel swollen weight and WDry is the dried polymer weight.
A perfectly crosslinked (or ‘ideal’) thiol-ene or Michael-type hydrogel network
without defects can be estimated by means of hydrogel equilibrium swelling [63].
Considering the structural information of the step-growth hydrogels (i.e., macromer
molecular weight and functionality), the average molecular weight between crosslinks
̅̅̅̅𝑐 ) is defined as [63]:
(𝑀
𝑀𝑊
𝑀𝑊
̅̅̅̅
𝑀𝑐 = 2( 𝑓 𝐴 + 𝑓 𝐵 )
𝐴

𝐵

(2.2)

Here, MWA and MWB represent the molecular weight of PEG4NB (or PEG4A)
and crosslinker, respectively. fA and fB are the number of reactive functionality for
PEG4NB (or PEG4A) and crosslinker. With a known ̅̅̅̅
𝑀𝑐 , the ideal network crosslinking
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density or density of elastically active chains (vc) and polymer volume fraction (v2) can
be calculated based on the Flory-Rehner theory [64]:
𝑉

1
𝑣𝑐 = ̅̅̅̅
=
𝑀 ̅̅̅
𝑣

−[ln(1−𝑣2 )+𝑣2 +ᵡ12 𝑣2 2 ]
2𝑣
𝑣2 1/3 − 2

𝑐 2

(2.3)

𝑓𝐴

Here, ̅̅̅
𝑣2 is the specific volume of PEG (0.92 cm3/g at 37 oC), V1 is the molar
volume of water (18 cm3/mole) and ᵡ12 is the Flory-Huggins interaction parameter for a
PEG-H2O system (0.45). After obtaining v2, ideal hydrogel mass swelling ratio q can be
obtained using the following equation:
̅̅̅
𝑣

2
𝑣2 = (𝑞−1)𝑣̅̅̅+𝑣
̅̅̅
1

2

(2.4)

where ̅̅̅
𝑣1 is the specific volume of water (1.006 cm3/g at 37 oC).
̅̅̅̅𝑐 ) of these
Based on Equation (2.2), the molecular weight between crosslinks (𝑀
two step-growth hydrogel systems without defect should be identical (neglecting the
minor difference in the molecular weight of norbornene and acrylate moiety) and was
calculated as 10,154 Da (Table 2.1). Thus, the ideal crosslinking density or density of
crosslinked elastic chains (vc) for these step-growth hydrogels was estimated to be
1.93×10-3 using Equation (2.3). Accordingly, the mass swelling ratio of a perfectly
crosslinked step-growth hydrogel (qeq, ideal) was calculated as 9.6 using Equations (2.3)
and (2.4) (Table 2.1 and dashed line in Figure 2.6). Experimentally, however, we found
that thiol-ene hydrogels, when compared to Michael-type gels at identical macromer
compositions, had lower mass swelling ratio (28.5 ± 2.2 vs. 44.5 ± 3.8) at the equilibrium
state [62]. This indicates that radical mediated thiol-ene hydrogels exhibit higher degree
of network ideality compared to gels formed from Michael-type addition. These results
confirmed a previous notion that radical-mediated thiol-ene reaction, when compared to
Michael-type conjugation reaction, produce step-growth hydrogels with faster gelation
kinetics, less structural defects, higher degree of crosslinking, and improved gel
mechanical properties [41, 65].
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Table 2.1. Characteristics of step-growth Michael-type and thiol-ene hydrogels [62]
̅̅̅̅
𝑴𝒄 (Da)

qeq, ideal

qeq, actual

PEG4A* (Michael-type)

10,154

9.6

44.5 ± 3.8

PEG4NB* (Thiol-ene)

10,154

9.6

28.5 ± 2.2

*4-arm PEG-derivatives (4 wt%, 20 kDa), crosslinked by DTT.

2.3.3 Tunable crosslinking density of thiol-norbornene hydrogels
Based on the Flory-Rehner theory, an ‘ideal’ step-growth network with a fixed
macromer composition and without defect should only have a single equilibrium swelling
ratio [62]. With the same gel formulation, the swelling ratio should be independent of
macromer concentrations at equilibrium swelling state. However, the experimental
equilibrium mass swelling ratios of thiol-norbornene hydrogels exhibited high
dependency on PEG4NB macromer concentration, indicating the existence of network
non-ideality (Figure 2.6). For instance, when the concentration of PEG4NB macromer
was increased from 4 wt% to 20 wt%, swelling ratios decreased from ~29 to ~12 and
approached ideal equilibrium swelling ratio (~9.6). Hydrogels with lower swelling ratios
(at higher macromer contents) had higher elastic moduli. This inverse relationship was
commonly observed in chain-growth polymerized hydrogel networks. The result
suggested a higher possibility of network defects formed at lower PEG4NB contents.
When cross-linked at a low macromer concentration, step-growth photopolymerization
tends to yield more intramolecular reactions (i.e., primary cycles) [63, 66, 67] . On the
other hand, at a higher macromer concentration, the probability of forming intermolecular
cross-linking increases. The outcomes of increased intramolecular reactions at lower
macromer concentrations include higher gel swelling and lower gel modulus (Figure 2.6).
Although thiol-ene hydrogels contain network defects at lower polymer contents, the
stiffness of these hydrogels is physiologically relevant (shear moduli between 1 to 10
kPa) and ideal for studying the influence of matrix stiffness on cell fate processes [68,
69].
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Figure 2.6. Effect of PEG4NB macromer concentration on thiol-ene hydrogel equilibrium
swelling (left y-axis) and elastic modulus (right y-axis). Swelling ratio of an ideal
̅̅̅̅𝑐 ) of given
network was calculated based on the molecular weight between crosslinks (𝑀
macromer molecular weights (MWPEG4NB = 20 kDa, MWDTT = 154 Da) and
functionalities (fPEG4NB = 4, fDTT = 2) [62].

2.4 Degradation of Thiol-ene Hydrogel

2.4.1 Hydrolytic degradation

In addition to the chain-growth polymerized hydrogels, step-growth polymerized
gels could also be rendered hydrolytically degradable. For example, Hubbell and coworkers developed Michael-type addition hydrogels through nucleophilic reactions
between acrylates on multi-arm PEG macromer and sulfhydryl groups on the crosslinkers
[63]. Thioether-ester linkages formed between acrylate and sulfhydryl moieties were
hydrolytically labile and the degradation rates of these hydrogels could be tuned by
controlling macromer concentration and functionality. Bowman and colleagues
performed experimental and theoretical investigations on hydrolytic degradation of stepgrowth thiol-acrylate and thiol-allylether photopolymers [66, 70-72]. Degradation was
readily tuned and predicted using monomers with different concentration, functionality,
and degradability. Leach and colleagues developed hydrolytically degradable Michaeltype hydrogels based on 4-arm PEG-vinylsulfone (PEGVS) and PEG-diester-dithiol [73,
74]. Degradation of these step-growth hydrogels was altered by tuning the number of
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methylene groups between the thiol and ester moieties in the PEG-diester-dithiol linkers.
In the above examples, acidic by-products (i.e., carboxylic acid) are obtained from the
ester hydrolysis mechanism.
Due to the presence of thio-ester bond forming between thiol and backbone PEG,
thiol-ene hydrogels can be rendered hydrolytically degradable. Metters and Hubbell
previously established a statistical-co-kinetic model for predicting the hydrolytic
degradation of step-growth Michael-type hydrogels. Due to structural similarities
between step-growth Michael-type and thiol-ene hydrogels, Shih and Lin utilized this
model to study the hydrolytic degradation of step-growth thiol-ene hydrogels and showed
the high predictability of thiol-ene hydrogels. Based on this model, the degradation of
thiol-ene hydrogels was assumed to be purely due to ester bond hydrolysis with a pseudofirst order degradation kinetics [45, 46]. With this assumption, the fraction of hydrolyzed
ester bonds (PEster) at any given time in the system is expressed as:
[𝐸𝑠𝑡𝑒𝑟]

𝑃𝐸𝑠𝑡𝑒𝑟 = 1 − [𝐸𝑠𝑡𝑒𝑟] = 1 − 𝑒 −𝑘

′𝑡

(2.5)

0

Here, k’ is the pseudo-first order ester bond hydrolysis rate constant [Ester] and
[Ester]0 are the current and initial numbers of intact ester bonds in the system.
The fraction of intact elastic chains (i.e., crosslinkers such as DTT or biscysteine containing peptides) within these crosslinked networks at any given time is
expressed as:
1 − 𝑃𝐶ℎ𝑎𝑖𝑛 = (1 − 𝑃𝐸𝑠𝑡𝑒𝑟 )𝑁 = 𝑒 −𝑁𝑘

′𝑡

(2.6)

where N is the number of degradable units (i.e., ester bonds) connected to one elastic
chain (e.g., N = 2 for the case of PEG4NB-DTT hydrogels).
To obtain the degree of crosslinking in the system, one must also consider the
connectivity of multi-arm PEG macromers. For an ideal step-growth network, the
fraction of fA-armed macromer with i arms still connected to the network at any time
point during ester hydrolysis is expressed as [63]:
𝐹𝑖,𝑓𝐴 = (𝑓

𝑓𝐴 !
𝐴 −𝑖)!𝑖!

(𝑓 −𝑖)

𝐴
𝑃𝑐ℎ𝑎𝑖𝑛
(1 − 𝑃𝑐ℎ𝑎𝑖𝑛 )𝑖

(2.7)

The crosslinking density of the degrading network is expressed as:
𝑓

𝑖

𝐴
𝑣𝑐 = (∑𝑖=3
𝐹 )[𝐴]0
2 𝑖,𝑓𝐴

(2.8)
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Here, i ≥ 3 because any fA-arm (fA ≥ 3) macromer with only two arms connected to intact
elastic chains forms an extended loop, rather than a crosslink.

[A]0 represents the

concentration of fA-arm macromers (e.g., PEG4NB) in the equilibrium swelling state
before the onset of network degradation, which is correlated to the crosslinking density of
a network:
𝑓

𝑣𝑐,0 = 𝑓𝐴 [𝐴]0

(2.9)

𝐵

When the functionalities of the macromer and crosslinker (fA = 4 and fB = 2) are
taken into account, the crosslinking density of a perfectly crosslinked thiol-ene network
in the equilibrium state could be derived from Equations (2.3) to (2.9) and expressed as:
′

′

𝑣𝑐 = (6𝑒 −3𝑁𝑘 𝑡 − 4𝑒 −4𝑁𝑘 𝑡 )[𝐴]0,𝑎𝑐𝑡𝑢𝑎𝑙

(2.10)

For gels with non-idealities or structural defects, [A]0,actual is obtained using actual
crosslinking density as:
[𝐴]0,𝑎𝑐𝑡𝑢𝑎𝑙 =

𝑣𝑐,𝑎𝑐𝑡𝑢𝑎𝑙
𝑣𝑐,𝑖𝑑𝑒𝑎𝑙

[𝐴]0

(2.11)

where vc,actual represents the experimental crosslinking density converted from
experimental mass swelling ratio using Equations (2.3) and (2.4) and vc,ideal represent
ideal crosslinking density calculated based on the molecular weight between cross-links:
̅̅̅̅
𝑀𝑐 .
The hydrolytic degradation of thiol-ene hydrogels was found to be pH-dependent.
It was demonstrated that PEG4NB-DTT hydrogels incubated in acidic condition (pH 6.0)
had an almost constant swelling ratio over a 45-day period, whereas hydrogels with the
same compositions exhibited increasing swelling over time in slightly basic conditions
(pH 7.4 and pH 8.0) (Figure 2.7). If the degradation follows the same ester hydrolysis
mechanism at an elevated pH value (e.g., from pH 7.4 to pH 8.0), degradation profiles at
different pH values could be described using a pseudo-first order equation [76]:
[𝐸𝑠𝑡𝑒𝑟] = [𝐸𝑠𝑡𝑒𝑟]0 𝑒 −𝑘

′ [𝑂𝐻 − ]𝑡

(2.12)

Through experimental curve fitting, it was shown that the degradation of thiol-ene
hydrogels was not solely governed by simple ester bond hydrolysis and other factors
could also play a role on the degradation rate of these thiol-ene hydrogels. A potential
explanation for this phenomenon is base-catalyzed oxidation of thioether bond forming
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between norbornene and thiol groups, which may be promoted at higher pH values.
Another possible reason for the lower-than-predicted degradation rate at higher pH values
was that the degradation process produced acidic by-products, which decreased acidity

Mass swelling ratio (q)

and retarded the degradation.
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Figure 2.7. Effect of buffer pH on mass swelling ratio of 4 wt% PEG4NB-DTT
hydrogels. Symbols represent experimental data while dashed curves represent
exponential curve fitting to the experimental data. The apparent degradation rate
constants (khyd) for gels degraded in pH 7.4 and pH 8.0 were 0.024 ± 0.001 and 0.057 ±
0.002 day-1, respectively. Solid curves represent model predictions with best-fit kinetic
rate constants: k’pH 7.4 = 0.011 day-1 and k’pH 8.0 = 0.027 day-1. No curve fitting or model
prediction was made for gels degraded in pH 6.0 due to the stability of gels in acidic
conditions.

In addition to the influence of pH, degradation rate of thiol-ene hydrogels can be
affected by other factors such as macromer concentrations. Theoretically, thiol-ene
hydrogels formed at a higher macromer concentration have a higher degree of network
crosslinking. The later property is directly correlated to the concentration of thiol-etherester bonds formed in the network. Experimentally, it was demonstrated that given the
same amount of time and hydrated environment, thiol-ene hydrogels with higher degree
of network crosslinking would degrade slower. The degree of network crosslinking can
also be altered by changing the ratio of thiol to ene. At higher thiol-to-ene ratio, higher
network crosslinking (e.g., higher [A]0) led to slower rate of degradation. Furthermore,
hydrolytic degradation rate of thiol-ene hydrogels can be affected by the sequence of biscysteine-bearing peptide linker. Hydrogels crosslinked by peptides containing aromatic
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(e.g., Cys-Gly-Gly-Tyr-Cys or CGGYC) or hydrophobic (e.g., Cys-Gly-Gly-Leu-Cys or
CGGLC) residues yielded slower degradation rates compared to gels crosslinked by
peptide linker without side group (i.e, Cys-Gly-Gly-Gly-Cys or CGGGC), potentially due
to steric hindrance and hydrophobic effect of tyrosine and leucine residues that retarded
degradation [62].

2.4.2 Enzymatic degradation

Thiol-ene hydrogels can be rendered enzymatic degradable when protease
sensitive peptides are used as gel cross-linkers. The termini of these peptides are usually
flanked with cysteine residues to provide sylfhldryl groups needed for the orthogonal
thiol-ene photo-click reactions. Enzyme-sensitive thiol-ene hydrogels can serve as
carriers for delivering therapeutic agents in response to specific enzymatic activity, which
causes cleavage of the peptide cross-linkers. For example, Aimetti et al reported a human
neutrophile elastase (HNE) responsive thiol-ene hydrogels for delivering therapeutic
agents on demand [57]. Lin et al. reported a cymotrypsin degradable peptide (i.e., CysGly-Gly-Tyr-Cys, CGGY↓C) for enzyme responsive recovery of pancreatic β-cell
aggregates from thiol-ene hydrogels [52]. In Figure 2.8, a linear relationship for hydrogel
mass loss as a function of time suggests that the enzymatic degradation of thiol-ene
hydrogels was governed by a surface erosion mechanism. A significantly faster rate of
erosion was observed when hydrogels were incubated in solution with higher
chymotrypsin concentration [52].
In addition to utilizing a surface erosion mechanism to release drugs or cells,
thiol-ene hydrogels can also be used to study cellular behaviors, such as proliferation and
migration that are related to local enzymatic reactions. During these processes, cells can
secrete enzymes such as the matrix metalloproteinases (MMPs). When a hydrogel is
cross-linked with a peptide senstive to MMPs, the local protease activity can cause
peptide cleavage and reduction in local gel cross-linking density. This process permits the
cells to explore their neighboring matirx, which has been shown to improve tissue
regeneration

[77].

In

particular,

bis-cysteine

MMP

sensitive

peptide

(i.e.,
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KCGPQG↓IWGQCK) has been used as a crosslinker for encapsulating cells in thiol-ene
hydrogels [54]. It has been shown that cells, such as hMSCs or pancreatic cancer PANC1 cells, secrete MMPs to cleave thiol-ene hydrogels as they spread or proliferate [54, 78,
79]. Although this type of enzymatic degradation is mostly restricted to local cellular
activites, significant reduction in bulk gel mechanical properties could also be observed
after prolong culture.

Figure 2.8. Effect of chymotrypsin concentration on mass loss of PEG4NB-CGGYC
hydrogel (4wt% PEG4NB, N = 3, mean ± SEM) [52].

2.4.3 Photolytic degradation

There is a growing interest in the development of biomimetic materials with
dynamically tunable gel properties during the course of the studies. For example,
macromers with photolabile groups can be used to fabricate hydrogels with dynamically
tunable cross-linking density. This will allow users to change gel biomechanical (i.e.,
reduction of gel cross-linking density) or biochemical properties (e.g., removal of
pendent bioactive motifs) through additional light-mediated bond cleavage. Additionally,
drugs or cells immobilized/entrapped within a photodegradable gel can be released on
demand via light-induced matrix degradation. The cleavage of photolabile linkers can
lead to the reduction of matrix stiffness that allow one to observe the influence of matrix
properties on cell fate processes [80, 81].
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Currently available photolabile units often contain an ortho-nitrobenzyl (o-NB)
moiety that is highly susceptible to UV light. The absorbance of o-NB-containing
macromers usually peaks between 280-400 nm [81-84]. When exposing to lights at these
wavelengths, o-NB groups are effectively photo-lysed. This photolysis reaction liberates
the initially immobilzied molecules or reduces the gel cross-linking density. Current
methods to prepare photodegradable hydrogels are restricted to non-photo-mediated
process, such as redox reactions, thermal polymerizations, Michael-type conjugations, or
orthogonal ‘click’ chemistries [53, 75, 81, 85-87]. Photodegradable hydrogels can also be
synthesized by photopolymerization, given that an appropriate photopolymerization
system is utilized such that the photodegradable unit remain intact during network
formation. Ki et al. recently reported the synthesis of photodegradable step-growth thiolene hydrogels by visible light-initiated thiol-ene photo-click reactions. A visible light
source was utilized to excite eosin-Y, which initiated the cross-linking of PEG4NB and
linker dithiothreitol (DTT) [80]. This new step-growth hydrogel system preserves the
favorable preoperties offered by photochemistry, including photopolymerization and
photodegradtion. Visible light wavelengths (400-700nm) were used to photopolymerized
the thiol-ene hydrogels, whereas an orthogonal wavelength (302nm and 365nm) was used
to cleave the peptide linker (Cys-Gly-NPA-Gly-Cys) containing a photolabile amino
acid, L-2-nitrophenylalanine (NPA) (Figure 2.9A). The rate of hydrogel degradation was
easily manipulated by wavelength and UV light intensity. As shown in Figure 2.9B,
shorter wavelength and higher light intensity resulted in faster rate of photolysis. The
applications of this simple photodegradable thiol-ene hydrogel include patterning of
bioactive motifs in a spatial-temporal fashion, and releasing of biomolecules that are
tethered with photolabile group.
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Figure 2.9. (A) Schematic of visible light mediated photo-crosslinking and UV-mediated
photodegradation of step-growth thiol-ene hydrogels crosslinked by PEG4NB and
photolabile peptide CGOGC (O: L-2-nitrophenylalanine). (B) Effect of different
wavelength UV lights (302 or 365 nm, 10 mW/cm2) on reduction of residual hydrogel
mass (N = 3, mean  SEM) [80].

2.4.4 Multifaceted degradation mechanisms

While the radical-mediated thiol-ene hydrogels can be designed to be degraded
via hydrolysis, proteolysis, or photolysis, it is also possible to combine several
degradation mechanisms into one hydrogel matrix. For instance, a simple dual-mode
enzymatic and hydrolytic degradable hydrogel was created without altering hydrogel
molecular structure or hydrophilicity [62]. As shown in Figure 2.10, thiol-ene hydrogels
were cross-linked by non-cleavable CGGGC and chymotrypsin-sensitive CGGY↓C
peptides at various compositions [62]. When these gels were exposed to chymotrypsin
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solution, hydrogels containing high percentage of CGGYC cross-linker (100−75%)
eroded in a surface erosion mechanism, evidenced by linearly increasing mass loss
profiles with time. When the total content of CGGYC peptide was decreased to 50 and
25%, chymotrypsin treatment led to increased gel mass (i.e., negative mass loss). This
indicated the protease treatment led to a “loosened” gel structure and increased water
uptake. Under this condition, the degradation mode was likely transitioned from a surface
erosion mechanism to a bulk degradation mechanism. On the other hand, chymotrypsin
treatment had no effect on the swelling or mass loss of thiol-ene hydrogels cross-linked
by purely non-chymotrypsin sensitive linker (CGGGC). These results suggested that by
combining peptide cross-linkers with various protease sensitivities, the degradation
behaviors of thiol-ene hydrogels could be manipulated between surface erosion and bulk
degradation for dynamically controlled growth factors or drug delivery.
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Figure 2.10. Effect of peptide crosslinkers on PEG4NB-peptide hydrogels
erosion/degradation. PEG4NB hydrogels crosslinked by different percentage of
chymotrypsin sensitive (CGGYC) and non-degradable (CGGGC) peptides. Figure
legends indicate the percent molar ratio of CGGYC:CGGGC. (4 wt% PEG4NB-peptide
hydrogels, pH 7.4, N = 4) [62]

26

2.5 Applications of Thiol-ene Hydrogels in
Controlled Release and Tissue Engineering
2.5.1 Protein delivery

Protein therapeutics (e.g., gorwth factors, cytokines, chemokines, etc.) play an
important role in promoting wound healing and tissue regeneration. In situ encapsulation
of proteins in chemically cross-linked hydrogels has been a favorable option due to the
simplicity of material prepration and drug loading process. Releasing proteins from a
hydrgoel can positively affect the healing/regeneration process of a damaged or diseased
tissue. When co-encapsulated with cells, the network-entrapped proteins can also direct
cell fate processes within the hydrogels. However, maintaining the structural integrity
and bioactivity of a protein-based biomacromolecule during network corss-linking has
proven a challenging task, in large part due to the presence of reactive radical species [40,
57]. For example, Lin and Metters demonstrated a significant reduction of structural and
functional integrity of model proteins bovine serum albumin (BSA) and lysozyme in
chain-growth photopolymerized PEGDA hydrogels, as well as the effect of
photoinitiators on protein bioactivity [88]. McCall and Anseth later compared the
influence of chain-growth and step-growth photopolymerized hydrogels on the stability
of lysozyme and transforming growth factor β (TGFβ) [40]. A 1000-fold increase in
bioactive protein recovery was observed in thiol-ene hydrogels compared to chain-growth
PEGDA hydrogels. Results of this study demonstrated that thiol-ene click reactions are
capable of forming a cross-linked network more rapidly at a lower initiator concentration
and with little to no impact on protein bioactivity. The highly efficient and orthogonal
thiol-ene reaction, together with its non-oxygen inhibited nature, preserves the structure
and function of sensitive proteins.
In addition to preserving the bioactivity of encapsulated proteins, thiol-ene
hydrogels are also a class of versatile matrices for sustained and stimuli-responsive
protein delivery. For example, Aimetti et al. have developed an enzyme-responsive thiolene hydrogels with potential for delivering anti-inflammatory drugs in responding to
human neutrophil elastase (HNE), a protease secreted by neutrophil [57]. The hydrogels
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were cross-linked by low molecular weight PEGNB macromer and HNE-sensitive biscysteine-bearing peptides. The sequences of HNE-sensitive peptide substrates were
systematically altered, from which to identify appropricate sequences for rapid linker
cleavage and subsequent liberation of the otherwise entrapped proteins. The release of
model protein was purely governed by matrix cleavage and proceeded in a surface
erosion manner. Ideally, this system can be used to release anti-inflammatory drugs upon
the onset of inflammation.
Thiol-ene hydrogels could also be formulated into microgels. Murphy and
colleagues used aqueous two-phase separation, in conjunction with radical-mediated
thiol-ene photopolymerization, to prepare micro-scale hydrogels [89]. Affinity peptides
capable of sequestering vascular endothelial growth factor (VEGF) were also
immobilized within the permeable hydrogels. This molecular sequestering approach
increased the binding and sustained the release of VEGF in vitro, which affected the
proliferation of human umbilical vein endothelial cells. More recently, Fraser et al.
prepared microgels formed by visible light mediated thiol-ene photopolymerization using
eosin-Y as the photoinitiator [90]. Through a sequential thiol-ene polymerization, a thin
gel coating was formed on the core microgels. Although not demonstrated in that
publication, the multilayer microgels can be used to regulate the rate of drug release.

2.5.2 3D cell culture

In addition to the mild and rapid reaction kinetics, radical-mediated thiol-ene
hydrogels have high cytocompatibility for cells derived from either mesenchymal or
epithelial origins. Thiol-ene hydrogels have been used to encapsulate a host of
mammalian cells, including fibroblasts [38, 55], valvular interstitial cells (VICs) [56],
HT1080 fibroscarcoma [55], human mesnechymal stem cells [54, 78], pancreatic β-cells
[52], pancreatic ductal epithelial cells [79, 91], and embryonic stem cells [92]. Thiol-ene
hydrogels impreganated with bone morphogenic protein 2 (BMP2) have also been used to
accelerate bone healing (as compared to commercially available BME-2 delivery matrix)
in vivo. Although the cross-linking of thiol-ene hydrogels is initiated by light sensitive
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photoinitiators, the concentration of radicals needed to initiate rapid gelation is orders of
magnitude lower than that in chain-growth polymerization, in large part due to the nonoxygen-inhibited nature of thiol-ene reaction. This is significant because during the
encapsulation process, some cells are prone to damage induced by free radicals. Insulin
producing β-cells are one type of radical-sensitive cells. Lin and colleagues compared the
differentces in chain-growth PEGDA and step-growth thiol-ene hydrogels in terms of
gelation kinetics and cytocompatibility using a pancreatic β-cell line, MIN6. It was found
that thiol-ene hydrogels were more cytocompatible than conventional PEGDA hydrogels
for MIN6 cells. Furthermore, β-cells were able to proliferate into spheroids within these
thiol-ene hydrogels [52, 59]. The cell spheroids could be recovered upon enzymaticmediated cleavage of the step-growth hydrogel network.
Using PEG-norbornene macromers and protease-sensitive peptides as the gel
cross-linkers, local matrix remodeling can be dictated by local cellular activity. Thiol-ene
hydrogels can also be prepared to be degradabled hydrolytically and/or proteolytically, or
completely non-degradable (Figure 2.11). The tunable degradability of the thiol-ene
hydrogels allows one to examine the influence of microscale network properties on the
encapsulated cell fate. For example, Anseth and colleages utilized thiol-ene hydrogels
with different degree of matrix metalloproteinase (MMP) degradability to evaluate the
potential of thiol-ene hydrogels as a 3D cell culture platform. MMP-sensitive peptide
flanked with terminal cysteines (e.g., KCGPQGIWGQCK) was mixed with non-labile
PEG-dithiol in different ratios [54]. The resulting thiol-ene hydrogels exhibited different
degrees of protease sensitivity. The facile incorporation of CRGD motifs rendered the gel
adhesive to the encapsulated human mesenchymal stem cells (hMSCs). Results showed
that thiol-ene hydorgels were highly suitable for culturing and differentiate hMSCs.
Following Anseth’s work, a recent study utilized two PEGNB macromers that are
hydrolytically labile or hydrolytically stable to evaluate the effects of single-mode
(purely hydrolytic or enzymatic) or dual-mode (hydrolytic and enzymatic) network
degradation on hMSCs viability and morphology [78]. It was found that dual-mode
degradable thiol-ene hydrogels provided a more cytocompatible environment for
promoting cell survival, proliferation, and morphogenesis in 3D. The results in the study
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demonstrated significant influence of network degradation and cell-mediated matrix
remodeling on cell fate process.
A.

B.

Figure 2.11. (A) Schematics of a thiol-ene cross-link. Arrows indicate potential cleavage
sites. (B) Different modes of thiol-ene hydrogel degradation. PEG-ester-norbornene (R =
O) or PEG-amide-norbornene (R = NH) can be used to construct gels with different
hydrolytic degradability (only one arm is shown). With a proper combination of
macromer and cross-linker, thiol-ene hydrogels can undergo different modes of
degradation and produce different degradation products.
Recently, thiol-ene hyodrgels were used to study cancer cells in 3D. Lin and
colleagues have established a highly tunable biomimetic thiol-ene hydrogel platform for
studying the growth and morphogenesis of pancreatic ductal epithelial cells in 3D [79,
91]. The thiol-ene hydrogels were tuned to render the otherwise inert PEG environment
responsive to epithelial cell morphogenesis. The growth and morphological changes in
PANC-1 cells, a pancreatic ductal adenocarcinoma cell line, were affected by macromer
molecular weight, gel stiffness, cross-linker chemistry, and additional cell-matrix
interaction. The use of MMP-sensitive or RGDS-immobilized gels promoted the
formation of cyst-like cell clusters, whereas the cell clusters proliferated from single cells
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were more compact and exhibited epithelial cell phenotype in non-MMP sensitive or
YIGSR-immobilized gels [79]. Furthermore, thiol-ene PEG-peptide hydrogels serve as a
promising platform for evaluating the efficacy of peptide drugs toward pancreatic cancer
cells in 3D. The viability of PANC-1 cells under the influence of epidermal growth factor
receptor (EGFR) inhibition was altered by the dosage of the inhibitor and by the
conditions of the matrix in which the cells reside [91]. The use of 3D hydrogel matrices
with adaptable and well-defined biophysical and biochemical properties may facilitate the
identification of anti-cancer drugs that are effective in tumor tissues but with minimal
side effects to normal tissues.

2.6 Conclusion

In

summary,

thiol-ene

hydrogels

formed

by

radical

mediated

photopolymerizations have emerged as a versatile biomaterial platform for controlled
release of therapeutics and tissue engineering applications. Thiol-ene hydrogels have
improved network crosslinking than the conventional chain-growth PEGDA and stepgroth Michael-type addition hydrogels. Depending on the type of photoinitiator used,
thiol-ene hydrogels can be prepared via UV light or visible light irradiation. Thiol-ene
hydrogels can be rendered completely non-degradable, degradable only by hydrolysis,
proteolysis, photolysis, or by the combination of different mechanisms. The diverse
gelation and degradation of thiol-ene hydrogels offer researchers a new platform to
design hydrogel matrices suitable for protein delivery and three dimensional cell culture.
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CHAPTER 3
VISIBLE LIGHT-INITIATED INTERFACIAL
THIOL-ENE PHOTOPOLYMERIZATION FOR
FORMING ISLET SURFACE CONFORMAL COATING

3.1 Abstract

A visible light-mediated interfacial thiol-ene photopolymerization scheme
was developed for creating an immunoisolation coating on islets. Islets were stained
with photoinitiator eosin-Y, followed by sequential incubations in macromer
solutions. Upon visible light exposure, a step-growth thiol-ene hydrogel was formed
around islets. The coated islets maintained viable in vitro.

3.2 Introduction

Type 1 diabetes mellitus (T1DM) is an autoimmune disorder caused by autoreactive T-cells that destroy insulin-producing pancreatic β-cells in the islets of
Langerhans [1, 93-95]. The direct outcome of β-cell destruction is hyperglycemia due to
the lack of insulin secretion. Current gold standard of therapy to restore glucose
homeostasis is insulin administration, such as insulin injections or implantation of insulin
delivery devices [2]. However, tight glycemic control through insulin administration
requires frequent monitoring of blood glucose levels, and all forms of exogenous insulin
therapy cause various degrees of patient discomfort. While whole pancreas or islet
transplantation can provide T1DM patients with insulin-independence, these approaches

Chaper 3 here is as appeared in H. Shih, R.G. Mirmira and C. Lin, Journal of Materials Chemistry B,
2015(3) 170-175
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are reserved for diabetic patients with hypoglycemia unawareness due to a significant
shortage of donor organs [3-5, 96, 97]. In addition, patients transplanted with allogenic
islets are required to receive prolonged immunosuppressant therapy, which unfortunately
cannot prevent instant blood mediated inflammatory response (IBMIR) that often
destroys more than half of the transplanted islets shortly after surgery [6-8].
In a hope to improve the lifespan of transplanted islets, scientists and engineers
have been developing encapsulation technologies to immunoisolate allogenic or even
xenogenic islets from host tissues [9-18]. A few critical considerations of islet
encapsulation are the cytocompatibility of the encapsulation process, the stability of the
coating, and the permeability of the barrier. A successful permselective immune isolation
barrier should be able to prevent infiltration of host immune cells while permitting facile
exchange of nutrients and metabolites, including oxygen, glucose, and insulin [2].
Existing encapsulation technologies include macromolecular self-assembly [13, 15, 98],
cell surface engineering [13], and covalent crosslinking of hydrogels [2, 99]. For
example, islets can be encapsulated in polyplexes formed by layer-by-layer (LbL) selfassembly between ionic macromolecules (e.g., polyanionic alginate with divalent barium
or calcium cation) [100-102]. Recent work has explored multi-layer coatings formed by
affinity

binding

between

labeled

macromers

(e.g.,

biotinylated-PEG-N-

hydroxysuccinimide, streptavidin, and biotin-peptide) [103, 104], and hydrogen bonding
between polar macromers (e.g., poly(N-vinylpyrrolidone) and tannic acid) [105]. The
long-term stability of these physically assembled coatings depends highly on the microenvironmental conditions in the transplantation site, such as pH and ionic strength [106,
107]. Alternatively, islets can be encapsulated through cell surface engineering. In one
example, islets were functionalized with hetero-bifunctional maleimide-poly(ethylene
glycol)-lipid (maleimide-PEG-lipid), which was subsequently reacted with thiolcontaining molecules via thiol-maleimide Michael-type addition [20, 108, 109]. The
drawbacks of this maleimide-based coating chemistry are slow gelation rate (from
minutes to hours) [63, 73, 110], and potential cytotoxicity of maleimide moieties that
may not be ideal for islet cell encapsulation [111].
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Hubbell and colleagues pioneered an islet conformal coating technique based on
visible light-initiated chain-growth photopolymerization [9, 19, 112-115]. The coating
process starts with staining islets with a type II photoinitiator, eosin-Y. The stained islets
are then incubated in a precursor solution containing macromer PEG-diacrylate
(PEGDA), co-initiator triethanolamine (TEA), and co-monomer N-vinylpyrrolidone
(NVP). Upon exposure to a visible light source, eosin-Y on islet surface initiates
interfacial photopolymerization. Thickness of the coating could be controlled by light
exposure time, as well as the concentrations of PEGDA macromer, co-initiator, and comonomer [112]. Although this technique achieved early success in animal and nonhuman primate models [116], the chain-growth polymerization scheme suffers from the
potential cytotoxicity of co-monomer and co-initiator [117, 118], as well as the formation
of a heterogeneous network containing hydrophobic polyacrylate kinetic chains [50].
Since the chain-growth polymerization is initiated from islet surface, the gelation yielded
a dense hydrogel layer immediately adjacent to the cell surface [19]. The gradient of
crosslinking density would complicate the permeability of nutrients, oxygen, and insulin
[119], all of which are essential in maintaining islet survival and functions.

3.3 Results and Discussion

Unlike a chain-growth network that contains heterogeneous cross-links, the stepgrowth thiol-norbornene photo-click reaction produces orthogonal cross-links with
enhanced cytocompatibility [40, 52, 59]. We recently reported a visible light mediated
step-growth thiol-ene hydrogelation without using co-monomer (NVP) and cytotoxic coinitiator (TEA) [59]. We hypothesized that this visible light initiated orthogonal thiol-ene
reaction could be adapted to form interfacial islet surface conformal coating. Prior to
testing this hypothesis, we evaluated the cytocompatibility of this cell surface initiated
thiol-ene photopolymerization. Here, we used MIN6 cell aggregates generated from
rotating suspension culture as the cell model. These aggregates were cultured in high
glucose DMEM supplemented with 50 μM β-mercaptoethanol, 10 % fetal bovine serum
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(FBS, Gibco), and 1× antibiotic-antimycotic (Invitrogen) and maintained at 37 oC and 5
% CO2. Since different compositions are required for chain-growth and step-growth
coating chemistries, in this study, we used non-gelling components (e.g., PEGMA or
PEGdNB) to examine the cytocompatibility of these coating chemistries (Figure 3.1A)
under similar radical concentrations. After 10 days in culture, MIN6 β-cell aggregates
(average aggregate diameter ~100 μm) were retrieved from media, washed with HBSS
and stained with 10 mM of eosin-Y (Fisher Scientific) for 5 minutes. After staining,
aggregates were washed 3 times with HBSS to remove excess eosin-Y and were
transferred to non-gelling precursor solutions containing: (i) 16 wt% PEGMA2kDa
(Monomer-Polymer), 50 mM of TEA, and 9 mM of NVP, or (ii) 20 wt% PEGdNB10kDa
[120]

and dithiothreitol (DTT, Fisher Scientific) at a unity functional group molar ratio

(R[thiol]/[ene] = 1).These tubes were exposed to visible light using a fiber optic microscope
illuminator (wavelength: 400 to 700 nm, AmScope) for 1 minute. In Figure 3.1B and
3.1C, aggregates were recovered in culture media for 1 hour, followed by staining with
live/dead staining reagents (i.e., 0.25 μL/mL Calcein AM and 2 μL/mL Ethidium
homodimer-3, respectively) for 1 hour before imaging with a confocal microscope
(Olympus Fluoview, FV1000). Similar to our previous work on bulk cell encapsulation
using UV-light irradiation [52], visible light-based chain-growth photopolymerization
(initiated by eosin-Y/TEA/NVP) was less cytocompatible compared with the step-growth
photopolymerization initiated by eosin-Y and DTT. As shown in Figure 3.1B (left),
numerous dead cells were found on the surface of MIN6 cell aggregates in the visible
light-based chain-growth polymerization system, which was attributed to the high
concentrations of radical species in the chain-growth polymerization, [40] as well as the
potential cytotoxicity of TEA [117, 118]. In contrast, the visible light-initiated orthogonal
step-growth thiol-ene reaction caused less cell death (Figure 3.1B, right) [52, 59]. Due to
technical difficulties in quantifying aggregates viability, aggregates viability is only
qualitatively analysed using live/dead staining.
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Figure 3.1. (A) Schematic of visible light-initiated interfacial chain-growth (top) or stepgrowth thiol-ene (bottom) photopolymerization (EY: eosin-Y). (B) Viability of
aggregates after non-gelling interfacial photopolymerization reactions (Green: live cells.
Red: dead cells. Scales: 100 μm).
Next, we prepared interfacial thiol-ene coating on MIN6 β-cell aggregates. MIN6
β-cell aggregates were stained with 10 mM of eosin-Y for 5 minutes. Eosin-Y stained cell
aggregates were washed three times with HBSS (centrifugation for 3 minutes at 500 rpm
each), suspended in 50 μL of macromer solution contained 20 wt% 8-arm PEGnorbornene (PEG8NB) with stoichiometric ratio of thiol from DTT (Figure 3.2A &
3.3A), and exposed to bright visible light. Note that in all the coating experiments,
aggregate density was fixed at approximately 500 aggregates/mL and more than 200
aggregates were analysed. Representative phase contrast images (Nikkon Eclipse Ti)
revealed the formation of a thin thiol-ene hydrogel coating on β-cell aggregates after only
30 seconds of light exposure (Figure 3.3B, left). Furthermore, live/dead staining results
showed that the coated β-cell aggregates remained viable (Figure 3.3C, left). This direct
coating method (i.e., one-step incubation) produced a wider distribution of gel coating
thickness, ranging from 20 μm to 60 μm (Figure 3.3D), which averaged to approximately
33 μm (Figure 3.3E) quantified by estimating circular diameter using NIS-Elements BR
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3.2 software. In addition, the one-step method only yielded a coating efficiency of 64 %
(Figure 3.3F), and there was a strong dependency between the coating thickness and the
size of the cell aggregates (Figure 3.3G). Here, coating efficiency is the percent fraction
of coated aggregates over the sum of coated and non-coated aggregates. While the onestep coating method is easy and cytocompatible to β-cell aggregates, it did not show high
coating efficiency and consistency. Thus, it is essential to establish a coating strategy that
provides high consistency and repeatability for isolated islets, which are heterogeneous in
size (a few tens to a few hundreds micron) [121]. We hypothesized that the conformal
coating results could be improved by providing additional thiols near the surface of the
cell aggregates. These surface-anchored thiols could reduce the variability of coating
thickness and increase coating/polymerization efficiency. Our recent work has shown that
PEG exhibits affinity to eosin-Y [122]. Hence, we hypothesized that by incubating eosinY stained aggregates with PEG-di-thiol (PEGdSH) would allow PEGdSH to anchor on
the surface of cell aggregates via affinity binding to cell surface adsorbed eosin-Y (Figure
3.2B). To test this hypothesis, stained aggregates were incubated in 20 wt% of PEGdSH
for 5 minutes, and washed three times with HBSS before suspending in macromer
solution containing PEG8NB with DTT (Figure 3.2B). After 30 seconds of light
exposure, conformal hydrogel coating also formed on β-cell aggregates (Figure 3.3B,
right). Two-step coating process is also cytocompatible to MIN6 aggregates (Figure 3.3C,
right). More cell death observed in two-step coating potentially due to the increased in
radical reactions on the surface of aggregates. This two-step incubation process produced
thiol-ene conformal gel layer with a narrower distribution of coating thickness (Figure
3.3D, ~20 to 40 μm) and a lower average coating thickness (Figure 3.3E, ~ 26 μm). More
importantly, the two-step coating method yielded higher coating efficiency (Figure 3.3F,
80 %) and a reduced dependency between coating thickness and the size of cell
aggregates (Figure 3.3G).
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Figure 3.2. Schematic of visible light-mediated interfacial thiol-ene photopolymerization
and conformal coating on β-cell aggregates or islets via: (A) one-step or (B) two-step
coating method.
Results shown in Figure 3.3 have demonstrated the benefits and importance of
additional PEGdSH incubation in interfacial thiol-ene photopolymerization. Therefore,
we further investigated the effect of PEGdSH on coating thickness and efficiency. In
general, the thiol-ene coating thickness decreased with increasing molecular weight
(MW) of PEGdSH (i.e., from 35 μm, 26 μm, to 13 μm for 2 kDa, 3.4 kDa, and 10 kDa
PEGdSH, respectively, Figure 3.4A-D & 3.5A). The use of higher MW of PEGdSH
resulted in decreased coating efficiency (Figure 3.5B, from 98 % to 64 %). It is worth
noted that in these experiments, the concentration of PEGdSH (20 wt%) as well as the
stoichiometric ratio of thiol (from DTT) and norbornene (from PEG8NB) in the precursor
solution were maintained. PEGdSH at a lower MW has higher thiol content when
comparing with its counterpart at a higher MW and at the same macromer concentration.
Therefore, increased coating thickness and efficiency at a lower PEGdSH MW were
likely due to increased availability of thiols near the surface of the aggregates, which
accelerated the thiol-ene cross-linking reaction.
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Figure 3.3. (A) Schematic of visible light-initiated step-growth orthogonal thiol-ene
reaction to form idealized hydrogel network. (B) Representative phase-contrast images of
the conformal coated aggregates. (C) Representative live/dead stained images of the
conformal coated aggregates (Scales: 50µm). (d-f) Effects of coating methods on (D) the
cumulative distribution of conformal gel coating thickness, (E) the average coating
thickness, and (F) the percent of coated aggregates. (G) Effect of aggregate diameter on
thiol-ene conformal coating thickness. (One-step: 20 wt% PEG8NB-DTT and 30 seconds
of light exposure. Two-step: 20 wt% PEG8NB-DTT, 3.4 kDa PEGdSH and 30 seconds of
light exposure. Mean ± SEM, n > 200 aggregates)
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Figure 3.4. (A-C) Representative phase-contrast images of MIN6 cell aggregates with
thiol-ene conformal gel coating (two-step coating method). PEGdSH MW: (A) 2 kDa,
(B) 3.4 kDa, and (C) 10 kDa. Arrows and dashed lines indicate the boundary of the
hydrogel coating (Scales: 50 µm). (D-F) Parameters affecting thiol-ene conformal coating
thickness: (D) molecular weight of PEGdSH, (E) photopolymerization time, and (F)
concentration of macromer PEG8NB. Coating conditions: (A-D) 20 wt% of PEG8NBDTT and 30 seconds of light exposure. (E) 3.4 kDa of PEGdSH and 30 seconds of light
exposure. (F) 20 wt% of PEG8NB-DTT and 3.4 kDa of PEGdSH (Mean ± SEM, n > 200
aggregates).

40

A.
Cumulative
distribution (%)

100
80
60
40

2kDa
3.4kDa
10kDa

20
0

0

20

40

60

Gel thickness (m)

80

Coated aggregates (%)

B.
100

Not coated

Coated

80
60
40
20
0

2

3.4

10

MWPEGdSH (kDa)

Figure 3.5. Effects of molecular weight of PEGdSH on (A) cumulative distribution of
conformal gel coating thickness, and (B) percent of coated aggregates. (20 wt% of
PEG8NB-DTT, R[PEG8NB]:[DTT] = 1, 30 seconds of light exposure. Mean ± SEM)

We also evaluated the influence of other parameters on the thiol-ene interfacial
conformal coating. For example, when the polymerization time was increased from 20 to
60 seconds, gel thickness was increased from 15 to 43 μm (Figure 3.4E & 3.6). Longer
polymerization time resulted in increasing coating efficiency (Figure 3.6B, from 53 % to
98 %) and the likelihood of encapsulating more than one aggregate per gel capsule (~20
% at 60 seconds). In addition, when the concentration of PEG8NB in the precursor
solution was increased from 10 wt% to 20 wt%, gel thickness increased from 14 to 26 μm
(Figure 3.4F & 3.7A). The use of a higher PEG8NB concentration also increased coating
efficiency (from 24 % to 84 %, Figure 3.7B). Regardless of the coating thickness, our
analysis showed that thiol-ene hydrogels have controllable mesh size depending on the
concentration of PEG8NB used. Based on the Flory-Rehner theory of elasticity, the mesh
size of a step-growth hydrogel with an ideal network (e.g., PEG8NB-DTT hydrogel,
MWPEG8NB = 20 kDa, MWDTT = 154 Da, and fPEG8NB = 8 and fDTT = 2) is 9.1 nm
(Equation 3.1 to 3.6) [123]. The mesh sizes of all thiol-ene hydrogels prepared here
(Figure 3.8, from 15.1 nm to 9.9 nm for 5 to 20 wt% of PEG8NB, respectively) were all
larger than the hydrodynamic radius (2.0 nm) and diameter (4.0 nm) of insulin [124].
This indicates that the diffusion of insulin from thiol-ene gel coating will not be
significantly retarded.
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Figure 3.6. Effects of PEG8NB concentration in the precursor solution on (A) cumulative
distribution of conformal gel coating thickness, and (B) percent of coated aggregates.
(MW of PEGSH = 3.4 kDa, R[PEG8NB]:[DTT] = 1, 30 seconds of light exposure. Mean ±
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Figure 3.7. Effects of polymerization time on (A) cumulative distribution of conformal
gel coating thickness, and (B) percent of coated aggregates. (MW of PEGSH = 3.4 kDa,
20 wt% of PEG8NB-DTT, R[PEG8NB]:[DTT] = 1. Mean ± SEM)
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Following the optimization of interfacial thiol-ene photopolymerization
conditions using MIN6 aggregates, we prepared orthogonal thiol-ene hydrogel conformal
coating on isolated islets. CD1 mice (7- to 8-week old) were obtained from Charles River
and islets were isolated from CD1 mice following established protocol [125]. Permission
for animal studies was approved by Indiana University School of Medicine IACUC
(protocol #10235-MD/R). CD1 murine islets were used in this study while the main
macromer was replaced with hydrolytically stable 8-arm PEG-amide-NB (PEGa8NB,
Figure 3.9A) [59]. It is worth noted that thiol-ene hydrogels formed from PEGa8NB have
similar degree of cross-linking efficiency (i.e., gel fraction above 90 %) and swelling (up
to 2 weeks) when compared with hydrolytically labile ester-containing PEG8NB (Figure
3.9). Specifically, hydrogels formed from hydrolytically labile PEG8NB showed
significant degradation after three weeks. During the month-long incubation, no
significant gel degradation was observed in gels formed from hydrolytically stable
PEGa8NB (Figure 3.9C). As shown in Figure 3.10A, coated islets remained viable 24
hours post coating. Furthermore, the coated hydrogel layer maintained its stability
throughout 2 weeks of in vitro culture (Figure 3.10B, 3.10C & 3.10D). The average
thickness of coating was ~30 μm with 90% of coating efficiency (data not shown). In
long-term in vitro culture of primary islets, the production of cellular debris and the
darkening of islets core are common phenomena, likely due to necrosis in the isolated
islets (Figure 3.10D) [126]. Clearly, the cellular debris was free floating in culture media
with the non-coated islets. On the other hand, the dark debris was ‘trapped’ within the
conformal coating layer on the coated islets. These results suggest that the coating serves
as a bi-directional immuoisolation barrier as it not only blocks the infiltration of host
immune cells, but also prevents the liberation of graft debris to the transplantation site
that would otherwise trigger host immune response [127, 128]. To examine insulin
secretion from the coated islets, glucose-stimulated insulin secretion (GSIS) was
performed at day 2 and day 14 (Figure 3.10E & 3.10F). Here, glucose solution was
prepared (2.5 or 25 mM of glucose) with Krebs-Ringer bicarbonate (KRB) buffer
containing sodium chloride (23 mM), potassium chloride (1 mM), sodium bicarbonate
(4.8 mM), magnesium chloride hexahydrate (0.2 mM), calcium chloride dehydrate (0.2
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mM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 0.5 mM) and bovine
serum albumin (BSA, 0.1 vol%). The temperature of glucose solutions were equilibrated
to 37 oC. Coated or non-coated islets were washed with HBSS, hand-picked and
transferred into micro-centrifuge tube (30 islets per tube, N = 4 tubes per sample group).
Islets were primed with 500 μL of low glucose solution for 1 hour at 37 oC and 5 % CO2.
Then, islets were incubated with 500 μL of low or high glucose solution (at 37 oC, 5 %
CO2) for 2 hours each. The glucose solution was collected after each glucose treatment.
After glucose stimulation, islets were lysed with acid ethanol extraction buffer (75 vol%
of ethanol, 1.5 vol% 1N hydrochloric acid and 23.5 vol% ddH2O) and the samples were
diluted accordingly with KRB mixture [129]. The amounts of insulin were quantified by
mouse insulin ELISA kit (Mercodia) and normalized to their corresponding total insulin
content (i.e., the sum of intracellular and secreted insulin). We found that the amounts of
insulin secreted from the thiol-ene hydrogel coated islets were not statistically different
from the non-coated islets. Within each non-coated or coated islets group, statistically
significance (p < 0.05) was found between insulin secretion at 2.5 mM and 25 mM
glucose. The GSIS index, which is the ratio of insulin secretion in high glucose buffer to
low glucose buffer, showed no statistical significance between coated and non-coated
islets throughout 2 weeks of in vitro culture (Figure 3.11). These results suggest that,
after the thiol-ene interfacial coating process, the thiol-ene conformal gel coated islets
preserved their responsiveness to glucose.
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Figure 3.8. (A) Effect of PEG8NB concentration on the mesh size (ξ) of hydrogels. The
mesh size of an ideal network (ξideal) was determined by Flory-Rehner equations
(Equation 3.1 to 3.6). The experimental mesh size (ξexp) was calculated from the swelling
ratio of PEG8NB-DTT hydrogels at different macromer contents (Equation 3.4, 3.5 &
3.6). Diameter of insulin was obtained from reference [124]. (B) Effect of PEG8NB
concentration on the diffusion coefficient (Dg) of insulin in swollen hydrogel. The
diffusion coefficient of insulin in pure solvent is obtained from reference [6] and the
calculation of Dg was based on Lustig-Peppes model in reference [130]. (PEG8NB-DTT,
0.1 mM of eosin-Y, 5 minutes of light exposure, N = 5. Mean ± SEM)
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Figure 3.9. (A) Schematic representation of thiol-ene hydrogels formed by hydrolytically
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PEGa8NB-DTT, 0.1 mM of eosin-Y, 5 minutes of light exposure, N = 5. Mean ± SEM)
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Figure 3.10. (A) Representative live/dead stained images of non-coated and coated CD1
mice islets (24 hours after coating). (B-C) Representative phase contrast images of noncoated (top) and coated (bottom) CD1 mice islets on day 2 (B), and day 14 (C). Arrows
and dashed lines in (B-C) indicate the boundary of the hydrogel coating (Scales: 50 µm).
(D-E) In vitro glucose stimulated insulin secretion (GSIS) of isolated islets on (D) day 2
and (E) day 14. Asterisks indicate statistical significance between 2.5 and 25 mM of
glucose within each group (Mean ± SEM, p < 0.05). Coating conditions: 3.4 kDa
PEGdSH, 20 wt% PEGa8NB-DTT, 25 seconds light exposure.

47

GSIS Index

5

Non-coated
Coated

4
3
2
1
0

2

14

Time (Day)
Figure 3.11. In vitro glucose stimulated insulin secretion (GSIS) index of CD1 murine
islets. GSIS index is the normalization of insulin secreted at high glucose to low glucose.
(Coating conditions: 3.4 kDa PEGdSH, 20 wt% PEGa8NB-DTT and 25 seconds light
exposure. Mean ± SEM)

3.4. Materials and Methods

Materials: Eosin-Y disodium salt and DTT were purchased from Fisher Scientific. 8-arm
PEG-hydroxyl (MW: 20 kDa) and 8-arm PEG-amine (MW: 20 kDa) were purchased
from JenKem Technology USA. PEG-monoacrylate (MW: 2 kDa) was purchased from
Monomer-Polymer. Linear raw PEG-hydroxyl (MW: 2, 3.4 or 10 kDa) and all other
chemicals were obtained from Sigma-Aldrich unless noted otherwise. CD1 mice (7- to 8week old) were obtained from Charles River as islet donors. Permission for animal
studies was approved by Indiana University School of Medicine IACUC (protocol
#10235-MD/R).

Synthesis of Poly(ethylene glycol)-ester-norbornene (PEGNB) macromer: Linear or 8arm PEGNB was synthesized by reacting linear or 8-arm hydroxyl-terminated PEG with
5-norbornene-2-carboxylic acid (5-fold excess to hydroxyl group) in anhydrous
dichloromethane (DCM) using N,N’-dicyclohexylcarbodiimide (DCC, 2.5-fold excess) as
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a coupling reagent. Norbornene acid was mixed with DCC and stirred at room
temperature for 1 hour. The resulting norbornene anhydride was filtered into an addition
funnel and added drop wise into a flask containing linear (10 kDa) or 8-arm PEG (20
kDa), 4-(dimethylamino) pyridine (DMAP, 0.5-fold excess), and pyridine (5-fold excess)
in anhydrous DCM. The flask was kept in an ice bath and the mixture was reacted for
overnight in dark. The product was filtered and precipitated in cold ethyl ether on ice.
After drying in vacuuo, PEGNB product was re-dissolved in water and dialyzed for 2
days (in pH 6 ddH2O). 1H NMR (Bruker 500) was used to confirm the degree of PEG
functionalization (> 90 %).

Synthesis of Poly(ethylene glycol)-amide-octa-norbornene (PEGa8NB) macromer:
Norbornene acid (5-fold excess to amine groups) was activated by HBTU/HOBT (5.5fold excess to amine group) in dimethylformamide (DMF) for 3 minutes. With nitrogen
gas purging, N,N-Diisopropylethylamine (DIEA, 6-fold excess to amine group) was
added to the activated norbornene acid solution and stirred for 5 minutes. The solution
was added drop wise to a two-neck flask containing PEG-octa-amine in DMF. After
overnight reaction at room temperature, the product was precipitated in cold ethyl ether.
After drying in vacuuo, PEGaNB product was re-dissolved in water and dialyzed for 2
days . 1H NMR (Bruker 500) was used to confirm the degree of PEG functionalization (>
90 %).

Synthesis of PEGdSH macromer: PEGdSH was synthesized following established
protocol. In brief, linear PEG (2, 3.4 or 10 kDa) was dissolved in anhydrous toluene and
dried by evaporating toluene. Dried PEG was re-dissolved in anhydrous tetrahydrofuran
(THF), to which sodium hydride (1.5-fold excess of hydroxyl group) was added slowly
and the mixture was stirred until no hydrogen gas bubble was visible, the set up was
purged with nitrogen gas in an oil bath at 40 °C. Allyl bromide (6-fold excess of hydroxyl
group) was added drop wise to the PEG solution and the reaction was allowed to continue
overnight in dark. Sodium bromide salt was filtered off to obtain a clear solution
containing PEG-allylether (PEGdAE), which was precipitated out in cold ethyl ether,

49

filtered, and dried in vacuuo. Next, thiolacetic acid (2-fold excess to allylether group) was
added slowly to dichloromethane (DCM) solution containing PEGdAE and photoinitiator
Irgacure I-2959 (0.5 wt%). Photoconjugation was initiated by UV-light exposure
(Omicure S1000, 365 nm and 10 mW/cm2) for 15 minutes and continued for another 30
minutes after supplementing with another portion (0.5wt%) of I-2959. Linear PEGthiolacetate was precipitated in cold ethyl ether, filtered, and dried in vacuuo. After redissolving PEG-thiolacetate in ddH2O (30 mL), 15 mL of sodium hydroxide (2N) was
added to the solution for 5 minutes. Then, equal amount of hydrochloride acid (2N) was
added to neutralize PEG-thiolacetate solution. After dialysis for 2 days at room
temperature, PEGSH was obtained from lyophilization. The purity (> 90 %) was
characterized with H1NMR Bruker 500).
Cytocompatibility of interfacial thiol-ene photopolymerization on β-cell aggregates or
islets: MIN6 β-cell aggregates were formed on an orbital shaker in a non-treated tissue
culture plate. These aggregates were cultured in high glucose DMEM supplemented with
50 μM β-mercaptoethanol, 10 % fetal bovine serum (FBS, Gibco), and 1× antibioticantimycotic (Invitrogen) and maintained at 37 oC and 5 % CO2. After 10 days in culture,
MIN6 β-cell aggregates (average aggregate diameter ~100 μm) were retrieved from
media, washed with HBSS and stained with 10 mM of eosin-Y for 5 minutes. After
staining, aggregates were washed 3 times with HBSS to remove excess eosin-Y and were
transferred to non-gelling precursor solutions containing: (i) 16 wt% PEGMA2kDa, 50
mM of TEA, and 9 mM of NVP, or (ii) 20 wt% PEGdNB10kDa and DTT at a unity
functional group molar ratio (R[thiol]/[ene] = 1). These tubes were exposed to visible light
using a fiber optic microscope illuminator (wavelength: 400 to 700 nm, AmScope) for 1
minute. Aggregates were recovered in culture media for 1 hour, followed by staining with
live/dead staining reagents (i.e., 0.25 μL/mL Calcein AM and 2 μL/mL Ethidium
homodimer-3, respectively) for 1 hour before imaging with a confocal microscope
(Olympus Fluoview, FV1000). Pancreatic islets were isolated from CD1 mice following
established protocol [125]. These islets were cultured in RPMI media supplemented with
10 % fetal bovine serum, and 1× antibiotic-antimycotic. In a similar manner as described
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above, islets were stained with live/dead dyes and evaluated viability with a confocal
microscope.
Coating of β-cell aggregates or pancreatic islets: MIN6 β-cell aggregates or isolated
CD1 islets were stained with 10 mM of eosin-Y for 5 minutes. For the one-step coating
method, aggregates were washed three times with HBSS (centrifugation for 3 minutes at
500 rpm each) and suspended in 50 μL of macromer solution contained 20 wt% PEG8NB
with stoichiometric ratio of thiol (from DTT) (Figure 3.2A). For the two-step coating
method, stained aggregates/islets were incubated in 20 wt% of PEGdSH for 5 minutes,
and washed three times with HBSS before suspending in macromer solution containing
PEG8NB or PEGa8NB with DTT (Figure 3.2B). The mixture containing macromer
components and stained aggregates/islets was exposed to visible light (between 20 to 60
seconds). In these experiments, aggregate/islet density was fixed at approximately 500
aggregates/mL. Coated aggregates or islets were imaged with phase-contrast microscope
(Nikkon Eclipse Ti) and coating thickness was quantified by estimating circular diameter
using NIS-Elements BR 3.2 software.

Glucose stimulated insulin secretion (GSIS) and ELISA: Glucose solution was prepared
(2.5 or 25 mM of glucose) with Krebs-Ringer bicarbonate (KRB) buffer containing
sodium chloride (23 mM), potassium chloride (1 mM), sodium bicarbonate (4.8 mM),
magnesium chloride hexahydrate (0.2 mM), calcium chloride dehydrate (0.2 mM), 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 0.5 mM) and bovine serum
albumin (BSA, 0.1 vol%). The temperature of glucose solutions were equilibrated to 37
o

C. Coated or non-coated islets were washed with HBSS, hand-picked and transferred

into micro-centrifuge tube (30 islets per tube, N = 4 tubes per sample group). Islets were
primed with 500 μL of low glucose solution for 1 hour at 37 oC and 5 % CO2. Then, islets
were incubated with 500 μL of low or high glucose solution (at 37 oC, 5 % CO2) for 2
hours each. The glucose solution was collected after each glucose treatment. After
glucose stimulation, islets were lysed with acid ethanol extraction buffer (75 vol% of
ethanol, 1.5 vol% 1N hydrochloric acid and 23.5 vol% ddH2O) and the samples were
diluted accordingly with KRB mixture. The amounts of insulin were quantified by mouse
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insulin ELISA kit (Mercodia) and normalized to their corresponding total insulin content
(i.e., the sum of intracellular and secreted insulin).
Hydrogel fabrication and swelling: Step-growth thiol-ene hydrogels were formed by
radical-mediated photopolymerization using 0.1 mM of eosin-Y under visible light
exposure at an intensity of 70,000 Lux using a fiber optic microscope illuminator
(AmScope) for 5 minutes. To quantify hydrogel swelling, circular hydrogel discs were
prepared from 50 μL precursor solution. Immediately after gelation, hydrogels were
incubated in ddH2O at 37 oC on an orbital shaker for 24 hours to remove sol fraction.
Gels were then dried and weighed to obtain dried polymer weights (W Dry). The dried
polymers were incubated in 5 mL of buffer solution (pH 7.4 PBS) at 37 oC on an orbital
shaker. At specific time points, hydrogels were removed from the medium, blotted dry
with Kimwipe, and weighed to obtain swollen weights (WSwollen).

Hydrogel mass

swelling ratios (qexp) were determined by a ratio of WSwollen to WDry.
Hydrogel mesh size: For an ‘ideal’ thiol-ene hydrogel network containing no structural
defects, the ideal mesh size was determined with structural information. First, the average
̅̅̅̅𝑐 ) is defined as [129]:
molecular weight between crosslinks (𝑀
𝑀𝑊
𝑀𝑊
̅̅̅̅
𝑀𝑐 = 2( 𝑓 𝐴 + 𝑓 𝐵 )
𝐴

𝐵

(3.1)

Here, MWA and MWB represent the molecular weight of PEG8NB and crosslinker DTT,
respectively. fA and fB are the number of reactive functionality for PEG8NB and DTT,
which were 8 and 2, respectively. With a known ̅̅̅̅
𝑀𝑐 , the ideal network crosslinking
density or density of elastically active chains (vc) and polymer volume fraction (v2) can
be calculated based on the Flory-Rehner theory [63]:
𝑉

1
𝑣𝑐 = ̅̅̅̅
=
𝑀 ̅̅̅
𝑣

−[ln(1−𝑣2 )+𝑣2 +ᵡ12 𝑣2 2 ]

𝑐 2

2𝑣
𝑣2 1/3 − 2

(3.2)

𝑓𝐴

Here, ̅̅̅
𝑣2 is the specific volume of PEG (0.92 cm3/g at 37 oC), V1 is the molar volume of
water (18 cm3/mole) and ᵡ12 is the Flory-Huggins interaction parameter for a PEG-H2O
system (0.45).

After obtaining v2, ideal hydrogel mass swelling ratio qideal can be

obtained using the following equation:
𝑣2 = (𝑞

̅̅̅
𝑣2
̅̅̅+𝑣
1 ̅̅̅
2
𝑖𝑑𝑒𝑎𝑙 −1)𝑣

(3.3)
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where ̅̅̅
𝑣1 is the specific volume of water (1.006 cm3/g at 37 oC).
The polymer volume fraction in the swollen state (v2,s) was obtained using the
following equation:
𝑣2,𝑠 =

1
𝜌2

(3.4)

𝑞
1
+
𝜌1 𝜌2

where ρ1 and ρ2 are the densities of the solvent and polymer, respectively. Here, q was
either qideal or qexp.
Second, the root-mean-squared end-to-end distance of network chains between
two crosslinks in the neutral state or (𝑟02 )1/2 was determined based on:
1

1

̅̅̅̅𝑐
𝑛𝑀
2 2
2
(𝑟̅̅̅
0 ) = 𝑙(𝐶𝑛 𝑀 )

(3.5)

𝑟

Here, Cn is the Flory characteristic ratio, l is the average bond length along the polymer
backbone, and n is the number of chemical bonds within a repeating unit (e.g., n equals to
3 for PEG). Mr is the molecular weight of the repeating units of the polymer chain.
With calculated v2,s and (𝑟02 )1/2, mesh size of the hydrogel (𝜉) was obtained as the
product of the two parameters:
1

1

2 2
𝜉 = 𝑣2,𝑠 −3 (𝑟̅̅̅
0)

(3.6)

Diffusion coefficient of insulin: To estimate the diffusivity of insulin in a swollen
hydrogel, a diffusivity model adapted by Lustig and Peppas was used [130]:
𝐷𝑔
𝐷0

𝑟

𝑣

= (1 − 𝜉𝑠 )exp[(−𝑌 (1−𝑣2,𝑆 )]
2,𝑆

(3.7)

where Dg is the insulin diffusion coefficient in the swollen thiol-ene hydrogel, D0 is the
diffusion coefficient of insulin in pure solvent (1500 µm2/second) [131], and rs is the
hydrodynamic radius of insulin (2 nm) [124]. Here, Y is assumed to be 1 which is the
ratio of the critical volume required for a successful movement of insulin and the average
free volume per molecule of solvent.
Data Analysis: Data analysis was performed on Prism 5 software. Unless otherwise
noted, all experiments were conducted independently for three times and the results were
reported as mean ± SEM. Student’s t-test was conducted for statistical analysis where
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significance was reported for p < 0.05. For coating thickness characterizations, at least
200 aggregates were analyzed per experimental condition.

3.5 Conclusion

In summary, we have developed a visible light-mediated thiol-norbornene
interfacial coating process to prepare step-growth conformal hydrogel coating on islet
surface. Using MIN6 -cell aggregates as a model, we evaluated the parameters critical
in determining coating thickness (e.g., MW of PEGdSH, polymerization time, and
macromer concentration). The results of live/dead staining and GSIS demonstrated high
cytocompatibility of thiol-norbornene hydrogel coating on murine islets. This visible
light mediated thiol-norbornene interfacial photopolymerization provides an alternate
coating option and should be of great interest to the field of islet transplantation. Future
work will focus on modifying thiol-norbornene gel formulation to create multi-functional
immuno-isolation barrier, and on determining the inflammatory response and long-term
efficacy of the transplanted coated islets on maintaining euglycemia.
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CHAPTER 4
PHOTO-CLICK HYDROGELS PREPARED
FROM FUNCTIONALIZED CYCLODEXTRIN AND
POLY(ETHYLENE GLYCOL) FOR DRUG DELIVERY
AND IN SITU CELL ENCAPSULATION

4.1 Abstract

Polymers or hydrogels containing modified cyclodextrin (CD) are highly useful in
drug delivery applications as CD is a cytocompatible amphiphilic molecule that can
complex with a variety of hydrophobic drugs. Here, we designed modular photo-click
thiol-ene hydrogels from derivatives of βCD and poly(ethylene glycol) (PEG), including
βCD-allylether (βCD-AE), βCD-thiol (βCD-SH), PEG-thiol (PEGSH), and PEGnorbornene (PEGNB). Two types of CD-PEG hybrid hydrogels were prepared using
radical-mediated thiol-ene photo-click reactions. Specifically, thiol-allylether hydrogels
were formed by reacting multi-arm PEGSH and βCD-AE, and thiol-norbornene
hydrogels were formed by cross-linking βCD-SH and multi-arm PEGNB. We
characterized the properties of these two types of thiol-ene hydrogels, including gelation
kinetics, gel fractions, hydrolytic stability, and cytocompatibility. Compared with thiolallylether hydrogels, thiol-norbornene photo-click reaction formed hydrogels with faster
gelation kinetics at equivalent macromer contents. Using curcumin, an anti-inflammatory
and anti-cancer hydrophobic molecule, we demonstrated that CD-crosslinked PEG-based
hydrogels, when compared with pure PEG-based hydrogels, afforded higher drug loading
efficiency and prolonged delivery in vitro. Cytocompatibility of these CD-crosslinked
hydrogels were evaluated by in situ encapsulation of radical sensitive pancreatic MIN6 βcells. All formulations and crosslinking conditions tested were cytocompatible for cell
Chaper 4 here is as appeared in H. Shih and C. Lin, Biomacromolecules, 2015(16) 1915-1923
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encapsulation. Furthermore, hydrogels crosslinked by βCD-SH showed enhanced cell
proliferation and insulin secretion as compared to gels crosslinked by either dithiothreitol
(DTT) or βCD-AE, suggesting the profound impact of both macromer compositions and
gelation chemistry on cell fate in chemically crosslinked hydrogels.

4.2 Introduction

As defined by the Food and Drug Administration (FDA), amphiphilic
cyclodextrins (CDs) are a class of ‘Generally Recognized as Safe (GRAS)’
macromolecules [132-134]. The hydrophobic cavity of CD can accommodate a broad
range of poorly soluble drugs through host-guest complex formation, whereas the
hydrophilic surface of CD facilitates the dissolution of the CD-drug complex in aqueous
solutions [135]. Three types of CD, α-, β-, and γ-CD (with 6, 7, and 8 repeating units of
glycopyranose, respectively), are commonly used for increasing the solubility of
hydrophobic drugs [136]. In addition to serving as a drug-dissolving agent, CDs can be
easily modified for forming multifunctional macromolecules, including linear polymers
and network hydrogels [137-139]. For example, hydroxyl groups of βCD could be
functionalized with acrylate for crosslinking into hydrogel for binding and releasing anticancer drug, such as chlorambucil. The release rate was controlled by adjusting pH or
degree of network crosslinking [140]. CD could also be functionalized with azide for
chemical crosslinking with PEG-di-alkyne via the copper-catalyzed azide-alkyne
cycloaddition (CuAAC) [141]. Unfortunately, copper is a cytotoxic metal that induces
oxidative damage to cells [142]. Hence, CuAAC is mostly not compatible with live cell
experiments [143]. Recently, Sanyal et al. reported the formation and characterization of
Michael-type thiol-maleimide hydrogels using hepta-thiol-substituted βCD (βCD-SH7)
and linear poly(ethylene glycol)-maleimide (PEG-maleimide) [144]. However,
maleimide group deprives topoisomerase II catalytic activity of cells that can lead to cell
apoptosis [145] and the presence of unreacted maleimide might create adverse effects on
cell viability [145, 146]. In addition, thiol-maleimide gelation proceeds via a nucleophilic
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reaction that does not allow one to easily control polymerization kinetics. In this regard,
Arslan et al. prepared CD-PEG hybrid hydrogels through photo-crosslinking of
commercially available βCD-SH7 and PEG-allylether and the hydrogels were used to
deliver hydrophobic puerarin [147]. This hydrogel crosslinking, however, was carried out
in an organic condition using dimethylformamide (DMF) as the solvent. As a result, this
system was not compatible for in situ cell encapsulation.
In the past few years, we and other groups have explored the aqueous-based stepgrowth thiol-norbornene photo-click chemistry to prepare highly cytocompatible and
tunable hydrogels for tissue engineering applications [148]. The gelation of thiolnorbornene hydrogels can be initiated by type I photoinitiator (e.g., Irgacure-2959 or
lithium arylphosphinate (LAP)) under long wavelength, low intensity ultraviolet (UV)
light irradiation (365 nm, 5–10 mW/cm2). Thiol-norbornene gelation could also be
initiated by visible light (400-700 nm) exposure with type II photoinitiator (e.g., eosin-Y
or rose bengal) as the sole photosensitizer [58, 59]. The advantages of step-growth thiolnorbornene photopolymerization include rapid, ambient, and aqueous reaction conditions,
as well as spatial-temporal control over gelation kinetics [36, 37, 120]. More importantly,
thiol-norbornene hydrogels are highly cytocompatible even for radical-sensitive
pancreatic β-cells [52, 149]. In addition to PEG-norbornene, other macromers containing
non-homopolymerizable ‘ene’ moieties have been explored for forming step-growth
thiol-ene hydrogels. For example, Kloxin and colleagues recently reported an aqueous
thiol-allylether reaction to form thiol-ene hydrogel for in situ cell encapsulation. The
radical-mediated thiol-allylether hydrogel was formed between multi-arm PEG-thiol
(PEGSH) and bis-allyloxycarbonyl functionalized peptides [150]. This thiol-allylether
gelation produced hydrolytically stable hydrogels that were cytocompatible for
encapsulation of human mesenchymal stem cells (hMSCs).
Thiol-ene hydrogels have been exploited as platforms for encapsulating
hydrophilic biomolecules, drugs, and cells. Since CDs are capable of increasing the
solubility of poorly soluble molecules, a CD-crosslinked thiol-ene hydrogel can
potentially be used to encapsulate and to deliver both hydrophilic and hydrophobic
biomolecules. Furthermore, CD can be used to form supramolecular association with
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selected hydrophobic molecules, such as adamantane. A CD-immobilized hydrogel
formed by the aqueous thiol-ene photo-click reaction will not only permit in situ cell
encapsulation, but may also allow researchers to create hydrogels with dynamically
tunable properties in the presence of cells. As the first step toward achieving this goal, we
report here the synthesis and characterization of βCD derivatives, the crosslinking of
βCD-PEG hybrid hydrogels via radical-mediated thiol-ene photopolymerizations, the
delivery of a model hydrophobic drug, and the cytocompatibility of these step-growth
hydrogels. Specifically, a two-step synthesis procedure was developed for functionalizing
βCD with the desired number of allylether, which could be used to form hydrolytically
stable thiol-allylether photo-click hydrogel. Alternatively, allylether moieties could be
further converted to thiols, which could be used to form thiol-norbornene hydrogels. Both
thiol-ene gelation systems utilized a low concentration of LAP as the photoinitiator and
the gelation was initiated via light exposure at 365 nm. We investigated the gelation
kinetics and physical properties of these two types of thiol-ene hydrogels. Curcumin, a
hydrophobic molecule with anti-inflammatory and anti-cancer potential, was used as a
model drug to demonstrate the enhanced uptake and prolonged release of hydrophobic
drug from CD-crosslinked thiol-ene hydrogels. Furthermore, the cytocompatibility of
these step-growth CD-crosslinked thiol-ene hydrogels were evaluated via in situ
encapsulation of radical-sensitive pancreatic MIN6 β-cells.
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4.3 Results and Discussion
4.3.1 Preparation and characterization of βCD derivatives
A two-step process was employed to modify βCD with allylether moiety.
First, NaH was added at different concentrations to activate hydroxyl groups on
βCD (Figure 4.1A, step i). Following the secession of hydrogen gas, excess allyl
bromide was added to the reaction mixture (Figure 4.1A, step ii) to afford βCDAE. 1H NMR results (Figure 4.1B) showed that allylether group was successfully
introduced to βCD. Unexpected peaks between 4.1 to 4.3 ppm were likely due to
regioisomerism. Peaks of similar intensities (i.e., 3.8 or 4.6 ppm) were likely due
to the shifting of protons on βCD due to varied combinations of allylether
positions. The modification was confirmed by mass spectroscopy analysis. The
difference of the average molecular mass of βCD-AE and βCD was divided by the
molecular mass of allylether (i.e., 40 Da) to estimate the degree of allylether
functionalization. As the concentration of NaH or allylbromide to βCD was
increased (from 0 to 11.3-fold, Figure 4.2), so was the detected mass of the
modified βCD and the estimated degree of substitution (0, 1.5, 2.4 and 4.5,
respectively). To obtain thiol-substituted βCD, βCD-AE was first photoconjugated
with thioacetic acid via radical-mediated thiol-allylether addition (Figure 4.1A,
step iii). The intermediate product, βCD-thioacetate, was hydrolyzed with sodium
hydroxide, neutralized with hydrochloric acid, and purified via dialysis to obtain
the final product, βCD-SH (Figure 4.1A, step iv). 1H NMR results confirmed that
allylether was replaced with thiol group (Figure 4.1B, bottom panel). The presence
of thiol on modified βCD was further quantified by Ellman’s assay (Figure 4.3).
As the concentration of βCD-SH was increased from 0.02 to 1 mg/mL, the
concentration of thiol detected increased linearly (R 2 = 0.99) from 0.006 ± 0.001 to
0.362 ± 0.005 mM. As expected, no thiol was detected from unmodified βCD or
βCD-AE.
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Figure 4.1. (A) Schematics of βCD modifications. (i) NaH, DMF, room
temperature; (ii) allylbromide, DMF, room temperature; (iii) thioacetic acid, I2959, UV (365 nm, 10 mW/cm2), 30 min; (iv) sodium hydroxide (aq.), followed
by neutralization with hydrogen chloride. 1H NMR of (B) βCD, (C) βCD-AE, and
(D) βCD-SH (dissolved in (CD3)2SO).
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Figure 4.2. Mass spectroscopy of CD derivatives. (A) Mass-to-charge (m/z) for unmodified βCD (B-D) βCD-AE with increasing feed ratio of NaH and allylbromide (B:
2.3-, C: 4.5-, and D: 11.3-fold).
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Figure 4.3. Thiol-content on βCD, βCD-AE, and βCD-SH measured by Ellman’s assay.
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4.3.2 Preparation of thiol-ene photo-click hydrogels

We next demonstrated the crosslinking of CD-PEG hybrid hydrogels using
PEG8SH (M.W. 20 kDa) and βCD-AE through a radical-mediated thiol-allylether photoclick reaction (Figure 4.4) and the gelation was evaluated via in situ photorheometry
(Figure 4.4B, 4.5). Specifically, 5 wt% of PEG8SH was cross-linked with different
concentrations of βCD-AE (9 to 24 mg/mL). The gel points of all formulations evaluated
were similar regardless of βCD-AE concentration in the precursor solution (gel point ~
17 to 22 seconds, Figure 4.5). However, the formulation afforded the highest elastic
modulus (~2.5 kPa at 300 second) at 24 mg/mL of βCD-AE (Figure 4.4B). Further
increasing βCD-AE concentration did not yield higher gel modulus (data not shown).
Controlled experiment using unmodified βCD with PEG8SH showed no sign of gelation
even after 300 seconds of light exposure in the presence of photoinitiator (Figure 4.4C),
suggesting that the gelation was not due to disulfide bond formation. Since 24 mg/mL of
βCD-AE yielded the highest shear modulus of thiol-allylether hydrogel, we examined the
gelation of thiol-norbornene hydrogel (Figure 4.4D) using this concentration (24 mg/mL)
of thiol-substituted βCD (i.e., βCD-SH) and 5 wt% of 8-arm PEG-norbornene (PEG8NB,
M.W. 20 kDa). Even with slightly lower degree of functionalization (~85 % on
PEG8NB), the gelation of βCD-SH with PEG8NB still afforded a 5-fold faster gel point
(Figure 4.4E, gel point ~3 seconds). However, the final shear modulus of thiolnorbornene hydrogel formed with βCD-SH and PEG8NB only reached about 1.1 kPa
(Figure 4.4E). Control experiment showed that gelation was not possible when
unmodified βCD was mixed with PEG8NB (Figure 4.4F) and subjected to the same
radical-initiation

conditions,

indicative

of

the

lack

of

either

PEG8NB

homopolymerization or gelation due to supramolecular assembly (or threading) between
multi-arm PEG and βCD.
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Figure 4.4. (A) Scheme of light and radical mediated thiol-allylether gelation. (B) In situ
photorheometry of thiol-allylether photopolymerization (G’: storage modulus; G”: loss
modulus) between PEG8SH and βCD-AE. (C) In situ photorheometry of solution
containing PEG8SH and βCD. (D) Scheme of light and radical mediated thiol-norbornene
gelation. (E) In situ photorheometry of thiol-norbornene photopolymerization PEG8NB
and βCD-SH. (F) In situ photorheometry of solution containing PEG8NB and βCD (5
wt% PEG8SH or PEG8NB, 24 mg/mL of βCD-AE or βCD-SH, 1 mM LAP). Light (365
nm, 10 mW/cm2) was turned on at 30 seconds (dotted line). N = 3, error bars were
omitted for clarity.
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Figure 4.5. In situ photorheometry showing the evolution of storage modulus (G’) and
loss modulus (G”) of thiol-allylether photopolymerization at 5 wt% PEG8SH and various
CD-AE concentration in the precursor solution (1 mM LAP, 365nm light at 10 mW/cm2).
Light was turned on at 30 seconds (dotted line). N = 3, error bars were omitted for clarity.

The fast thiol-ene gelation using macromers functionalized with norbornene, a
strained ene, is well-documented in the literature. For example, we have shown that PEGpeptide thiol-norbornene gelation could be achieved rapidly (gel point ~ 2-3 seconds)
using low PEGNB and photoinitiator concentrations (e.g., 4 wt% PEG4NB20kDa with
DTT or bis-cysteine peptides and 1 mM LAP) [62]. On the other hand, Kloxin and
colleague designed a radical-mediated (1.1 mM of LAP) thiol-allylether hydrogel system
using 10 wt% of PEG4SH (M.W. 20 kDa) with alloc-functionalized peptides and
obtained a gel point of about 15 seconds [150]. While both allylether and norbornene
react with thiol via a strictly step-growth mechanism (i.e., no homopolymerization
between the ene groups) [151], the polymerization rate of thiol-norbornene is six times
faster than that of thiol-allylether due to the unity ratio of thiyl radical propagation to
chain transfer kinetic parameters (kpSC /kCT) [151]. It is worth noting that, while thiolnorbornene gelation was one order of magnitude faster than thiol-allylether gelation, the
final gel shear modulus of the former was only about half of the latter. This could be
explained by the fact that PEG8NB, which was synthesized in house, was lower in the
degree of functionalization (85%, per 1H NMR) as compared with commercially
acquired PEG8SH (>95%, per manufacturer’s certificate of analysis, respectively).
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Furthermore, since βCD-SH was modified from βCD-AE, it would make sense that gels
crosslinked by βCD-SH would have a lower degree of crosslinking, and hence lower
shear modulus, as compared with gels crosslinked by βCD-AE.
CD has been shown to assist the assembly of physical ‘pseudopolyrotaxane’ hydrogel through interactions with PEG or block co-polymers of
polypropylene oxide (PPO) and polyethylene oxide (PEO) (e.g., Pluronic).
Previously, Cooper-White and colleagues reported supramolecular gelation of
αCD with Pluronic co-polymers and concluded that the ‘threading’ induced
gelation would only occur in the presence of ‘poly-CD’ aggregates, which was
only apparent at a sufficiently high concentration of CD (at least 50-70 mg/mL)
[152]. The gelation in the work presented here was purely based on thiol-ene
photochemistry since the CD concentrations used in this study were less than 40
mg/mL and the fact that no gelation was observed by simply mixing unmodified
βCD with PEGNB (Figure 4.4C). Another relevant work reported by Elisseeff and
colleagues showed a tunable CD/PEG hybrid hydrogel crosslinked by chaingrowth photopolymerization. It is worth noting that the functionalized βCD motifs
were ‘threaded’ onto PEG-diacrylate after overnight incubation[153]. We believe
that the threading of CD to PEG chains was minimal, if any, since we added βCD
into the mixture right before photopolymerization in all experiments. Another
potential complication is the formation of LAP/βCD complex. We performed
isocratic HPLC using acetonitrile/phosphate buffer (35/65) containing βCD (0 to
10 mM) as the mobile phase. While the elution of LAP shifted slightly (Figure
4.6A), the elution time of injected LAP (0.1 mM) was not significantly different
from each other regardless of βCD concentration (Figure 4.6B). Since the gelation
was accomplished within 5 minutes, it is unlikely that the association between
LAP and βCD, if any, would impede light-induced initiator breakdown and
gelation. Furthermore, the potential association would also decrease after the
photoinitiators were broken down into fragments upon light irradiation.
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Figure 4.6. Evaluation of potential LAP/CD complex formation using reverse-phase
HPLC. (A) 0.1mM LAP was injected into C18 analytical column using
acetonitrile/phosphate buffer (35/65) as the mobile phase. The mobile phase also
contained different concentrations of βCD as indicated. Absorbance was measured at 280
nm. N = 3, error bars were omitted for clarity. (B) Elution time corresponds to maximum
absorbance of LAP. (Mean ± SD, N = 3)

4.3.3 Effects of macromer functionality and
molecular weight on gelation kinetics
Since thiol-norbornene reaction exhibits faster gelation kinetics than thiolallylether reaction, we evaluated the effects of PEGNB macromer functionality and
molecular weight on the gelation of CD-based thiol-norbornene hydrogels (Figure
4.7). PEG4NB (M.W. 20 kDa, Figure 4.7A) and PEG8NB (M.W. 40 kDa, Figure
4.7B) were selected as these two macromers provided the same total concentration
of norbornene at the same weight percentage (i.e., 10 mM at 5 wt%). Note that the
molar ratio of norbornene to thiol was maintained at one, whereas the
concentration of thiol from βCD-SH was determined by Ellman’s assay (Figure
4.3). Since the average molecular weight per arm in these two macromers was the
̅̅̅̅𝑐 ) of the
same (i.e., 5 kDa), the average molecular weight between crosslinks (𝑀
two was also the same (Eq. 3). This implied that the two sets of hydrogels would
have the same ideal crosslinking efficiency (Eq. 4). Experimentally, however, we
found that thiol-norbornene hydrogels cross-linked by PEG4NB (20 kDa) had a
slightly slower gel point (~6 seconds) and a lower shear modulus (~1 kPa) when
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compared with gels crosslinked by PEG8NB (40 kDa) (~4 seconds and ~3 kPa).
These results was consistent with the trend found in previously reported stepgrowth Michael-type hydrogels [154]. Theoretically, step-growth hydrogels with
the same ̅̅̅̅
𝑀𝑐 (Eq. 3) should have identical mesh size (Eq. 4) regardless of the
macromer concentration. Experimentally, however, macromer with lower
functionality formed hydrogel with higher swelling ratio compared with macromer
with higher functionality [62, 63]. The phenomenon was attributed to network
defects and inefficient cross-linking at lower macromer functionality. We also
compared gelation kinetics of CD-based thiol-norbornene hydrogels using
macromer PEG8NB with different molecular weight (Figure 4.7B & 4.7C). The
gel point of hydrogel cross-linked by 20 kDa PEG8NB was 2.2–fold faster, and the
elastic modulus was 1.5–fold higher, than the gels cross-linked by 40 kDa
PEG8NB. These results were also expected because of the higher molarity of
norbornene groups on 20 kDa PEG8NB at equivalent polymer weight content.

67

Figure 4.7. In situ photorheometry of thiol-ene hydrogels crosslinked by βCD-SH and
(A) PEG4NB (20 kDa), (B) PEG8NB (40 kDa) or (C) PEG8NB (20 kDa). (5 wt%
PEGNB, [thiol] = [norbornene], 1 mM LAP). Light (365 nm, 10 mW/cm2) was turned on
at 30 seconds (dotted line). N = 3, error bars were omitted for clarity.
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4.3.4 Effects of cross-linker on hydrogel properties

After examining the effect of CD-PEG macromer formulations on gelation,
we evaluated the influence of crosslinker on the physical properties of selective
groups of thiol-norbornene hydrogels. Three sets of macromers were used: (1)
DTT with PEG4NB (labelled as DTT in Figure 4.8), (2) βCD-SH with PEG4NB
(labelled as CD-SH), and (3) PEG4SH with βCD-AE (labelled as CD-AE). As
shown in Figure 4.8A, the gel fraction was not significantly different between the
three groups (86 ± 3 %, 79 ± 8 %, and 74 ± 6 % for DTT, CD-SH, and CD-AE gel,
respectively). However, the DTT gel exhibited the highest equilibrium shear
modulus when compared with gels crosslinked with CD-SH or CD-AE (Figure
4.8B, ~7.1, 3.4, and 2.4 kPa for DTT, CD-SH and CD-AE gel, respectively). The
differences in equilibrium shear moduli reflected the variation in network
crosslinking density, which was affected by the types of thiol (i.e., DTT, CD-SH,
or PEG4SH) and ene (i.e., norbornene or allylether) used in the formulations [62].
The lowest crosslinked CD-AE gels also had highest swelling ratio among the
three groups (Figure 4.8D). Interestingly, even though the modulus of DTT gel
was higher than that of CD-SH gel (Figure 4.8B & 4.8C), the swelling ratio of
DTT gel was also 2-fold higher than that of CD-SH gel (Figure 4.8D). This result
was contradictory to the inverse scaling of modulus and swelling ratio in
chemically crosslinked hydrogels. A significantly lower swelling ratio for CD-SH
gel might be a result of higher CD-SH concentration and mass (48 mg/mL)
required for this formulation. As a comparison, the concentration of DTT used was
only 1.5 mg/mL. Inclusion of higher content of amphiphilic CD in the gel
formulations might profoundly impact the ability of these gels to imbibe water.
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Figure 4.8. Effect of crosslinker on (A) gel fraction, (B) elastic modulus at
equilibrium gel swelling, (C) shear modulus as a function of time, and (D) swelling
ratio as a function of time. Asterisks indicate statistical significance (p < 0.05, 5
wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, 365 nm light, intensity at 5
mW/cm2, mean ± SD, N = 3).
The step-growth thiol-norbornene hydrogels were known to degrade
hydrolytically if ester bonds were presence in the PEGNB macromers [62]. We
evaluated the hydrolytic stability of the three groups of thiol-ene hydrogels (i.e.,
DTT, CD-SH, and CD-AE gel). The hydrolytic degradation of these thiol-ene
hydrogels in neutral buffer solution (pH 7.4) was not significant as the modulus
and swelling ratio remained relatively stable over 10 days (Figure 4.8C & 4.8D).
We reason that this was because these gels were either highly crosslinked (G’ ~7.1
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kPa and 3.4 kPa for DTT and CD-SH gel, respectively) or contained no
hydrolytically labile bonds (e.g., CD-AE thiol-allylether gel). We also conducted
an accelerated hydrolysis study (Figure 4.9) by incubating these hydrogels in basic
buffer (pH 9). As expected, a decline in G’ over time was observed for DTT and
CD-SH gels (both crosslinked with PEG4NB), indicative of base-catalysed
hydrolysis of ester bonds in PEG4NB macromer (Figure 4.9). On the other hand,
CD-AE gel remained intact over time (i.e., constant G’) since thiol-allylether
hydrogels did not contain hydrolytic degradable moieties.
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Figure 4.9. Effect of crosslinker on shear modulus as a function of time in pH 9
PBS. ( 5 wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, 365 nm light, intensity at
5 mW/cm2, mean ± SD, N = 3).

4.3.5 Uptake and release of hydrophobic
curcumin from thiol-allylether hydrogels
One potential application of the CD-PEG hydrogel system is to deliver
hydrophobic drugs. Many anti-inflammatory drugs, such as curcumin [155], are
hydrophobic and hence have lower bioavailability in vivo. Curcumin has also been a
subject of intensive research interest in diabetes because of its blood glucose lowering
effect [156]. Since thiol-norbornene hydrogels would be hydrolyzed in basic buffer [62],
we chose thiol-allylether hydrogels crosslinked by CD-AE and PEG4SH as a model gel
system to demonstrate the enhanced uptake and sustained release effect of curcumin from
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CD-PEG hybrid hydrogels. Pure PEG hydrogels crosslinked by PEGAE and PEG4SH
under the same gelation conditions were used as control. The two sets of gels (labeled as
PEGAE and CD-AE in Figure 4.10) were incubated in ddH2O suspended with
hydrophobic curcumin for 8 hours. As shown in the top panel of Figure 4.10A, hydrogels
crosslinked with CD-AE appeared more yellowish when compared to hydrogels
crosslinked with PEGAE, indicative of higher amount of curcumin (yellow in color)
uptake due to the presence of chemically crosslinked CD in the gel. Subsequently, these
gels were immersed in DMSO to completely liberate the curcumin. As shown in the
bottom panel of Figure 4.10A, both sets of gels appear transparent and identical,
indicating that all curcumin were released from the gels. The liberated curcumin was
quantified via UV/vis absorbance measurement (Figure 4.10B). Compared to pure PEG
hydrogels crosslinked with PEGAE and PEG4SH, hydrogels crosslinked with CD-AE
were capable of loading twice as much curcumin (~9 and ~20 µg/gel for PEGAE and
CD-AE gel, respectively).
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Figure 4.10. (A) Photographs of thiol-allylether hydrogels incubated in curcumin
suspended ddH2O for 8 hours (top) and after DMSO-treatment (bottom). (B) Curcumin
uptake in hydrogels formed by 5 wt% PEG8SH with 3.4 kDa of PEGAE or 24 mg/mL
βCD-AE (1 mM LAP, 365 nm light at 10 mW/cm2).
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Because the amount of curcumin loading in the control PEGAE gel was much
lower than that in the CD-AE gel, it would be difficult to compare the release of
curcumin from these two sets of gels. In order to form complex with βCD, Yadav et al
employed the pH shifting method to solubilize curcumin in an alkaline solution with βCD
[157]. Therefore, we believe that the alkaline condition did not affect the association of
βCD and curcumin.To demonstrate the sustained delivery of curcumin from CDcrosslinked hydrogels, we performed drug-loading in alkaline curcumin solution for 36
hours (curcumin was dissolved in 0.5 N NaOH first, followed by diluting with pH 7.4
PBS). Prior to drug loading the two sets of gels were equally transparent (Figure 4.11A,
panel 1). After drug loading (Figure 4.11A, panel 2), the two sets of thiol-allylether
hydrogels were equally opaque, suggestive of similar curcumin intake. The similar
amount of curcumin absorbed in the gels were quantified by DMSO treatment as
described earlier (Figure 4.11B, 6.6 ± 1.1 and 6.9 ± 0.4 µg/gel for PEGAE and CD-AE
gel, respectively). The gels were then incubated in buffer solution for curcumin release.
Significantly more curcumin was released from hydrogels crosslinked by PEGAE than by
CD-AE (Figure 4.11C, 85 % and 42 % of curcumin was released from PEGAE and CDAE hydrogels after 10 hours, respectively). Over the course of first 100 hours, a 1.8-fold
higher amount of curcumin was released from PEGAE-crosslinked gels than from CDAE crosslinked gels (Figure 4.11C, 87 % and 49 %, respectively\). After the release
study, CD-AE gel appeared slightly darker than PEGAE gel (Figure 4.11A, panel 3),
suggesting that a higher amount of curcumin was still retained in this gel. However, after
DMSO treatment for an additional 100 hours, the remaining curcumin were completely
released from both sets of hydrogels (Figure 4.11C) and the appearances of the gels were
similar in color (Figure 4.11A, panel 4).
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Figure 4.11. (A) Photographs of thiol-allylether hydrogels: (1) immediately after
photopolymerization, (2) after incubating in curcumin solution for 36 hours, (3) after 100
hours of release in pH 7.4 PBS, and (4) after an additional 100 hours of release in DMSO
(scale: 5 mm). (B) Effect of crosslinker on curcumin uptake in the gel. (C) Curcumin
release from thiol-allylether hydrogel formed by 5 wt% PEG8SH with 3.4 kDa of
PEGAE or 24 mg/mL βCD-AE (1 mM LAP, 365 nm light at 10 mW/cm2).
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The increase of curcumin solubility via guest-host interactions with CD is well
documented [158-160]. In our study, CD-AE was employed as both a hydrogel
crosslinker and a carrier for hydrophobic drug (i.e., curcumin). Compared to thiolallylether hydrogels crosslinked by PEGAE, gels crosslinked by CD-AE accommodated
significantly more curcumin due to the formation of inclusion complex. The presence of
CD/curcumin inclusion complex also resulted in delayed/sustained release of curcumin
from the CD-AE hydrogel. Since all curcumin absorbed in the gel could be liberated by
DMSO, we believe that the retention of curcumin was purely due to inclusion complex
formation but not Michael-type reaction occurred between curcumin and nucleophilic
thiols in the gels [161],[162] . For the purpose of proof-of-concept, current study only
demonstrated post-loading of curcumin by CD/PEG hydrogels. Future study will focus on
pre-complexing functionalized CD with curcumin, which can be used as crosslinker to
simultaneously encapsulate drugs and cells in a single reaction.

4.3.6 Cytocompatibility of CD-crosslinked thiol-ene hydrogels

Next, we evaluated the cytocompatibility of CD-crosslinked thiol-ene hydrogels
using in situ encapsulation of pancreatic MIN6 β-cells at a relatively low cell density
(2×106 cells/mL) [149]. Thiol-norbornene hydrogels crosslinked by DTT and PEG8NB
(M.W. 20 kDa) were used as a control group as similar gelation formulation has been
shown to be cytocompatible for radical-sensitive MIN6 β-cells [52]. One day after cell
encapsulation, live/dead staining was performed and the results show that thiolnorbornene hydrogels crosslinked by CD-SH were highly cytocompatible for MIN6 cells
(Figure 4.12A, ~83 % live cells), while hydrogels crosslinked by DTT or by CD-AE
contained slightly more dead cells (Figure 4.12A, ~72 % and 73 % live cells for gels
crosslinked by DTT and CD-AE, respectively). Regardless of the cross-linker used,
MIN6 -cells formed spherical aggregates in all hydrogels 10 days after cell
encapsulation (Figure 4.12A, right panel). The average diameters of the spheroids were
about 18 µm, 26 µm, and 32 µm for hydrogels crosslinked by DTT, CD-SH and CD-AE,
respectively. We also quantified cell metabolic activity using CellTiter-Glo® (for
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measuring intracellular ATP content) and AlamarBlue® regent (for measuring cell
metabolic activity). In DTT or CD-AE crosslinked hydrogels, the intracellular ATP
content increased from ~13 to 200 pmol of ATP per sample (Figure 4.13) from day 1 to
day 10. The difference between DTT and CD-AE crosslinked hydrogels was not
significantly on either day 1 or day 10. On the other hand, the amount of ATP increased
from ~70 to 390 pmol per sample in hydrogels crosslinked by CD-SH (Figure 4.13). The
increased in intracellular ATP was most likely due to the cell proliferation and the
formation of multi-cell aggregates. Cell proliferation in CD-PEG hydrogels was verified
by Alamarblue® reagent assay (Figure 4.12B) and the trends were consistent with
live/dead staining and ATP assay.

Figure 4.12. Effect of crosslinker on the cytocompatibility of thiol-ene hydrogels on
MIN6 β-cells. (A) Representative confocal z-stack images of MIN6 cells stained with
live/dead staining kit on day 1 and day 10. MIN6 cells were encapsulated (2×10 6
cells/mL) in thiol-ene hydrogels crosslinked by DTT, CD-SH or CD-AE. (B) Cells
viability as assessed by Alamarblue® reagent. (C) Normalized insulin secretion. All gel
formulations contained 5 wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, and 365 nm
light at 5 mW/cm2 (Scales: 100 μm).
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Figure 4.13. Effect of crosslinker on the intracellular ATP content of MIN6 β-cells
encapsulated in thiol-ene hydrogels. ATP contents were measured by CellTiter-Glo®
reagent (mean ± SD, N = 3). All gel formulations contained 5 wt% 20kDa PEG8SH or
PEG8NB, 1 mM LAP, and 365nm light at 5 mW/cm2.

Studies have shown that softer matrix and hydrolytic gel degradation promoted
the phenotype, function, and proliferation of MIN6 βcells in 3D [52, 163]. The thiolnorbornene hydrogels in the current study were slightly stiffer (Figure 4.8B) and
relatively stable at pH 7.4 over the course of 10 days (Figure 4.8C & 4.8D). Consistent
with our published work using PEG-based thiol-norbornene hydrogels [62], the
hydrolysis rate of CD-PEG hybrid hydrogels could be accelerated under basic condition
(e.g., pH 9, Figure 4.9). On the other hand, thiol-allylether hydrogels remained
hydrolytically stable (Figure 4.9). Therefore, compared to CD-SH crosslinked hydrogels,
the slightly higher initial cell death (Figure 4.12A to 4.12C) in DTT-crosslinked
hydrogels might be a result of higher gel stiffness. When we replaced PEG8NB with
PEG4NB without changing macromer molecular weight (20 kDa) or content (5 wt%), the
modulus of the hydrogels decreased by half (Figure 4.14, 3.1 kPa and 1.2 kPa for DTT
and CD-SH cross-linked gels, respectively). Additional cell encapsulation studies using
these softer gels showed improved viability of encapsulated MIN6 cells (Figure 4.15, top
panel, >98 % viable cells). In addition to gel stiffness, the presence of active radicals
could induce cellular damage during photo-encapsulation [164]. While thiol-allylether
hydrogels crosslinked by CD-AE were softer than thiol-norbornene hydrogel crosslinked
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by DTT (Figure 4.8B, ~2.4 kPa and 7.1 kPa for CD-AE and DTT gel, respectively), the
viability of MIN6 cells was not much higher (Figure 4.12). We reason that the radicalsensitive MIN6 cells were exposed to active radicals for a longer time during the thiolallylether gelation because of a much lower chain transfer kinetic constant, and hence the
benefits of a softer gel on cell viability was offset by longer exposure of the cells to
radical species.
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Figure 4.14. Effect of crosslinker on elastic modulus at equilibrium swelling. Asterisk
indicates statistical significant between crosslinker βCD-SH and DTT, R < 0.05. (5 wt%
PEG4NB20kDa, [thiol] = [norbornene] = 10 mM, 1 mM LAP, light intensity at 10
mW/cm2, mean ± SD, N = 3)

Finally, we evaluated function of encapsulated cells with static glucose stimulated
insulin secretion (GSIS, Figure 4.12C). Since the viability of MIN6 cells varied among
different conditions, the amount of insulin was normalized to the amount of intracellular
ATP, which scales with cell number at day 10. Compared with thiol-ene hydrogels
crosslinked by DTT or CD-AE, the secretion of insulin by MIN6 cells encapsulated in
thiol-ene hydrogel crosslinked by CD-SH was about 3-fold higher than thiol-ene
hydrogel crosslinked by DTT and CD-AE (Figure 4.12C, about 0.04 CD-SH, and 0.01 for
DTT and βCD-AE). This functional assay result also concurs with the notion that softer
gel matrix promotes phenotype of insulin secreting cells.
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Figure 4.15. Effect of crosslinker on the cytocompatibility of thiol-ene hydrogel on MIN6
β-cells. (A) Representative confocal z-stack images of MIN6 stained with live/dead
staining kit on day 1 and 10. MIN6 were encapsulated (2×106 cells/mL) in thiol-ene
hydrogels crosslinked by βCD-SH (left column) or DTT (right column). MIN6 β-cells
viability measured by (B) CellTiter-Glo®, and (C) Alamarblue® reagent (mean ± SD, N
= 3). All gel formulations contained 5 wt% PEG4NB20kDa, [thiol] = [norbornene] = 10
mM, 1 mM LAP, and light at 5 mW/cm2. (Scale: 100 μm).
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4.4. Materials and Methods

Materials: 4-arm PEG (20 kDa), 8-arm PEG (20 kDa and 40 kDa) and 8-arm PEG-thiol
(PEG8SH, 20 kDa) were purchased from JenKem Technology USA. βCD was purchased
from TCI America. 5-norbornene-2-carboxylic acid, N,N’-dicyclohexylcarbodiimide
(DCC), 4-(dimethylamino) pyridine (DMAP), sodium hydride, and allyl bromide were
obtained from Sigma-Aldrich. Dialysis membranes with MWCO 500-1000 Da and 60008000 Da were obtained from Spectrum Laboratories and Fisher Scientific, respectively.
Other chemicals were purchased from Fisher Scientific unless noted otherwise.

Synthesis of photoinitiator and PEG macromers: The synthesis of photoinitiator
lithium arylphosphonate (LAP) was described as reported elsewhere [38]. PEGtetra-norbornene (PEG4NB, 20 kDa) and PEG-octa-norbornene (PEG8NB, 20 kDa
and 40 kDa) were synthesized following an established protocol [120]. In brief, 5norbornene-2-carboxylic acid (5-fold excess of OH group) and coupling reagent
DCC (2.5-fold excess of OH group) were added to anhydrous dichloromethane
(DCM). The mixture was purged with nitrogen and stirred at room temperature for
1 hour. The resulting norbornene anhydride was filtered into an addition funnel
and added slowly to a flask containing PEG (4-arm or 8-arm), DMAP (0.5-fold of
OH group), and pyridine (0.5-fold of OH group) dissolved in anhydrous DCM.
The flask was purged with nitrogen, kept on ice and allowed to react overnight in
dark. The product was precipitated in cold ethyl ether and collected by filtration.
PEGNB product was re-dissolved in double distilled water (ddH2O) and proceed
with dialysis (MWCO 6000-8000 Da) for 2 days using slightly acidic ddH2O (pH
6.8) to prevent ester hydrolysis of PEGNB. The pure product was obtained from
lyophilization (degree of norbornene substitution >85 %). PEGNB: 1H NMR
(CDCl3, 500 MHz): δ – 4.25 (m, 2H), 5.98 (m, 1H), 6.23 (m, 1H). PEG-allylether
(PEGAE) was synthesized following a published protocol. Briefly, linear PEG (3.4
kDa) was dissolved in anhydrous toluene and dried with evaporation by reduced
pressure. Dried PEG was re-dissolved in anhydrous tetrahydrofuran (THF).
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Sodium hydride (1.5-fold excess of hydroxyl group) was added slowly to the PEG
solution under continuous nitrogen purging at 40 °C. Upon complete liberation of
hydrogen gas, allylbromide (6-fold excess of hydroxyl group) was added drop wise
to the solution. After overnight reaction in dark, sodium bromide salt was filtered
off to afford a PEG-allylether (PEGAE) solution. PEGAE was precipitated in cold
ethyl ether, filtered and dried in vacuuo. The purity of PEGAE product was
verified with H1 NMR in CDCl3 (96 %, Bruker 500). PEGAE: 1H NMR (CDCl3,
500 MHz): δ – 4.04 (m, 2H), 5.31 (m, 1H), 5.43 (m, 1H), 6.07 (m, 1H).
Synthesis of allylether or thiol functionalized βCD: βCD-AE was synthesized
following a published protocol with slight modification [165]. βCD was dried in
vacuum oven overnight and dissolved in 40 mL of anhydrous dimethylformamide
(DMF) in a flask. While purging the flask with nitrogen, desired amount of sodium
hydride (i.e., 2.3, 4.5 or 11.3-fold of [NaH] and [allylbromide] to [βCD]) was
added slowly and the mixture was stirred until no hydrogen gas bubbles were
visible (Figure 4.1A, step i). Allylbromide was added drop wise to the βCD
solution using an addition funnel and the reaction was allowed to continue
overnight in dark (Figure 4.1A, step ii). Next, the volume of βCD-AE mixture was
reduced using a rotary evaporator. βCD-AE was precipitated in cold acetone twice
and dried in a vacuum oven. βCD-AE: 1H NMR ((CD3)2SO, 500 MHz): δ – 4.04
(m, 2H), 5.31 (m, 1H), 5.43 (m, 1H), 6.07 (m, 1H). The exact mass of βCD-AE
was determined by using mass spectroscopy (Agilent Technologies 6520 AccurateMass Q-TOF LC/MS).
Next, thioacetic acid (2-fold excess to [βCD-AE]) was added slowly to 10
mL of DMF containing 1 g of βCD-AE and photoinitiator Irgacure I-2959 (0.5
wt%). Photo-conjugation was initiated by UV-light exposure (Omicure S1000, 365
nm and 10 mW/cm2) for 15 minutes and continued for another 30 minutes after
supplementing with another portion of 0.5 wt% I-2959 (Figure 4.1A, step iii).
βCD-thiolacetate was precipitated in cold acetone, filtered, and dried in vacuum
oven. After re-dissolving βCD-thioacetate in ddH2O (10 mL), while purging with
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nitrogen, 5 mL of sodium hydroxide (2 N) was added to the solution for 5 minutes
to hydrolyze the thioacetate group. The solution was neutralized by adding equal
volume of hydrochloride acid (2 N) solution, followed by dialysis (MWCO 5001000) for 2 days at room temperature (Figure 4.1A, step iv). The product βCDthiol (βCD-SH) was obtained from lyophilization. βCD-SH: 1H NMR ((CD3)2SO,
500 MHz): δ – 1.3 (s, 1H), 1.76 (m, 2H), 2.53 (m, 2H), 3.35 (m, 2H). Ellman’s
assay was performed to determine the concentration of thiol in βCD-SH solution.

Hydrogel fabrication and characterizations: Step-growth thiol-ene hydrogels were
formed by light mediated photo-click reactions using the following macromers: (1)
PEG8SH (20 kDa) and βCD-AE, (2) PEG8NB (20 kDa) and βCD-SH, or (3)
PEG8NB (20 kDa) and DTT. To obtain the best crosslinking efficiency in each
gelation formulation, the stoichiometric ratio of thiol to ene was maintained at one.
The concentration of PEGNB was adjusted based on 1H NMR results to afford
correct norbornene concentrations in the gelation mixtures. Photoinitiator LAP was
added to the precursor solution (50 μL/gel) to afford a final concentration of 1
mM. The precursor solution was injected in between two glass slides separated by
1 mm thick spacers. Hydrogel slabs were prepared by exposing the solution to 365
nm light at 5 mW/cm2 for 5 minutes. To characterize gel fractions, hydrogels were
immediately dried in vacuuo after gelation. Dry mass (W Dry,1) was measured and
the dried polymers were incubated in ddH2O at 37 oC on an orbital shaker for 24
hours to remove uncrosslinked (sol fraction) species. The swollen gels were dried
again in vacuuo and weighed to obtain dried polymer weights (W Dry,2). After
swelling hydrogels in pH 7.4 PBS for two days, the swollen gel weights were
measured (WSwollen). Gel fractions were obtained by the ratio of the two dry masses
(i.e., WDry,1/WDry,2). Hydrogel swelling ratios (q) were defined as the ratio of
swollen gel mass to the second dried polymer mass (i.e., WSwollen/WDry,2).
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Crosslinking efficiency of thiol-ene hydrogel: The average molecular weights
̅̅̅̅𝑐 ) of thiol-ene hydrogels can be obtained from the structural
between crosslinks (𝑀
information of the macromers (i.e., molecular weight and functionality) [63]:
𝑀𝑊
𝑀𝑊
̅̅̅̅
𝑀𝑐 = 2( 𝑓 𝐴 + 𝑓 𝐵 )
𝐴

𝐵

(4.1)

Here, MWA and MWB represent the molecular weight of PEGNB and βCD-SH, while fA
and fB are the number of reactive functionality for PEGNB and βCD-SH, respectively.
With a known ̅̅̅̅
𝑀𝑐 , the ideal network crosslinking density or density of elastically active
chains (vc) and polymer volume fraction (v2) can be calculated [64]:
𝑉

1
𝑣𝑐 = ̅̅̅̅
𝑀 ̅̅̅
𝑣
𝑐 2

(4.2)

Here, ̅̅̅
𝑣2 is the specific volume of PEG (0.92 cm3/g at 37 oC), V1 is the molar volume of
water (18 cm3/mole) and ᵡ12 is the Flory-Huggins interaction parameter for a PEG-H2O
system (0.45).
In situ photo-rheometry was performed at room temperature on a Bohlin
CVO 100 digital rheometer equipped with a light cure cell. A macromer solution
(100 µL) was placed on a quartz plate in the light cure cell and irradiated with light
(Omnicure S1000, 365 nm, 10 mW/cm2) through a flexible light guide. Light was
turned on 30 seconds after starting time-sweep measurement (10 % strain, 1 Hz
frequency, and a gap size of 90 µm) using a 25 mm parallel plate geometry. Gel
points (i.e., crossover time) were determined at the time when storage modulus
(G’) surpassed loss modulus (G”).
Oscillatory rheometry in strain-sweep mode was used to obtain elastic
modulus of the hydrogel. At equilibrium swelling (after 48 hours in pH 7.4 PBS), a
biopsy punch was used to punch out circular gel discs (8 mm in diameter) from the
gel slabs. Storage moduli of the hydrogels were measured using 8 mm parallel
plate geometry with a gap size of 800 μm. The elastic moduli from at least three
hydrogels for each gel formulation were recorded from the average of the linear
viscoelastic region (LVR, linear portion of G’ plotting against % strain).
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Uptake and release of curcumin: Thiol-ene hydrogel discs (25 μL; 4.8 mm dia. ×
1.1 mm height) were formed as described above using the following formulations:
(1) PEG8SH (20 kDa) and βCD-AE, or (2) PEG8SH (20 kDa) and PEGAE (3.4
kDa). After photo-crosslinking, hydrogels were incubated in 2 mL of curcumin
suspended in ddH2O (2 mg/mL). After 8 hours, hydrogels were removed from the
curcumin suspension, rinsed with ddH2O, and placed individually in 1.6 mL tube.
Hydrogels were individually incubated in 500 µL of DMSO. A portion of DMSO
(200 µL) was collected and fresh DMSO (200 µL) was added every 24 hours for
one week. The amount of released curcumin in DMSO was characterized via
measuring absorbance at 430 nm using a microplate reader (BioTek®, Synergy
HT).
In another experiment, hydrogels were transferred to 4 mL scintillation vials
containing 400 μL of curcumin solution, which was prepared by dissolving
curcumin in 0.5 N sodium hydroxide and then diluting with pH 7.4 PBS to a final
concentration of 2 mg/mL. This pH shifting method to dissolve curcumin was
adapted from Yadav et al [157]. After incubating the gels at room temperature for
36 hours, hydrogels were transferred to scintillation vials containing 400 μL of pH
7.4 PBS to rinse off the curcumin adsorbed on gel surface for 10 minutes. The
solution was removed from the vials and 1 mL of pH 7.4 PBS was added to each
vial for curcumin release study. Scintillation vials containing hydrogels were
placed on an orbital shaker (60 rpm) at room temperature. At specific time points,
500 μL of solution was collected from each vial, and fresh 500 μL of pH 7.4 PBS
was added back to the vial. After 48 hours, PBS was completely removed from the
vials, and 1 mL of DMSO was added to each hydrogel to extract the remaining
curcumin from the gels. At specific time points, 500 μL of DMSO was collected
from each vial, and fresh DMSO was added back to the vial to maintain the total
volume at 1 mL. The absorbance of all collected curcumin samples (from
curcumin release and DMSO, 200 µL/sample) were measured using a microplate
reader (BioTek®, Synergy HT) at 430 nm. Measured absorbance was blanked with
either pH 7.4 PBS or DMSO, and correlated to standard curves with known
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concentrations of curcumin. The cumulative uptake of curcumin per gel was the
sum of curcumin released in PBS and DMSO.

Cell encapsulation and viability assay: Mouse insulinoma cells (MIN6, final cell
density in the gels at 2106 cells/mL) were suspended in polymer solutions
containing 1 mM LAP and macromers, including: (1) PEG8NB 20kDa with DTT, (2)
PEG8NB20kDa with βCD-SH or (3) PEG8SH20kDa with βCD-AE. Precursor solution
was exposed to light (365 nm, 5 mW/cm2) for 5 minutes to obtain cell-laden
hydrogels (25 μl/gel), which were maintained in high-glucose DMEM
supplemented with 10 % fetal bovine serum (FBS), 50 μM β-mercaptoethanol, and
1× antibiotic-antimycotic. To characterize cell viability, cell-laden hydrogels were
incubated in 500 μL Almarblue® reagent (10 % in cell culture medium) at 37 oC
and 5 % of CO2. After 14 hours of incubation, 200 μl of media were transferred to
a 96-well plate for fluorescence quantification (excitation: 560 nm and emission:
590 nm). To obtain qualitative cell viability, cells were stained with a live/dead
staining kit (Calcein AM stained live cells green and Edithium homodimer stained
dead cells red) and imaged with confocal microscopy. In each stained hydrogel,
three images were taken at a step size of 10 µm for a total depth of 100 µm per
image. The viability of MIN6 cells was quantified as the percent of live cells over
the total number of live and dead cells.

Insulin secretion from MIN6 cells: Cell function was assayed by glucose
stimulated insulin secretion (GSIS). Briefly, cell-laden hydrogels were rinsed with
HBSS, followed by priming in Krebs-Ringer bicarbonate (KRB) buffer (23 mM
sodium chloride, 1 mM potassium chloride, 4.8 mM sodium bicarbonate, 0.2 mM
magnesium chloride hexahydrate, 0.2 mM calcium chloride dehydrate, 0.5 mM 4(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 0.1 vol% bovine serum
albumin) containing 2.5 mM glucose for 1 hour at 37 oC and 5 % CO2. Then, the
gels were incubated with 500 μL of low (2.5 mM) or high (25 mM) glucose KRB
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for 2 hours each. The high glucose buffer solution was collected and subjected to
insulin ELISA (Mercodia).

HPLC to evaluate potential LAP/CD complex formation: Isocratic HPLC was performed
using acetonitrile and 0.05 M of pH 5 phosphate buffer at a ratio of 35 to 65 (vol.%) as
the mobile phase. βCD was dissolved at different concentrations (0, 1, 5, and 10 mM) in
the mobile phase. Photoinitiator LAP (dissolved at 0.1 mM in the same solvent as the
mobile phase without βCD) was injected and run through an analytical C18 column at a
flow rate of 1 mL/min. The elution of the samples were monitored at 280 nm.

Data analysis & statistics: All experiments were conducted independently for
three times and results were reported as mean ± SD. Data was analyzed with
student’s t-test or two way ANOVA using GraphPad Prism 5 (p < 0.05).

4.5 Conclusion

In summary, we have synthesized step-growth thiol-ene photopolymerized
hydrogel using derivatives of βCD and PEG. We found that thiol-norbornene hydrogels
crosslinked by CD-SH and PEGNB exhibited faster gelation kinetics and higher
crosslinking efficiency when comparing with thiol-allylether hydrogels crosslinked by
PEGSH and CD-AE. Furthermore, the gelation kinetics of thiol-norbornene depended
highly on the functionality of macromer used. In addition, CD/PEG hydrogels afforded
higher loading, as well as prolonged and sustained delivery, of hydrophobic curcumin.
The results of live/dead staining, cell viability assay, and GSIS demonstrated that cell
viability was maintained in these hydrogels, but in some cases affected by hydrogel
properties (e.g., stiffness). Future work will focus on utilizing this CD-based radicalmediated thiol-ene photopolymerized hydrogel as a delivery vehicle of hydrophobic
biomolecules.
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CHAPTER 5
IMPROVING GELATION EFFICIENCY AND
CYTOCOMPATIBILITY OF VISIBLE LIGHT
POLYMERIZED THIOL-NORBORNENE HYDROGELS
VIA ADDITION OF SOLUBLE TYROSINE

5.1. Abstract
Hydrogels containing biomimetic or therapeutic peptides have been used widely
for tissue engineering and drug delivery applications. An attractive technique to prepare
peptide-immobilized hydrogels is photopolymerization, which offers rapid and spatialtemporally tunable gelation kinetics. Recently, our lab introduced a visible light mediated
step-growth thiol-norbornene gelation scheme, in which eosin-Y was used as the sole
photoinitiator. Compared with conventional visible light mediated chain-polymerizations
where multiple initiator components are required, step-growth photopolymerized thiolnorbornene hydrogels are more cytocompatible for in situ encapsulation of radical
sensitive cells, such as pancreatic β-cells. While prior work has demonstrated the efficient
crosslinking of inert poly(ethylene glycol)-norbornene (PEGNB) hydrogels via visible
light irradiation, no peptide linkers were used to render the otherwise inert hydrogel
network bioactive. This contribution explored the crosslinking of various bis-cysteine
containing peptides with macromer 8-arm PEGNB to form biomimetic hydrogels suitable
for in situ cell encapsulation. Initial efforts to polymerize thiol-norbornene PEG-peptide
hydrogels through visible light and eosin-Y mediated crosslinking encountered
challenges in gelation efficiency. During the optimization processes, we found that the
addition of soluble tyrosine during polymerization significantly improved the
crosslinking efficiency of PEG-peptide hydrogels. In addition, soluble tyrosine drastically
enhanced the cytocompatibility of the resulting PEG-peptide hydrogels, as demonstrated
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by in situ encapsulation and culture of pancreatic β-cell line (MIN6) and primary mouse
islets.

5.2. Introduction

Ongoing efforts in biomaterials science and engineering are the design of
bioactive or biomimetic hydrogels for drug delivery and tissue engineering applications.
Towards this end, hydrogels have been fabricated from naturally derived materials such
as alginate [166], glycosaminoglycans [167-170], fibrin [171, 172], chitosan [173-175],
dextran [176], collagen [177], and gelatin [178, 179]. Although hydrogels derived from
natural matrices are inherently bioactive, it is difficult to tune their bioactivity,
mechanics, and degradation features [180]. On the other hand, hydrogels prepared from
purely synthetic polymers, such as polyethylene glycol (PEG) and polyvinyl alcohol
(PVA), have high tunability in mechanical properties but they do not possess bioactive
features necessary for promoting cell viability and function [181-183]. Hence,
biomimetic peptides are routinely used to render the otherwise inert synthetic hydrogel
bioactive.
A classical way of immobilizing peptides in synthetic hydrogel is through chaingrowth copolymerization of acrylated macromers and acrylated peptides [184].
Alternatively, cysteine containing peptides could be readily crosslinked with acrylated
macromers through a mixed-mode photopolymerization [185]. For example, Lin and
Anseth incorporated cysteine-bearing glucagon-like peptide 1 (GLP-1C) into PEGdiacrylate (PEGDA) hydrogel to improve the viability and insulin secretion of
encapsulated islets [186]. Alternatively, PEG-peptide hydrogel could be polymerized via
Michael-type addition between nucleophilic macromers (e.g., acrylate, maleimide, or
vinyl sulfone) and cysteine-containing peptides [73, 187-189]. For example, Garcia and
colleagues synthesized bioactive PEG-peptide hydrogels using 4-arm PEG-maleimide
with cysteine-containing protease-sensitive and integrin-binding peptides (i.e., CRGDS)
to promote the performance of encapsulated islets in vivo [190]. While these PEG-peptide
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hydrogels have found various successful applications, limitations and challenges exist.
For instance, chain-polymerized hydrogels are known to form network containing
heterogeneous and hydrophobic polyacrylate kinetic chains and high molecular weight
degradation products [47, 191-193]. On the other hand, while Michael-type hydrogels
were formed by orthogonal crosslinking, it is difficult to control gelation kinetics and the
resulting gel network often contains high degrees of structural defects [63].
To overcome some of the above-mentioned issues, Anseth and colleagues
introduced a new class of PEG-peptide hydrogels formed by radical-mediated stepgrowth thiol-norbornene photo-click reaction [38]. In this system, low intensity and long
wavelength ultraviolet (UV) light (5–10 mW/cm2, 365 nm) is used to generate primary
radicals from photoinitiator lithium acylphosphinate (LAP) [38]. The radicals deprotonate
protons from bis-cysteine-containing peptides, thus forming thiyl radicals capable of
adding to norbornene in a strictly orthogonal fashion. The replenished carbonyl radicals
are terminated through abstracting additional hydrogens from other thiol-containing
molecules, hence completing the step-growth cycle. Similar to other photopolymerization
schemes, the advantages of step-growth thiol-norbornene reaction include rapid, ambient,
and aqueous reaction conditions, as well as spatial-temporal control over gelation kinetics
[36, 37, 120]. Furthermore, thiol-norbornene photo-click reaction is not susceptible to
oxygen inhibition, providing rapid gelation when comparing to acrylate-based chaingrowth photopolymerizations at equivalent macromer concentration and functionality
[51, 52]. Thiol-norbornene photo-click reactions also hinder disulfide bond formation due
to radical-mediated cleavage [53], thus increasing the degree of crosslinking and
improved mechanical properties [38].
While current thiol-norbornene hydrogels have shown to be cytocompatible for
mammalian cells [38, 52, 54-56, 78, 79, 91, 92, 194], the use of UV-light still raised
concerns of DNA and protein damage [195, 196]. Recently, our lab developed stepgrowth thiol-norbornene photo-click PEG-based hydrogels using a visible light source
(400 nm to 700 nm) and type II photoinitiator eosin-Y [59]. This reaction scheme not
only preserves all advantages offered by photopolymerization, but also eliminates the use
of potentially cytotoxic components (i.e., co-initiator and co-monomer) used in the
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conventional visible light polymerized chain-growth hydrogels. We have shown that
purely synthetic hydrogels (i.e., PEGNB crosslinked with dithiothreitol, DTT) prepared
through this reaction are highly cytocompatible for in situ encapsulation of pancreatic βcells and human mesenchymal stem cells (hMSCs) [59]. In an attempt to create bioactive
hydrogels using visible light thiol-norbornene photopolymerization, we replaced DTT
with bis-cysteine-bearing peptides as the hydrogel crosslinker. However, we found that
the gelation efficiency was influenced significantly on the sequence of the bis-cysteine
peptides. During the optimization processes, we discovered that the addition of soluble
amino acid containing aromatic side chain (e.g., tyrosine, and tryptophan) could improve
the efficiency of cysteine deprotection to form thiyl radicals, implying that gelation
efficiency would be different in the presence of soluble amino acids. To test this
hypothesis, soluble tyrosine was added during visible light polymerization to form PEGpeptide hydrogel. We systematically studied the gelation kinetics and physical properties
of PEG-peptide hydrogel. In addition, we evaluated the cytocompatibility of PEG-peptide
hydrogels to both pancreatic β-cells and isolated mouse islets.

5.3. Results and Discussion

5.3.1. Tyrosine-assisted crosslinking of
thiol-norbornene PEG-peptide hydrogels
To evaluate the influence of soluble tyrosine on gelation kinetics of PEG-peptide
hydrogels formed by visible light mediated thiol-norbornene polymerization, hydrogel
was crosslinked from a bis-cysteine-containing peptide (i.e., CGGGC) and PEG8NB in
the presence of photoinitiator eosin-Y and visible light exposure (400-700 nm at 70,000
lux, Figure 5.1A). We found that PEG-peptide hydrogels crosslinked without soluble
tyrosine had a gel point of about 100 seconds and an ultimate elastic modulus of ~100 Pa
(Figure 5.1B). The poor gelation was unexpected as we had previously demonstrated
rapid gelation using PEGNB with an inert crosslinker – DTT [59]. Since visible lightmediated thiol-norbornene gelation starts with the deprotonation of thiol group by excited
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eosin-Y, we suspected that the poor gelation efficiency shown in Figure 5.1B might be a
result of insufficient deprotonation of thiol groups on cysteine residues, which are part of
the peptide sequence. Furthermore, we found that gelation efficiency depends highly on
the sequence of the bis-cysteine peptide crosslinkers (Figure 5.2). Indeed, the influence of
amino acids (e.g., tyrosine, tryptophan) on the half-life of eosin-Y radicals has been
documented in the literature [195, 197]. Therefore, we hypothesized the addition of
soluble tyrosine might improve the crosslinking efficiency of visible light-based thiolnorbornene hydrogels. To test this hypothesis, soluble tyrosine (e.g., 1 mM) was added
during gelation, which was monitored by in situ photorheometry. With the addition of
tyrosine, the gel point was five-fold faster (~22 seconds) than the gelation without
tyrosine. Furthermore, the ultimate elastic modulus increased ten-fold to ~1000 Pa
(Figure 5.1C). The significant improvement of gelation efficiency in the presence of
soluble tyrosine was indicative of an accelerated deprotonation of peptide-bound cysteine
side-chain and/or the thiol-norbornene coupling.
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Figure 5.1. (A) Scheme of visible light and eosin-Y mediated thiol-norbornene gelation.
(B, C) In situ photorheometry of thiol-norbornene photopolymerization between 3wt%
PEG8NB and 6mM CGGGC in the presence of 0 mM (B), and 1 mM of tyrosine (C). G’:
storage modulus; G”: loss modulus. Eosin-Y: 0.1 mM. Light intensity: 70,000 lux. N = 3.
Error bars were omitted for clarity. In collaboration with Hung-Yi Liu.
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Figure 5.2. In situ photorheometry of thiol-norbornene photopolymerization between
5wt% PEG4NB20kDa and 5 mM of DTT or di-cysteine containing peptide in the presence
of 0.1 mM eosin-Y. G’: storage modulus. Light intensity: 70,000 lux. N = 3. Error bars
were omitted for clarity.

To further examine the kinetics of tyrosine-assisted thiol-norbornene reaction, we
characterized thiol and norbornene consumptions using precursor solution containing
non-gelling components, including linear PEG-norbornene (PEGdNB. MW: 6 kDa),
soluble cysteine, eosin-Y, and soluble tyrosine at different concentrations. After visible
light exposure, the concentration of free thiol remaining in the solution was quantified by
Ellman’s reagent. Figure 5.3 shows that the rate of thiol conversion was faster at higher
soluble tyrosine concentrations. At 20 seconds (where gel point was previously
determined, Figure 5.1C), thiol conversion increased from 22 to 48 % as the
concentration of tyrosine was increased from 0 to 10 mM (Figure 5.3, right panel). This
higher thiol conversion rate in the presence of soluble tyrosine could explain the faster
gel point shown in Figure 5.1C. Regardless of the amount of soluble tyrosine added, all
non-gelling formulations eventually reached similar thiol conversion (~95% at 300
seconds of visible light exposure). Even though all non-gelling formulations had similar
thiol conversion (Figure 5.3), hydrogels formed without soluble tyrosine showed lower
ultimate elastic modulus than that formed in the presence of soluble tyrosine (Figure
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5.1B). The faster gelation assisted by soluble tyrosine likely decreased network non-

Thiol Conversion (%)

ideality, and hence higher gel modulus.

60

100
80

40

60

10 mM
1 mM
0.1 mM
0 mM

40
20
0
0

100

200

20

300

Time (seconds)

0

0

10

20

30

Time (seconds)

40

Figure 5.3. Thiol conversion quantified by Ellman’s assay. The right panel shows the
shaded region in the left plot. (3.4 wt% PEGdNB6kDa, 12 mM L-cysteine, 0.1 mM eosinY. Tyrosine was added at indicated concentration, N = 3) In collaboration with Hung-Yi
Liu.
In a separate experiment, we examined the consumption of norbornene in nongelling samples using 1H NMR. The areas under the norbornene signature peaks (Figure
5.4 and 5.5A, norbornene peaks: δ 5.8-6.2 ppm) were used to represent norbornene
conversion. As the concentration of soluble tyrosine was increased from 0 to 10 mM
(Figure 5.4A and 5.5B, tyrosine peaks: δ 6.8-7.2 ppm), the area under the norbornene
signature peaks decreased from 1.86 to 0.37 a.u. (Table 5.1). When compared with
unreacted PEGNB (Table 5.1, area under norbornene peaks: 7.05 a.u.), the norbornene
consumption increased from 74 to 95 % when the concentration of soluble tyrosine was
increased from 0 to 10 mM (Table 5.1). Since the step-growth thiol-norbornene reaction
is strictly orthogonal (i.e., no homo-polymerization between norbornene groups under
current experimental conditions), the amount of norbornene consumed after the reaction
could be attributed to thiol-norbornene coupling.
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Figure 5.4. Effect of tyrosine on norbornene conversion determined by 1H NMR using
non-gelling components: PEGdNB6kDa (3.6 wt%), soluble cysteine (12 mM), eosin-Y (0.1
mM), and tyrosine from 0 mM to 10 mM (from top to bottom). All prepared with D2O (at
4.8 ppm). The integration of the areas under the norbornene peaks are reported in Table
5.1.
Table 5.1. Area of norbornene peaks integrated from 1H NMR results (Figure 5.4).
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Figure 5.5. 1H NMR of (A) PEGdNB6kDa and (B) L-tyrosine methyl ester. All prepared
with D2O (at 4.8 ppm).

5.3.2. Effect of tyrosine on the
spectrophotometric properties of eosin-Y
In addition to the alteration of gel properties, we observed a decreased in the redness of
hydrogels with increasing tyrosine used during gelation (Figure 5.6A). The color of the
gels was due to the intrinsic color of eosin-Y sequestered within thiol-ene gel network
during gelation [58]. Since the concentration of eosin-Y was the same across the four
formulations, the disappearance of redness was potentially due to the quenching of eosinY by tyrosine through a proton-coupled electron transfer process [198, 199]. To verify
this, we evaluated the spectrophotometric properties of precursor solution containing
non-gelling components. Before exposing solution to light, the UV/Vis spectra of these
solution were similar regardless of the concentration of tyrosine used (peak absorbance of
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~0.5 at 516 nm, Figure 5.6B to 5.6D). However, after exposing the non-gelling solution
to visible light, the reduction in peak absorbance (at 516 nm) with increasing
concentration of tyrosine (Figure 5.6B to 5.6D, 0.25 to 0.18 a.u. for 0 mM to 10 mM of
tyrosine, respectively) confirmed the quenching of eosin-Y by tyrosine.
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Figure 5.6. (A) Photograph of hydrogels at equilibrium swelling. UV-vis spectra of eosinY before (thick blue) and after (thin red) visible light exposure for 5 minutes in the
presence of PEGdNB, CGGGC, and varied concentrations of tyrosine. Tyrosine
concentration: (B) 0 mM, (C) 0.1 mM, (D) 1 mM, and (E) 10 mM. Eosin-Y concentration
in all measurements: 0.1 mM. (3.4 wt% PEGdNB6kDa or 3 wt% PEG8NB20kda, 6 mM
CGGGC, 0.1 mM eosin-Y, 400-700 nm light, intensity at 70,000 lux, mean ± SD, N = 3).
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5.3.3. Effect of tyrosine, macromer content and
thiol-to-norbornene ratio on hydrogel properties
We further investigated hydrogel properties with respect to the concentration of
soluble tyrosine added during gelation. Here, CGGGC was used as a model peptide for
gel characterizations. As we increased the concentration of soluble tyrosine from 0 to 1
mM, gel fraction increased from 50 to 65 % (Figure 5.7A), elastic modulus increased
from 1 to 3 kPa (Figure 5.7B), and equilibrium swelling ratio decreased from 16 to 10
(Figure 5.7C). These metrics were indicative of an improved crosslinking in the presence
of soluble tyrosine. This implies that the network crosslinking density of these PEGpeptide hydrogels could be tuned easily with the amount of tyrosine added during
reaction. Interestingly, further increasing tyrosine from 1 to 10 mM led to a decreased in
gel fraction, elastic modulus and an increased in swelling ratio. The negative impact of
high tyrosine concentration on gel properties was unexpected as the results obtained from
thiol and norbornene consumption (Figure 5.3 and 5.4) showed a monotonic increase of
functional group conversion. We hypothesize that the increased network non-idealities at
high tyrosine content (i.e., 10 mM) was likely due to steric inference caused by tyrosine.
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Figure 5.7. Effect of tyrosine on (A) gel fraction, (B) elastic modulus at equilibrium gel
swelling, and (C) swelling ratio as a function of time. (3 wt% PEG8NB, 6 mM CGGGC,
0.1 mM eosin-Y, 400-700 nm light, intensity at 70000 lux, mean ± SD, N = 3). In
collaboration with Hung-Yi Liu.
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In addition to tuning gel properties by varying the concentration of soluble
tyrosine, the physical properties of gels could also tuned by varying PEG8NB
macromer and the ratio of ene to thiol. As PEG8NB concentration was increased
from 3 to 9 wt%, there was a 25–fold increase in elastic modulus at equilibrium
swelling (Figure 5.8A, from 1.3 to 32 kPa). In addition, increasing ratio of
norbornene to thiol from 0.6 to 1 led to a 26–fold increase in elastic modulus at
equilibrium swelling (Figure 5.8B, 0.05 to 1.3 kPa). These studies demonstrated
the high tunability of visible light polymerized step-growth PEG-peptide hydrogels
[59, 62].
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5.3.4. Cytocompatibility of PEG-peptide hydrogels

Next, we evaluated the cytocompatibility of thiol-ene hydrogel crosslinked in the
presence of soluble tyrosine using in situ encapsulation of pancreatic MIN6 β-cells.
Thiol-norbornene hydrogels were crosslinked by laminin-derived peptide (i.e.,
KCYIGSRCK) and non-degradable 8-arm PEGNB (PEG8aNB, 20 kDa) with or without
adding soluble tyrosine. Here, laminin-derived peptide was used to mimic β-cells
extracellular microenvironment [200-202]. To ensure that matrix stiffness would not a
confounding factor when evaluating cellular fate, cell-laden hydrogels were formulated to
have similar modulus (Figure 5.9, ~2 kPa), which was achieved through adjusting
stoichiometric ratio of thiol to norbornene (i.e., R[thiol]/[ene] = 1 for gelation without
tyrosine and 0.85 gelation with 1 mM of tyrosine). Hydrogels crosslinked with PEG8aNB
were hydrolytically stable throughout the course of study (Figure 5.9). One day after cell
encapsulation, live/dead staining was performed and more than 90 % of cells were
stained green indicating that hydrogels were cytocompatible for in situ encapsulation of
β-cells. However, we observed slightly more dead cells (stained red) when encapsulation
was performed without tyrosine (Figure 5.10A, top). Regardless of the initial cell
viability, β-cells formed cell spheroids after 10 days of culture in both formulations
(Figure 5.10A, bottom). In addition, AlamarBlue® reagent was used to quantify
metabolic activity of the cells encapsulated within the hydrogels. Compared with cells
encapsulated in the absence of tyrosine, cells encapsulated in the presence of tyrosine
showed higher cell metabolic activity throughout the course of study (Figure 5.10B).
Most importantly, β-cells encapsulated in the presence of tyrosine had higher insulin
secretion than cells encapsulated without the addition of tyrosine (Figure 5.10C, 2-fold
and 3-fold higher on day 1 and 10, respectively). We examined the expression of insulin
(ins) and pancreatic duodenal homeobox-1 (pdx1) on the mRNA level. These two genes
were chosen because of their importance in glycemic control and in proliferation of
pancreatic β-cells [203, 204]. The mRNA expression of ins and pdx1 showed that the
addition of tyrosine did not create adverse influence on β-cells (Figure 5.11). Together,
the addition of soluble tyrosine increased cell viability, insulin secretion, and did not
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negatively impact beta cell-related gene expression. These results were most likely due to
faster gelation kinetics, which reduced exposure time of radicals on radical sensitive βcells.
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Figure 5.9. Effect of tyrosine concentration on the degradability of PEG-peptide
hydrogels. All gel formulations contained β-cells at 5×106 cells/mL, 3.5 wt% PEG8aNB,
7 mM KCYIGSRCK, 0.1 mM eosin-Y, and 400-700 nm light at 70000 lux.
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Figure 5.11. Effect of tyrosine on the mRNA expression of MIN6 β-cells. mRNA level of
(A) Ins and (B) Pdx1 evaluated by qPCR. Actβ was used as a house keeping gene. *
indicates comparison between day 1 and day 10, while % indicates comparison between 0
to 1 mM of tyrosine, p < 0.05. All gel formulations contained β-cells at 5×106 cells/mL,
3.5 wt% PEG8aNB, KCYIGSRCK, 0.1 mM eosin-Y, and 400-700 nm light at 70000 lux.
Ratio of [thiol] to [norbornene] was 1 and 0.85 for 0 mM and 1 mM of tyrosine,
respectively.

In addition to encapsulate β-cells, in situ cell encapsulation was also performed on
islets isolated from CD1 mice. One day post encapsulation, live/dead images of
encapsulated islets showed a significant amount of cell death (cells stained red) when
islets were encapsulated without tyrosine (Figure 5.12A). When islets were challenged
with glucose, only islets encapsulated in the presence of tyrosine showed a significant
enhancement in insulin secretion (Figure 5.12B, 4-fold increased with 1 mM of tyrosine
used). Collectively, the decreased cell viability and insulin-secreting function was
potentially due to longer exposure of cells to radicals.
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Figure 5.12. Effect of tyrosine on the cytocompatibility of CD1 mouse islets. (A)
Representative confocal z-stack images of islets stained with live/dead staining kit on day
1. (B) Glucose stimulated insulin secretion normalized by ATP content per gel (day 1).
Gel formulations: 3.5 wt% PEG8aNB, KCYIGSRCK, 0.1 mM eosin-Y, and 400-700 nm
light at 70000 lux (Scales: 100 μm).

5.4. Materials and Methods

Materials: 8-arm PEG and PEG-amide were purchased from JenKem Technology USA.
Fmoc-protected amino acids, HBTU, and HOBT were purchased from AnaSpec. Linear
PEG (6 kDa), 5-norbornene-2-carboxylic acid, N,N’-dicyclohexylcarbodiimide (DCC),
4-(dimethylamino) pyridine (DMAP) were obtained from Sigma-Aldrich. Dialysis
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membranes and other chemicals were obtained from Fisher Scientific unless noted
otherwise.

PEGNB synthesis: Linear PEG-norbornene (PEGNB, 6 kDa) and PEG-octa-norbornene
(PEG8NB, 20 kDa and 40 kDa) was synthesized following an established protocol [120].
In brief, 5-norbornene-2-carboxylic acid (5-fold excess of OH group) and coupling
reagent DCC (2.5-fold excess of OH group) were added to anhydrous dichloromethane
(DCM). The mixture was purged with nitrogen and stirred at room temperature for 1
hour. The resulting norbornene anhydride was filtered into an addition funnel and added
slowly to a flask containing PEG, DMAP (0.5-fold of OH group), and pyridine (0.5-fold
of OH group) dissolved in anhydrous DCM. The flask was purged with nitrogen, kept on
ice and allowed to react overnight in dark. The reaction was repeated for the second time
to improve the functionalization of norbornene on PEG. The product was precipitated in
cold ethyl ether and collected by filtration. PEGNB product was re-dissolved in double
distilled water (ddH2O) and proceed with dialysis for 2 days using slightly acidic ddH2O
(pH 6.8) to prevent ester hydrolysis of PEG8NB. The pure product was obtained from
lyophilization (degree of norbornene substitution >85 %). PEGNB: 1H NMR (CDCl3, 500
MHz): δ – 4.25 (m, 2H), 5.98 (m, 1H), 6.23 (m, 1H).
To

synthesize

hydrolytically

stable

PEG-amide-norbornene

(PEGaNB),

norbornene acid (5-fold excess to amine groups) was first activated by HBTU/HOBT
(5.5-fold excess to amine group) in dimethylformamide (DMF) for 3 minutes. With
nitrogen gas purging, N,N-Diisopropylethylamine (DIEA, 6-fold excess to amine group)
was added to the activated norbornene acid solution and stirred for 5 minutes. The
solution was added drop wise to a two-neck flask containing PEG-octa-amine in DMF.
After overnight reaction at room temperature, the product was precipitated in cold ethyl
ether. After drying in vacuuo, PEGaNB product was re-dissolved in water and dialyzed
for 2 days.

1

H NMR (Bruker 500) was used to confirm the degree of PEG

functionalization (> 90 %).
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Peptide synthesis: All peptides were synthesized in an automated microwave-assisted
peptide synthesizer (CEM Discover SPS attached with Liberty 1). Crude peptides were
cleaved from resins using phenol, trifluoroacetic acid (TFA), triisopropylsilane (TIS), and
ddH2O. Cleaved peptides were precipitated in cold ethyl ether, collected through
centrifugation, dried in vacuuo, and purified by reverse phase HPLC (PerkinElmer Flexar
system). Peptide identity was confirmed by mass spectrometry (Agilent Technologies
Model 1200-6520).

Hydrogel fabrication and characterization: Step-growth thiol-norbornene hydrogels were
formed by visible light mediated photo-click reactions using PEG8NB and di-cysteine
peptide (i.e., Cys-Gly-Gly-Gly-Cys or CGGGC) in the presence of 0.1 mM of eosin-Y.
L-tyrosine methyl ester (i.e., soluble tyrosine) was added in selected formulations. The
concentration of PEG8NB was adjusted based on 1H NMR results to afford correct
norbornene concentrations in the gelation mixtures. The precursor solution was injected
in between two glass slides separated by 1 mm thick spacers or in 1 mL syringe mold
with an open tip. Hydrogel crosslinking was initiated by exposing the solution to 400-700
nm light at 70,000 lux (equivalence of 10mW/cm2 at 550nm) for 5 minutes. To
characterize gel fractions, hydrogels were immediately dried in vacuuo after gelation.
Dry mass (WDry,1) was measured and the dried polymers were incubated in ddH2O at 37
o

C on an orbital shaker for 24 hours to remove un-crosslinked (sol fraction) species. The

swollen gels were dried again in vacuuo and weighed to obtain second dried polymer
weights (WDry,2). Gel fractions were obtained by the ratio of the two dry masses (i.e.,
WDry,1/WDry,2). In selected experiments, gels were allowed to swell in pH 7.4 PBS for two
days prior to obtaining swollen gel weights (WSwollen). Hydrogel swelling ratios (q) were
defined as the ratio of swollen gel mass to the second dried polymer mass (i.e.,
WSwollen/WDry,2).

Rheometry: In situ photo-rheometry was performed at room temperature on a Bohlin
CVO 100 digital rheometer equipped with a light cure cell. A macromer solution (100
µL) was placed on a quartz plate in the light cure cell and irradiated with the visible light
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(400-700 nm, 70,000 lux) through a flexible light guide. Light was turned on 30 seconds
after starting time-sweep measurement (5 % strain, 1 Hz frequency, and a gap size of 90
µm) using a 25 mm parallel plate geometry. Gel points (i.e., crossover time) were
determined at the time when storage modulus (G’) surpassed loss modulus (G”).
Oscillatory rheometry in strain-sweep mode was used to obtain elastic
modulus of the hydrogel. At equilibrium swelling (after 48 hours in pH 7.4 PBS), a
biopsy punch was used to punch out circular gel discs (8 mm in diameter) from the
gel slabs. Storage moduli of the hydrogels were measured using 8 mm parallel
plate geometry with a gap size of 750 μm. The elastic moduli from at least three
hydrogels for each gel formulation were recorded from the average of the linear
viscoelastic region (LVR, linear portion of G’ plotting against % strain).

Thiol and norbornene consumption: Eosin-Y (at 0.1 mM) and various components (i.e.,
PEGdNB6kDa, L-cysteine HCl, and L-tyrosine methyl ester) were dissolved in PBS (pH
7.4) and exposed to visible light (400-700 nm, 70,000 lux). Concentrations of the
components were equivalent to those used in gelation studies (final concentration of
norbornene and thiol = 12 mM). To determine thiol-consumption, portions of non-gelling
solution throughout 5 minutes of light exposure were collected, and the content of the
free thiol was immediately assayed with Ellman’s reagent buffer. The thiol concentration
presented at the specific time was measured against a known standard (i.e., L-cysteine
HCl). In a separate experiment, non-gelling precursor solutions (1 mL each) were
lyophilized after exposing to light for 5 minutes. 1H NMR was used to evaluate the
signature peaks for norbornene (D2O was used for dissolution). The areas of the
norbornene peaks (δ 5.8-6.2 ppm) were obtained and all integrated areas obtained were
further compared to the area under the norbornene peaks for pure PEGdNB at the same
macromer concentration (Figure 5.5A and Table 5.1). Norbornene consumption was
calculated using the difference in the area of the norbornene peaks before and after
reaction over that before the reaction.
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Spectrophotometric properties: Eosin-Y (at 0.1 mM) and various components (i.e.,
PEGdNB6kDa, L-cysteine HCl, and L-tyrosine methyl ester) were dissolved in PBS (pH
7.4) and exposed to visible light for 5 minutes. Non-gelling components were used (e.g.,
PEGdNB and L-cysteine) to prevent gelation and to facilitate solution-based UV/Vis
spectrometric measurements. Concentrations of the components were equivalent to those
used in gelation studies (final concentration of norbornene and thiol = 12 mM). Using a
microplate reader (BioTek Synergy HT) in UV/Vis absorption mode (wavelength
between 400 and 700 nm at 2 nm increments), the absorbance spectra of the non-gelling
solutions were measured before and after the exposure of light. To prevent saturation in
absorbance, solution was diluted so the final concentration of eosin-Y is 0.02 mM.

Cell encapsulation and viability: Mouse insulinoma cells (MIN6, final cell density in the
gels at 5106 cells/mL) were suspended in polymer solutions containing 0.1 mM eosin-Y,
PEG8aNB, and di-cysteine peptide (i.e., Lys-Cys-Tyr-Ile-Gly-Ser-Arg-Cys-Lys or
KCYIGSRCK) with and without tyrosine. Precursor solution was exposed to the same
visible light for 5 minutes to obtain cell-laden hydrogels (20 μl/gel), which were
maintained in high-glucose DMEM supplemented with 10 % fetal bovine serum (FBS),
50 μM β-mercaptoethanol, and 1× antibiotic-antimycotic. Similar procedure was
performed to encapsulate isolated CD1 islets. CD1 mice (7- to 8-week old) were obtained
from Charles River and islets were isolated following established protocol [125].
Permission for animal studies was approved by Indiana University School of Medicine
IACUC (protocol #10235-MD/R). Islets encapsulated gels were maintained in RPMI1640 media supplemented with 10 % FBS, and 1× antibiotic-antimycotic. To
characterize cell viability, cell-laden hydrogels were incubated in 500 μL Almarblue®
reagent (10 % in cell culture medium) at 37 oC and 5 % of CO2. After specific hours of
incubation (16 hours for MIN6), 200 μl of media were transferred to a 96-well plate for
fluorescence quantification (excitation: 560 nm and emission: 590 nm). To obtain
qualitative cell viability, cells were stained with a live/dead staining kit (Calcein AM
stained live cells green and Edithium homodimer stained dead cells red) and imaged with
confocal microscopy (Olympus FV-1000 Laser Scanning Biological Microscope). For
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MIN6 encapsulated gels, three images were taken at a step size of 10 µm for a total depth
of 100 µm per image. For islets encapsulated gels, images were taken at a step size of 5
µm for a total depth of 50 µm per image.

Insulin secretion from islets: To access glucose stimulated insulin secretion
(GSIS), cell-laden hydrogels were rinsed with HBSS, followed by priming in
Krebs-Ringer bicarbonate (KRB) buffer (23 mM sodium chloride, 1 mM
potassium chloride, 4.8 mM sodium bicarbonate, 0.2 mM magnesium chloride
hexahydrate, 0.2 mM calcium chloride dehydrate, 0.5 mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid and 0.1 vol% bovine serum albumin) containing 2.5
mM glucose for 1 hour at 37 oC and 5 % CO2. Then, the gels were incubated with
500 μL of low (2.5 mM) or high (25 mM) glucose KRB for 2 hours each. The low
and high glucose buffer solutions were collected and analyzed using mouse insulin
ELISA kit (Mercodia). Cell viability was further quantified by CellTiter Glo®
assay (Promega). Insulin secretion obtained from ELISA was normalized by the
respective ATP content of the cell-laden hydrogels.

mRNA isolation and rtPCR: In preparation for RNA isolation, cell-laden gels were
rapidly frozen using liquid nitrogen and stored in -80 oC until use. Collected samples
were processed following NucleoSpin® RNA protocols (Clontech). The concentrations
of pure RNA were determined using NanoDrop 2000 Spectrophotometer (Thermo
Scientific). RNA was reverse transcribed into cDNA using PrimeScript TM RT Reagent
Kit (Clontech). SYBR Premix Ex Taq II kit (Clontech) was used for quantitative real
time PCR (Applied Biosystems 7500 Fast Real-Time PCR machine) for selected genes
(Table 5.2). The results for gene of interests were internally normalized by a house
keeping gene (i.e., β-actin), and further normalized to control (i.e., gels crosslinked
without tyrosine on day 1).
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Table 5.2. Mouse primer sequences used in real time PCR.
Gene Symbol

Primer Sequence

Reference

TGAGAGGGAAATCGTGCGTG
Actβ

[205]
TGCTTGCTGATCCACATCTGC
TGGCTTCTTCTACACACCCAAG

Ins

[206]
ACAATGCCACGCTTCTGCC
CGGACATCTCCCCATACGAAG

Pdx1

[207]
CCCCAGTCTCGGTTCCATTC

Data analysis: All experiments were conducted independently for three times and results
were reported as mean ± SD. Data was analyzed with student’s t-test using GraphPad
Prism 5 (p < 0.05).

5.5. Conclusion

In summary, we have synthesized visible light mediated step-growth thiolnorbornene photopolymerized hydrogel using multi-arm PEGNB and di-cysteine
containing peptides. We found that thiol-norbornene hydrogels crosslinked in the
presence of soluble tyrosine exhibited faster gelation kinetics and higher crosslinking
efficiency. Furthermore, the network crosslinking depended highly on the amount of
tyrosine, concentration of macromer and the ratio of norbornene to thiol used. In addition,
a series of cell viability tests revealed that hydrogels crosslinked in the presence of
tyrosine preserved the viability and insulin secreting function of pancreatic β-cells and
mouse islets. Together, this data show that PEG-peptide hydrogels formed by visible light
mediated thiol-ene polymerization should be of great interest for drug delivery and tissue
engineering applications.
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CHAPTER 6
TUNING STIFFNESS OF CELL-LADEN
HYDROGEL VIA HOST-GUEST INTERACTIONS

6.1 Abstract

We report a dynamic hydrogel system with on-demand tunable matrix stiffness.
The hydrogels are formed by thiol-allylether photo-click reaction using thiolated
poly(vinyl alcohol) (TPVA), 4-arm poly(ethylene glycol)-allylether (PEG4AE), and
mono-functional β-cyclodextrin-allylether (βCDAE). Adamantane-functionalized 4-arm
PEG (PEG4AD) is used to stiffen hydrogels, whereas unmodified βCD is used to induce
gel softening. The stiffening and softening processes are fully reversible and these
hydrogels are ideal for investigating the effect of matrix mechanics on cell fate processes.

6.2 Introduction

Dynamic cell-laden hydrogels are increasingly developed for studying the
influence of matrix mechanics on cell fate processes [208]. For example, stiffness of a
cell-laden hydrogel could be irreversibly decreased through user-controlled or cellmediated matrix degradation [62, 209-211]. On the other hand, the crosslinking density
of some hydrogels could be increased irreversibly by applying secondary photocrosslinking in the presence of the primary cell-laden hydrogel network [212, 213]. One
common feature of the aforementioned strategies is that the changes in matrix mechanics
are irreversible, hence these matrices might not be ideal for studying the impact of
Chaper 6 here is as appeared in H. Shih and C. Lin, Journal of Materials Chemistry B, 2016, DOI:
10.1039/C6TB00890A
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dynamic matrix stiffening on cellular mechanobiology [214, 215]. Here, we report a
dynamic cell-laden hydrogel platform with post-gelation tunability in matrix stiffness,
which is achieved by providing reversible host-guest interactions within the cell-laden
hydrogel network. The hydrogels are prepared by a single step light-mediated thiolallylether photo-click reaction using thiolated poly(vinyl alcohol) (TPVA), 4-arm
poly(ethylene glycol)-allylether (PEG4AE), and β-cyclodextrin-allylether (βCDAE). The
thiol-allylether photo-click gelation is compatible with in situ cell encapsulation and the
stiffness of the hydrogel are tuned through non-covalent host-guest interactions between
network-immobilized βCD and soluble 4-arm PEG-adamantane (PEG4AD) supplied on
demand. The stiffening/softening processes are fully reversible by means of incubating
gels in PEG4AD and βCD solutions, respectively. More importantly, the magnitude of
the stiffness change can be tuned from several hundreds to a few kilo-Pascals, a range
relevant to many cell fate processes [216].
The influence of matrix biomechanical properties on cell fate has been intensively
studied in the past decade [214, 217-221]. In particular, the differentiation of
mesenchymal stem cells (MSC) has been shown to depend on substrate stiffness [153,
216, 217, 222]. Furthermore, mechanical properties of tissues have been implicated in
invasion and drug resistance of cancer cells [214, 215, 223-225], as well as in
myofibroblastic activation of hepatic stellate cells and valvular interstitial cells [68, 226228]. It is commonly accepted that a cell culture matrix should present relevant
mechanical properties for maintaining appropriate cell phenotype [163, 229], and the
ultra-stiff tissue culture plastics (TCP) fail to provide such a physiologically relevant
context. On the other hand, commercially available three-dimensional (3D) cell culture
matrices are mechanically unstable and with limited tunability in stiffness post-gelation
[230]. In view of the challenges facing these cell culture platforms, the past decade has
witnessed increasing interests in 3D cell culture matrices with tailor-made and
dynamically tunable biophysical and biochemical properties [231, 232]. To affect cell
fate processes in 3D, synthetic polymeric cell-laden hydrogels can be designed to
undergo different modes of degradation, including hydrolytic, enzymatic, or photolytic
degradation [62, 209-211]. Hydrogels can also be hardened through secondary radical-
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mediated chain-growth or step-growth photopolymerizations [212, 213]. For example, the
presence of excess unreacted vinyl groups in the primary hydrogel network permits
additional crosslinking reactions for network stiffening [212, 213]. Although this
approach readily increases hydrogel crosslinking density and stiffness, additional radicals
formed during secondary photocrosslinking might be a confounding factor. While these
dynamic material systems have demonstrated improvements over the conventional static
cell culture systems, the stiffness of these hydrogels can only be decreased or increased
irreversibly.
A hydrogel system with reversibly tunable matrix crosslinking and stiffness
should be highly desirable in the study of cellular mechanobiology. An approach suitable
for achieving reversible matrix crosslinking is the supramolecular host-guest interactions,
which have been used extensively to enhance solubility of hydrophobic drugs and to
design self-healing polymers [233-235]. For example, the hydrophobic cavity of
macrocyclic molecules (e.g., CD, and cucurbit[8]uril) can reversibly bind to a variety of
hydrophobic drug molecules (e.g., curcumin, paclitaxel, doxorubicin, etc.) [235-239]. In
another example, light-responsive supramolecular hydrogels formed from azobenzenefunctionalized hyaluronan (Azo-HA) and CD-functionalized polymers were used to
encapsulate proteins and cells when Azo is in trans conformation, which permits CD/Azo
complexation and network formation [240, 241]. Upon light exposure, Azo undergoes
trans-to-cis isomerization, resulted in the disruption of CD/Azo complexes and the
liberation of proteins and cells [240, 241]. Supramolecular ’host-guest‘ interactions
between adamantane (AD) and CD have also been exploited for forming cell-laden
hydrogels exhibiting injectable and shear-thinning properties [242-245]. To the best of
our knowledge, however, supramolecular chemistry and host-guest interactions have not
been exploited to induce reversible post-gelation hydrogel stiffening and/or softening in
the presence of cells.
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Figure 6.1. (A) Schematics of thiol-allylether photo-click reaction using photoinitiator
LAP and long-wave ultraviolet light exposure (365 nm, 10 mW/cm2). (B-D) Chemical
structures of the major macromers used, including TPVA (B), PEG4AE (C), and βCDAE
(D).
Here, we report the design of cell-laden hydrogels with reversibly tunable
stiffness by means of non-covalent and reversible host-guest interactions between
pendant βCD and soluble PEG4AD. The primary hydrogel network was prepared from
thiol-allylether photopolymerization (Figure 6.1A) using TPVA (Figure 6.1B) and
PEG4AE (Figure 6.1C) as the macromolecular crosslinkers. βCD-allylether (βCDAE,
Figure 6.1D) was co-polymerized in the primary hydrogel network as pendant ‘host‘
motifs that can form additional physical crosslinks in the presence of soluble PEG4AD.
Thiol-allylether photopolymerization was used to create the primary hydrogel network
due to its orthogonal crosslinking, as well as its facile and quantitative immobilization of
pendant βCD. Through supramolecular host-guest interactions, chemically immobilized
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‘host’ molecules (i.e., βCDAE, Figures 6.1D and 6.2) interact with user-supplied ‘guest’
macromolecules (i.e., PEG4AD), resulting in increased hydrogel crosslinking density and
elastic modulus. When needed, this ‘stiffened’ hydrogel can be ‘softened’
thermodynamically or through competitive binding provided by soluble βCDs. In
principle, the process of hydrogel stiffening or softening can be repeated indefinitely if no
other degradation mechanism exists.
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Figure 6.2. (A) 1H NMR of βCD (top), and βCD-AE (bottom). Prepared with D2O (at
4.79 ppm). (B) Mass spectroscopy of βCDAE.
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6.3 Results and Discussion

To demonstrate the efficient crosslinking of orthogonal thiol-allylether hydrogels,
we conducted in situ photorheometry using TPVA and PEG4AE in the absence (Figure
6.1E) or presence of βCDAE (Figure 6.1F). After the light was switched on, the thiolallylether (TPVA-PEGAE) gelation occurred very rapidly (gel point: ~3 seconds) and the
time required to reach 95% of ultimate stiffness was only ~2 minutes. The addition of
βCDAE in the precursor solution led to a higher ultimate gel elastic modulus (G’ ~ 2.4
kPa) and higher gel fraction (Figure 6.3A). One potential explanation for the higher
initial gel stiffness in the presence of βCDAE (Figure 6.1F) is that some βCDAE might
have more than two allylether motifs that contribute to additional crosslinking (Figure
6.2B). Another potential is that immobilized bulky βCDAE decreased chain flexibility of
linear TPVA, thereby increasing hydrogel stiffness. It is worth noting that, compared
with similar light-mediated step-growth gelation using PEG-thiol and PEG-allylether, the
gelation using TPVA and PEG4AE was faster and with the use of a significantly lower
macromer contents (i.e., 1.6 wt% of PEG4AE with 2.5 wt% TPVA) [150, 246]. This is
likely due to the use of multi-functional TPVA (~10 thiol groups per molecule of
PVA6kDa). Overall, the use of efficient thiol-allylether photoclick reaction produces a
stable βCD-immobilized hydrogel network for subsequent evaluation of hydrogel
stiffening/softening using soluble PEG4AD macromers.
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Figure 6.3. Estimation of βCD-immobilization post-gelation: (A) gel fraction; (B)
normalized thiol concentration measured by Ellman’s assay; and (C) ATR-FTIR
characterization. 2.5 wt% TPVA at 0.8 mM PEG4AE and 27.6 mM βCDAE
(R[allylether]/[thiol] = 0.8) or βCD in the precursor solution (1 mM LAP, 365nm light at 10
mW/cm2).
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To ensure that βCDAE was successfully immobilized within the TPVA-PEG4AE
hydrogel network, we prepared hydrogels using off-stoichiometric ratio of allylether to
thiol (i.e., R[allylether]/[thiol] = 0.8). When compared with gelation using unmodified βCD,
significantly lower free thiol was detected in the presence of βCDAE, indicative of
βCDAE immobilization in the primary hydrogel network post-gelation (Figure 6.3B).
ATR-FTIR characterization results also confirmed the immobilization of βCDAE in the
thiol-allylether hydrogel network (1.5-fold and 34-fold increase in the areas under alcohol
and carbonyl peaks, respectively. Figure 6.3C). We also conducted additional in situ
photorheometry experiments to show that the gelation was indeed due to orthogonal
thiol-allylether reaction between TPVA and PEG4AE and not a result of
homopolymerization of allylether-macromers (i.e., βCDAE and PEG4AE, Figure 6.4A)
or supramolecular ‘threading’ of βCDAE/TPVA or βCDAE/PEG4AE (Figure 6.4B).
Another affirmation that βCD/PVA threading did not occur in this thiol-allylether
gelation system (completing within 5 minutes) is that the threading events are typically
achieved under extreme conditions such as high temperature (e.g., 90 oC), high βCD
concentration (e.g., 70 wt%) or long incubation time (e.g., 2-72 hours) [247-250].
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Figure 6.4. In situ photorheometry showing storage modulus (G’) and loss modulus (G”)
of thiol-allylether photopolymerization (A) at 2.5wt% TPVA and 27.6 mM βCDAE; and
(B) at 0.8 mM PEG4AE and 27.6 mM βCDAE in the precursor solution (1 mM LAP,
365nm light at 10 mW/cm2). Light was turned on at 30 seconds (dotted line).

118

We hypothesized that the reversible association and dissociation between
network-immobilized βCD and soluble multi-functional PEG4AD (MW: 10kDa)
macromer (Figures 6.5A) could increase the crosslinking density, and hence elastic
modulus, of this hydrogel [235, 251]. We first investigated the tunability of hydrogel
stiffness by incubating βCD-immobilized hydrogels in solution containing PEG4AD
(Figure 6.5B) at different concentrations. Since these thiol-allylether hydrogels were
stiffened via host-guest supramolecular assembly, the amount of soluble PEG4AD
supplemented to the βCD-immobilized hydrogels would affect the extent of host-guest
interactions, and hence the degree of stiffening (Figure 6.5C). As expected, hydrogel
stiffness increased from 1.6- to 2-fold when the concentration of PEG4AD was increased
from 2.5 wt% (i.e., 10mM AD) to 5 wt% (i.e., 20mM AD) (Figure 6.5D). However,
further increasing PEG4AD content to 10 wt% (i.e., 40mM AD) did not yield an even
higher degree of stiffening because the concentration of AD at this condition exceeded
the total βCD concentration (i.e., 27.6mM). As a result, additional PEG4AD became
‘pendant’ and did not contribute to the formation of additional crosslinking. We further
evaluated the stiffening effect using TPVA-PEG4AE hydrogels with different initial gel
stiffness. At a fixed TPVA content (2.5 wt%), increasing PEG4AE concentration yielded
hydrogels with higher initial elastic modulus (Figure 6.5E, 0.9 kPa to 4 kPa for 0.6 mM
to 1.1 mM of PEG4AE, respectively). These hydrogels were separately stiffened using
PEG4AD solution. Regardless of the starting equilibrium shear modulus, the stiffening
process yielded hydrogels with significantly increased final elastic moduli (Figure 6.5E,
2.3 kPa to 6.5 kPa). To evaluate the elastic nature of these hydrogels, we conducted
frequency sweep oscillatory rheometry after incubating gels in the absence (Figure 6.6A)
or presence (Figure 6.6B) of soluble PEG4AD. Results show that gel storage modulus
(G’) dominated loss modulus (G”) over the range of frequency tested, indicating the
elastic property of the thiol-allylether hydrogels pre- and post-incubation with PEG4AD.
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kDa) at different concentration. (E) Tuning the initial stiffness and dynamic stiffening of
hydrogels through adjusting the content of PEG4AE in the pre-polymer solution. (Mean
± SD, N = 3, * indicates p<0.05).
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Although results so far show that the range of elastic moduli of hydrogels before
and after PEG4AD-stiffening could be tuned in a physiologically relevant range (i.e.,
elastic moduli ranging from 0.03 to 6 kPa) [216], it is necessary to determine the longterm stability of the in situ stiffened hydrogels. As shown in Figure 6.7A, PEG4ADinduced gel stiffening (from ~2 to 3.5 kPa) could be maintained for more than one month
as long as the βCD-immobilized hydrogels were incubated in PEG4AD-containing
solution. After one month, the moduli of PEG4AD-stiffened gels started to decrease,
which could be attributed to the hydrolysis of ester bonds in PEG4AD macromers (Figure
6.5B). In a separate group where the stiffened hydrogels were transferred back to PBS
following in situ stiffening, elastic moduli of the stiffened hydrogel decreased gradually
(Figure 6.7A, from 3.5 to 2.2 kPa in 48 days), most likely a result of the thermal
relaxation of the host-guest interaction. Control experiments show that hydrogels
incubated in either 4-arm PEG or PBS solution had minimal change in stiffness
throughout the study, suggesting that the specificity of βCD/AD binding is essential in
the stiffening of the hydrogels.
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Figure 6.7. (A) Effect of gel
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Time
(hour) conditions on the elastic modulus of thiolallylether hydrogel. Right panel: timeline for the treatments of hydrogels. (B) Reversibly
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βCD/AD interactions are non-covalent, reversible, and can be disrupted through
thermal relaxation or through a competitive kinetic binding process. We have
demonstrated that PEG4AD-stiffened gels took weeks to soften when placed in PBS
(Figure 6.7A). This softening effect could be attributed to the dissociation and removal of
PEG4AD from pendant βCD over time. Alternatively, a faster gel softening could be
achieved by incubating the PEG4AD-stiffened hydrogels in solution containing
unmodified βCD. Soluble βCD competes with PEG4AD for binding to immobilized
βCD. As a result, the elastic moduli of PEG4AD-stiffened hydrogels incubated in βCD
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solution decreased from 3.1 to 2.3 kPa within 40 hours (Figure 6.7B). When the in situ
softened hydrogels were incubated in PEG4AD solution for another 40 hours, the
hydrogels were stiffened again and the process of stiffening/softening was repeatable
(Figure 6.7B). For gels incubated in either PBS or 4-arm PEG/βCD, the stiffness
remained steady throughout the study (Figure 6.7B).
Comparing to other hydrogels with stiffening or softening potential [62, 209-213],
our dynamic thiol-allylether hydrogel offers a wider range of stiffness tunability (i.e.,
from hundreds to thousands Pascals). For example, Rosales et al. prepared step-growth
Michael-type hydrogels crosslinked with azobenzene-modified peptides that undergo
trans-to-cis isomerization upon UV/visible light exposure [252]. The conformational
change in azobenzene-containing peptide leads to changes in crosslinker length, and
hence gel stiffness was controlled depending on light irradiation conditions. However, the
magnitude of the elastic modulus change reported was about 100-200 Pa. Another
difference between our approach and the light-responsive azobenzene-modified hydrogel
or the secondary photo-crosslinking system was that the stiffening/softening of thiolallylether hydrogels is a more gradual process (i.e., hours in our system vs. minutes in
previous stiffening processes) that should be more relevant to the time scale of most cell
fate processes [212].
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Figure 6.8. Effect of thiol-allylether hydrogel stiffness on the cytocompatibility of MIN6
β-cells. (A) Representative confocal z-stack images of MIN6 cells stained with live/dead
staining kit on day 1 and day 10. MIN6 cells were encapsulated (2×106 cells/mL) in thiolallylether hydrogels. (B) Cells viability as assessed by Alamarblue® reagent. (C)
Normalized insulin mRNA expression on day 10. All gel formulations contained β-cells
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LAP, and 365 nm light at 5 mW/cm2 (Scales: 200 μm).

To evaluate the cytocompatibility of this dynamic thiol-allylether hydrogel
system, we performed in situ encapsulation of pancreatic MIN6 β-cells at a relatively low
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cell density (2×106 cells/mL). This cell density was used because a previous work has
shown that MIN6 cells encapsulated in radical-mediated chain-growth photopolymerized
PEG-diacrylate hydrogels did not survive well if the cell density was below 5×106
cells/mL [149]. We found that the step-growth thiol-allylether polymerization is highly
cytocompatible for MIN6 β-cells as the encapsulated cells were viable regardless of the
initial gel elastic modulus (0.6, 1.5 or 3.5 kPa, Figure 6.8A) [52, 246]. Furthermore, the
encapsulated cells all formed multi-cell spheroids after 10 days of culture. While higher
metabolic activity was detected in cells encapsulated in softer gel at day-10 postencapsulation (Figure 6.8B), insulin mRNA level was lower in these cells (Figure 6.8C).
Specifically, insulin expression was ~1.7-fold and 3.5-fold for soft and stiff gel,
respectively (1-fold: insulin expression in cells encapsulated in 0.6 kPa gels). Another
interesting phenomenon is that the sizes of cell spheroids formed within the stiffer
hydrogels were noticeably smaller than those formed in the softer hydrogels, most likely
because the stiffer hydrogels have higher crosslinking density that restricts the growth of
the cell spheroids. The difference in cell spheroid sizes might be another confounding
factor affecting insulin expression.
The higher insulin expression from cells encapsulated in stiffer hydrogel does not
concord with a previous study conducted by Desai and colleagues, who cultured MIN6 βcells using polymeric microwells with various moduli [163]. The conclusion from that
study was that softer microwells promoted insulin expression in MIN6 β-cells and
isolated islets. The discrepancy between current study and the reported results was likely
due to the difference in cell-matrix interactions, because microwell does not provide
uniform matrix contact for the cells. Furthermore, the function of β-cells in static thiolallylether hydrogels might be affected by different amounts of radicals formed during cell
encapsulation, different gel elastic moduli post-gelation, and/or different cell spheroids
sizes.
Using the thiol-allylether dynamic hydrogel system, it is possible to study the
influence of gel stiffness on cell fate without introducing additional radicals post cell
encapsulation and without the confounding factor of cell spheroid sizes. Here, we
encapsulated MIN6 β-cells in βCD-immobilized thiol-allylether hydrogels and cultured
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the cells for 5 days to allow the formation of multi-cell spheroids (Figure 6.11A,
condition ii). After in situ gel stiffening (Figure 6.9, from 1.8 kPa to 2.5 kPa), the
viability of cells was evaluated using live/dead staining. Compared to cell-laden gels that
did not undergo stiffening, cells encapsulated in PEG4AD stiffened gels had slightly
more cell death as revealed by the confocal images of live/dead stained MIN6 β-cells
(Figure 6.11A). Quantitative ATP assay showed a reduction (not statistically significant)
in total intracellular ATP when cell-laden hydrogels were subjected to PEG4AD (Figure
6.11B, ~250 and 220 pmol of ATP/gel with and without exposure to PEG4AD,
respectively). Since the concentration of PEG4AD selected was within the non-cytotoxic
range (Figure 6.10A) and cells remained viable post-stiffening (Figure 6.11A), it is
highly plausible that the increased gel stiffness altered intracellular metabolism/signalling
that led to a lower intracellular ATP content. More interestingly, MIN6 β-cells
encapsulated in PEG4AD-stiffened gels had a 1.5-fold higher insulin mRNA level when
compared with cells encapsulated in gels that did not undergo stiffening process (Figure
6.11C). Results from control experiments show that PEG or PEG4AD did not induce upregulation of insulin mRNA (Figure 6.10B). The effect of softening on cell fate was
evaluated by incubating PEG4AD-stiffened gels in media containing βCD for 3 days
(Figure 6.9). Compared to control gels that were not exposed to PEG4AD or βCD (Figure
6.11A, condition iii), MIN6 cells encapsulated in hydrogel that underwent
stiffening/softening had similar viability (Figure 6.11A, condition iv) and ATP content
(Figure 6.11B, ~180 pmol/gel). More importantly, there was a reduction in insulin
mRNA expression after in situ softening (Figure 6.11C, from 1.5 to 1.2-fold for condition
(ii) and (iv), respectively), suggesting that the effect of matrix mechanics on insulin
expression can be reversed upon softening of the hydrogel matrix.
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Figure 6.9. Effect of PEG4AD and βCD on the stiffening and softening of thiol-allylether
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Figure 6.10. (A) Effect of PEGAD on the cytocompatibility of MIN6 β-cells. Cells
viability as assessed by MTT. PEGAD (10 kda) was used. (B) Effect of PEG4AD (10
kDa) on the Ins mRNA expression. Cells were all cultured on 2D TCP.
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Figure 6.11. Effect of PEG4AD stiffening and βCD softening on the cytocompatibility
and functions of MIN6 β-cells. (A) Representative confocal z-stack images of MIN6 cells
stained with live/dead staining kit on day 8 with or without PEG4AD stiffening (i & ii)
and on day 11 with or without βCD softening (iii & iv). (B) Cells viability as assessed by
CellTiter Glo® reagent. (C) Insulin mRNA expression was normalized to condition (i).
All gel formulations contained 2.5 wt% TPVA, 0.8 mM PEG4AE and 27.6 mM βCDAE,
1 mM LAP, 2×106 cells/mL, and 365 nm light at 5 mW/cm2 (Scales: 200 μm). Mean ±
SD, N = 3, * or # indicate p<0.05 compared to condition i and iii, respectively.
Since the stiffening and softening of cell-laden thiol-allylether hydrogel did not
introduce additional radicals and did not change the size of cell spheroids significantly, it
is indicative that the insulin expression was affected in large part due to matrix stiffness.
We hypothesize that the up-regulation of insulin in cells encapsulated in stiffened
hydrogels was a collective result of altered cell-cell interactions [253-255], hypoxiarelated gene expression [256, 257], or stiffness-induced mechanotransduction in the cells.
In the stiffened gels, tighter gel networks might constrain the encapsulated cells to make
close contact with their neighboring cells. Furthermore, the stiffened matrix may alter
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other molecular targets downstream of mechanosensing pathways. While further
investigations are required to elucidate the molecular mechanisms by which matrix
stiffness affects mechanotransduction in cells encapsulated in this dynamic hydrogel, the
current work demonstrates the concept and potential of using supramolecular host-guest
interactions to tune matrix stiffness in cell-laden hydrogels.

6.4 Materials and Methods

Materials: 4-arm PEG-OH (10 and 20 kDa) was purchased from JenKem Technology
USA. Poly(vinyl alcohol) (PVA, 6 kDa), 3-mercaptopropionic acid (MPA), βCD, 1adamantaneacetic acid and all other chemicals were obtained from Fisher Scientific
unless noted otherwise.
Synthesis of βCDAE, LAP, TPVA and PEG macromers: Poly(ethylene glycol)-tetraallylether (PEG4AE, 20 kDa), poly(ethylene glycol)-adamantane (PEG4AD, 10 kDa),
allylether functionalized βCD (βCDAE),[246] and photoinitiator lithium acylphosphinate
(LAP) were synthesized using established protocols without modifications.[38]
Functionalized βCDAE was analyzed with

1

H NMR (Figure 6.2A) and mass

spectrometry (Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS, Figure 6.2B).
TPVA was synthesized followed established protocol with modified purification
method.[258, 259] Briefly, mixture of hydrochloric acid (5 ml, 12 N) and MPA (25 mL)
was added slowly into PVA (5 g) pre-dissolved in 50 mL ddH2O at 60 oC. After 24 hours
of reaction (60 oC), the product was transferred to a dialysis bag (MWCO: 3600 Da,
Spectrum lab) and dialyzed for 3 days in slightly acidic ddH2O (pH 6.5). The TPVA
product was recovered and lyophilized. The degree of thiolation was quantified by
Ellman’s assay to be about 16 mM of thiol per wt% of TPVA (Figure 6.12).
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4-arm PEG-allylether (PEG4AE, 20 kDa) was synthesized following a published
protocol. Briefly, 4-arm PEG (20 kDa) was dissolved in anhydrous toluene, and dried
with evaporation by reduced pressure. Dried PEG was re-dissolved in anhydrous
tetrahydrofuran (THF). Sodium hydride (1.5-fold excess of hydroxyl group) was added
slowly to the PEG solution under continuous nitrogen purging at 40 °C. Upon complete
liberation of hydrogen gas, allylbromide (6-fold excess of hydroxyl group) was added
slowly to the solution. After overnight reaction in dark, sodium bromide salt was filtered
off to obtain a PEG4AE solution. PEG4AE was precipitated in cold ethyl ether, filtered
and dried in vacuuo. The purity of PEG4AE product was verified with H1 NMR in CDCl3
(Figure 6.13A, 90 %, Bruker 500). 4-arm PEG-adamantane (PEG4AD, 10 kDa) was
synthesized following an established protocol. In brief, 4-arm PEG and glassware were
dried overnight in vacuum oven. Under continuous stirring and purging with nitrogen,
dried PEG was dissolved in anhydrous dichloromethane (DCM). A required amount of 1adamantaneacetic acid (2-fold excess of hydroxyl group), 4-dimethylaminopyridine
(DMAP, 1-fold of hydroxyl group) and N,N-diisopropylcarbodiimide (DIC, 4-fold excess
of hydroxyl group) were added to PEG solution. After an overnight reaction, PEG4AD
was filtered, precipitated in cold ethyl ether and dried in vacuuo. Dried PEG4AD was
redissolved in ddH2O, filtered and transferred to a dialysis bag. After two days of dialysis
in slightly acidic ddH2O (~pH 6.8), PEG4AD were freeze-dried. The purity of PEG4AD
product was verified with H1 NMR in CDCl3 (Figure 6.13B, >95 %, Bruker 500).
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Hydrogel fabrication and reversible stiffening: Thiol-allylether hydrogels (45
μL/gel) were formed by light mediated photo-click reactions using precursor
solution prepared in the order of mixing pH 7.4 PBS, 1 mM LAP, PEG4AE,
βCDAE and TPVA. Immediately after mixing the components, solution was
injected in between two glass slides separated by 1 mm thick spacers. Hydrogel
slabs were prepared by exposing the solution to 365 nm light at 10 mW/cm 2 for 5
minutes. The elastic moduli (G’) of hydrogels were measured after 48 hours of
swelling in PBS at 37 oC. Hydrogel stiffening was achieved by incubating βCDimmobilized hydrogels in PEG4AD solution (48-well plate, 200 μL/well/gel) and
placed on an orbital shaker (130 rpm) for 40 hours unless mentioned otherwise.
After measuring the stiffness of hydrogels, gels were placed in either pH 7.4 PBS
or 1 wt% of βCD (48-well plate, 400 μL/well/gel) for softening.

Rheometry: For rheometrical property measurements, hydrogel discs (8 mm in diameter
and 1 mm in height) were fabricated as described previously and placed in pH 7.4 PBS
for 48 hours. Frequency sweep (0.01 to 10 Hz, at 1 % strain) and strain sweep (0.1 % to
5 %, at 1 Hz frequency) oscillatory rheometry were performed on a Bohlin CVO 100
digital rheometer. Shear moduli of the hydrogels were measured using a parallel plate
geometry (8 mm) with a gap size of 750 μm. The average of elastic moduli obtained from
the linear viscoelastic region (LVR) was reported. In situ gelation rheometry for
hydrogels was conducted in a light cure cell using a parallel plate geometry (25 mm) at
room temperature. Briefly, the macromer solution was placed on a quartz plate in the
light cure cell, and irradiated with liquid light guide (365 nm, 10 mW/cm2). Light was
turned on 30 seconds after the time sweep in situ rheometry (5 % strain, 1 Hz frequency,
and a gap size of 90 μm). Gel point was determined at the time when G’ surpassed loss
modulus (G”).
βCDAE immobilization efficiency: Following hydrogel preparation procedure as
described previously, hydrogels (30 µL/gel) were fabricated using syringes with cut-off
tips as molds. Hydrogels were synthesized in the presence of βCDAE or non-modified
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βCD. To detect the concentration of non-reacted thiol after photopolymerization reaction,
immediately after gel polymerization, hydrogels were individually placed in 48-well plate
containing Ellman’s reaction buffer (300 µL/well/gel). After 30 minutes of incubation at
room temperature, these collected Ellman’s reaction buffer was compared against a
standard curve with known cysteine concentrations. In a separate experiment,
immediately after polymerization, hydrogels were dried in a desiccator and the first dry
mass were obtained. After incubating gels in ddH2O for a day to allow sol fraction to
leach out, gels were dried and the second dry mass were measured. Gel fraction of
hydrogel was reported as the percentage of the second dry weight to the first dry weight.
Furthermore, ATR-FTIR was used to detect the presence of immobilized βCDAE in the
hydrogel.
Cytocompatibility of βCD and PEGAD: MIN6 β-cells were cultured on 96-well tissue
culture treated plate for two days at 37 oC and 5 % of CO2. β-cells were treated with
different concentrations of soluble βCD and PEGAD (10 kDa) dissolved in media (highglucose DMEM with L-glutamine and sodium pyruvate, 10 % FBS, β-mercaptoethanol
and antibiotic-antimycotic) at 37 oC and 5 % of CO2. After incubating for 40 hours, βCD
and PEGAD containing media were removed, cells were supplemented with media
containing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) at 37 oC
and 5 % of CO2 (100 μL/well). After 4 hours of incubation, dimethyl sulfoxide (DMSO,
100 μL/well) was added to wells, and plate was further incubated in oven for 10 minutes
(at 60 oC). The absorbance was measured at 540 nm and DMSO was used as a blank.
Cell encapsulation and cytocompatibility: MIN6 β-cells (final density 2×106 cells/mL)
was suspended in polymer solutions (i.e., PBS, LAP, PEG4AE, βCDAE and TPVA) and
exposed to light for 5 minutes (365 nm at 5 mW/cm2). These MIN6 cell-laden hydrogels
(20 μl/gel) were cultured in growth media (high-glucose DMEM with L-glutamine and
sodium pyruvate, 10 % fetal bovine serum (FBS), β-mercaptoethanol and antibioticantimycotic) and maintained at 37 oC and 5 % of CO2. Fresh media was changed every
two days. After a week, cell-laden hydrogels were transferred to 48-well plate (2
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gels/well), supplemented with media containing 5 wt% of PEG4AD (200 μL/well), and
placed on a rotary platform in 37 oC and 5 % of CO2 for 3 days. For quantitative cell
viability study, cell-laden hydrogels were incubated in 500 μL Alamarblue® reagent (10
% in cell culture medium; AbD Serotec) at 37 oC and 5 % of CO2. After 16 hours of
incubation, 200 μl of incubated Alamarblue® media was transferred to a transparent 96well plate. Using a microplate reader, the Alamarblue® fluorescence (excitation: 560 nm
and emission: 590 nm) due to cell metabolic activity was determined. Cell viability was
quantified by CellTiter Glo® assay (Promega). In addition, confocal imaging (FV1000
Laser Scanning Biological Microscope) of cell-laden hydrogels were stained with
Biotium live/dead kit (Calcein AM stained live cells green and Ethidium homodimer-1
stained dead cells red) for an hour and washed with HBSS for 10 minutes. The confocal
imaging was performed with a step size of 10 μm for a total image thickness of 100 μm.
In preparation for RNA isolation, cell-laden gels were rapidly frozen using liquid
nitrogen and stored in -80 oC until use. Collected samples were processed following
NucleoSpin® RNA protocols (Clontech). The concentrations of pure RNA were
determined using NanoDrop 2000 Spectrophotometer (Thermo Scientific). Reverse
transcription PCR (rt-PCR) was performed on Applied Biosystems 2720 Thermal Cycler
to convert RNA into cDNA using PrimeScriptTM RT Reagent Kit (Clontech). cDNA
samples were further prepared with SYBR Premix Ex Taq II kit (Clontech) and primers
(Sigma-Aldrich, Table S1) for quantitative real time PCR (Applied Biosystems 7500 Fast
Real-Time PCR machine).
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Table 6.1. Mouse primer sequences used in real time PCR.
Gene Symbol

Primer Sequence

Reference

ACCCTTCACCAATGACTCCTATG
Tbp

[205]
ATGATGACTGCAGCAAATCGC
TGGCTTCTTCTACACACCCAAG

Ins

[206]
ACAATGCCACGCTTCTGCC

6.5. Conclusion
In summary, we have synthesized a step-growth thiol-allylether photopolymerized
hydrogel containing chemically immobilized βCD that complexes with soluble PEG4AD
to form a dynamic hydrogel network with tunable stiffness. Thiol-allylether hydrogels
crosslinked by TPVA, PEG4AE, and βCDAE exhibited rapid gelation kinetics and high
tunability in crosslinking density. The process of gel stiffening/softening was repeatable
by exposing gels in either PEGAD or βCD solutions, respectively. Most importantly,
MIN6 β-cell fate is regulated in hydrogels that are stiffened in situ. Thiol-allylether
hydrogel with immobilized βCD provided a wider range of stiffness tunability over
existing dynamic hydrogels, and should be of great interest for studying the influence of
biomechanical properties on cell fate processes.
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CHAPTER 7
CONCLUSIONS AND RECOMMENDATION

In

summary,

thiol-ene

hydrogels

formed

by

radical

mediated

photopolymerizations have emerged as a versatile biomaterial platform for controlled
release of therapeutics and tissue engineering applications. Thiol-ene hydrogels have
improved network crosslinking than the conventional chain-growth PEGDA and stepgroth Michael-type addition hydrogels. Type I and type II photoinitiator can be used to
prepared thiol-ene hydrogels via UV light or visible light irradiation, respectively. In
addition, thiol-ene hydrogels can be rendered completely non-degradable, or degradable
only by hydrolysis, proteolysis, photolysis, or by the combination of different
mechanisms. The diverse gelation and degradation of thiol-ene hydrogels offer
researchers a new platform to design hydrogel matrices suitable for protein delivery and
three dimensional cell culture. Using this thiol-ene hydrogelation scheme, the following
objectives were met:

Objective

1:

Establish

a

visible

light

mediated

interfacial

thiol-ene

photopolymerization for microencapaulation of islets. I have developed a visible lightmediated thiol-norbornene interfacial coating process to prepare step-growth conformal
hydrogel coating on islet surface. Using MIN6 -cell aggregates as a model, I evaluated
the parameters critical in determining coating thickness (e.g., molecular weight of
PEGdSH, polymerization time, and macromer concentration). The results of live/dead
staining and GSIS demonstrated high cytocompatibility of thiol-ene hydrogel coating on
murine islets. This visible light mediated thiol-ene interfacial photopolymerization
provides an alternate coating option and should be of great interest to the field of islet
transplantation. Future work will focus on modifying thiol-ene gel formulation to create
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multi-functional immuno-isolation barrier, and ondetermining the inflammatory response
and long-term efficacy of the transplanted coated islets on maintaining euglycemia.

Objective 2: Synthesize biomimetic and anti-inflammatory thiol-ene hydrogel for
macroencapsulation of β-cells. Step-growth thiol-ene photopolymerized hydrogel was
synthesized using derivatives of βCD and PEG. Thiol-norbornene hydrogels crosslinked
by βCD-SH and PEGNB exhibited faster gelation kinetics and higher crosslinking
efficiency when comparing with thiol-allylether hydrogels crosslinked by PEGSH and
βCD-AE. Furthermore, the gelation kinetics of thiol-norbornene depended highly on the
functionality of macromer used. In addition, βCD/PEG hydrogels afforded higher
loading, as well as prolonged and sustained delivery, of hydrophobic curcumin. The
results of live/dead staining, cell viability assay, and GSIS demonstrated that cell viability
was maintained in these hydrogels, but in some cases affected by hydrogel properties
(e.g., stiffness).

In addition, I have explored the crosslinking of various bis-cysteine containing
peptides with macromer 8-arm PEGNB to form biomimetic hydrogels suitable for in situ
cell encapsulation. Initial efforts to polymerize thiol-norbornene PEG-peptide hydrogels
through visible light and eosin-Y mediated crosslinking encountered challenges in
gelation efficiency. During the optimization processes, I found that the addition of
soluble tyrosine during polymerization significantly improved the crosslinking efficiency
of PEG-peptide hydrogels. Furthermore, soluble tyrosine drastically enhanced the
cytocompatibility of the resulting PEG-peptide hydrogels, as demonstrated by in situ
encapsulation and culture of pancreatic β-cell line (MIN6) and primary mouse islets.
Objective 3: Investigate the effect of biomechanical stimulus on the survival of βcells. A step-growth thiol-allylether photopolymerized hydrogel containing chemically
immobilized βCD that complexes with soluble PEG4AD to form a dynamic hydrogel
network with tunable stiffness. Thiol-allylether hydrogels crosslinked by TPVA,
PEG4AE, and βCDAE exhibited rapid gelation kinetics and high tunability in
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crosslinking density. The process of gel stiffening/softening was repeatable by exposing
gels in either PEGAD or βCD solutions, respectively. Most importantly, MIN6 β-cell fate
is regulated in hydrogels that are stiffened in situ. Thiol-allylether hydrogel with
immobilized βCD provided a wider range of stiffness tunability over existing dynamic
hydrogels, and should be of great interest for studying the influence of biomechanical
properties on cell fate processes. Future work will focus on evaluating the molecular
mechanisms by which matrix stiffness affects mechanotransduction, cell-cell interactions
and their correlations with insulin expression in β-cells.
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